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caregiver role may be acutely stressful. Little is known, however, about caregivers' experiences in the very early
period of caregiving or how caregiver stress may contribute subsequently to health. The purpose of this study
was to examine the effect of uncertainty on caregiver perceived and physiological stress and psychological
outcomes (burden, health-related quality of life [HRQOL] and depressive symptoms) within 2 weeks
poststroke (baseline) and at 6 weeks poststroke. In addition, the mediator effect of stress on the relationship
between uncertainty and psychological outcomes was explored. A prospective, longitudinal observational
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at 6 weeks poststroke (p < 0.001). Uncertainty, however, was not a significant predictor of physiological stress
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poststroke, perceived stress fully mediated the relationship between uncertainty and depressive symptoms.
Healthcare providers in neuroscience must become sensitized to caregiver uncertainty in the early period of
caregiving. Using uncertainty as a predictor may help identify caregivers at risk for stress, burden, poor
HRQOL or depressive symptoms, that is, those in need of additional support. Further research exploring
uncertainty and the development and testing of target interventions for it may reduce the early uncertainty
and stress of caregivers of stroke survivors and prevent negative longer term health outcomes.
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ABSTRACT 
EFFECTS OF UNCERTAINTY ON PERCEIVED AND PHYSIOLOGICAL STRESS 
AND PSYCHOLOGICAL OUTCOMES IN STROKE-SURVIVOR CAREGIVERS 
Eeeseung Byun 
Lois K. Evans 
Barbara J. Riegel 
Caregiver status is a known risk factor for morbidity and mortality. In the time period 
immediately after a stroke, high levels of uncertainty about the family member’s recovery 
and the sudden assumption of a new caregiver role may be acutely stressful. Little is 
known, however, about caregivers’ experiences in the very early period of caregiving or 
how caregiver stress may contribute subsequently to health. The purpose of this study 
was to examine the effect of uncertainty on caregiver perceived and physiological stress 
and psychological outcomes (burden, health-related quality of life [HRQOL] and 
depressive symptoms) within 2 weeks poststroke (baseline) and at 6 weeks poststroke. In 
addition, the mediator effect of stress on the relationship between uncertainty and 
psychological outcomes was explored. A prospective, longitudinal observational study 
was conducted using a convenience sample of 63 caregivers and their stroke-survivor 
relatives recruited from acute-care settings in two academic health-science centers. 
Multivariate stepwise regression was used to achieve the overall aim of this study. 
Additionally, multivariate regression was used to explore the mediator effect of stress on 
the relationship between uncertainty and psychological outcomes. Level of uncertainty at 
baseline was higher than reported in several other caregiver populations and it remained 
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so at 6 weeks poststroke. Greater level of uncertainty was associated with higher 
perceived stress at baseline (p < 0.001) and at 6 weeks poststroke (p < 0.001). 
Uncertainty, however, was not a significant predictor of physiological stress at either time 
point. Overall, greater uncertainty was associated with greater burden (p < 0.001 at 
baseline and p = 0.031 at 6 weeks poststroke), poorer HRQOL (p < 0.001 at baseline and 
p = 0.023 only in univariate analysis at 6 weeks poststroke) and greater depressive 
symptoms (p = 0.002 at both observations). By 6 weeks poststroke, perceived stress fully 
mediated the relationship between uncertainty and depressive symptoms. Healthcare 
providers in neuroscience must become sensitized to caregiver uncertainty in the early 
period of caregiving. Using uncertainty as a predictor may help identify caregivers at risk 
for stress, burden, poor HRQOL or depressive symptoms, that is, those in need of 
additional support. Further research exploring uncertainty and the development and 
testing of target interventions for it may reduce the early uncertainty and stress of 
caregivers of stroke survivors and prevent negative longer term health outcomes. 
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CHAPTER 1: INTRODUCTION 
In the United States, approximately 66 million people serve as informal caregivers 
of family members or friends who are older, chronically ill or disabled (National Alliance 
for Caregiving and AARP, 2009). Caregiver status is a known risk factor for morbidity 
and mortality (Haley, Roth, Howard, & Safford, 2010; Schulz & Beach, 1999). Further, 
immune-system suppression in caregivers is quite common (Bauer et al., 2000) and a 
meta-analysis reports that stress hormones such as cortisol are elevated in caregivers 
(Vitaliano, Zhang, & Scanlan, 2003). Although the literature on the long-term effects of 
caregiving is well developed, little is known about either the immediate period (within 
the first 2 weeks) when a family or friend initially assumes the caregiver role, or the long-
term consequences for caregivers of their experiences during this period. To better 
understand what occurs during this early period, which may impact caregiver outcomes, I 
studied stroke-survivor caregivers. This population exemplifies those who encounter the 
uncertainties and other stressors associated with a family member’s sudden, serious 
health event (Brereton & Nolan, 2002; Burman, 2001; Forsberg-Warleby, Moller, & 
Blomstrand, 2001; Hunt & Smith, 2004; O’Connell, Baker, & Prosser, 2003) and 
subsequent caregiver-role assumption. Caregiving in this population is associated with 
stressors related to both physical and psychological health as well as related morbidities 
and illness-related symptoms, such as depression (Anderson, Linto, & Stewart-Wynne, 
1995; Bauer et al., 2000; Berg, Palomaki, Lonnqvist, Lehtihalmes, & Kaste, 2005; Blake, 
Lincoln, & Clarke, 2003; Burman, 2001; Forsberg-Warleby, Moller, & Blomstrand, 
2002; McCullagh, Brigstocke, Donaldson, & Kalra, 2005; Pierce, Steiner, Hicks, & 
Holzaepfel, 2006; White, Mayo, Hanley, & Wood-Dauphinee, 2003), hypertension and  
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angina (White et al., 2003). 
Background 
Stroke is a common global phenomenon, with more than 15 million stroke cases 
annually worldwide (Mackay & Mensah, 2004). Stroke caregiving is also an important 
public health problem in the United States where approximately 795,000 new or 
recurring strokes occur each year. Of these, a large proportion—65%—occurs among 
adults aged 65 and older (Lloyd-Jones et al., 2009). More than 7 million stroke survivors 
live with poststroke effects in the United States (National Stroke Association, 2013), and 
40% have permanent moderate-to-severe impairments (National Stroke Association, 
2013). Because of these impairments and associated functional deficits (Forsberg-
Warleby et al., 2001, 2002; Visser-Meily et al., 2009), stroke survivors often require 
assistance from caregivers in performing activities of daily living. Because stroke is 
usually a sudden event, family members must abruptly assume the role of informal 
caregiver without an opportunity to adjust. In contrast, family members of persons with a 
chronic illness can more gradually adapt to the caregiver role. These differences in 
caregiver populations warrant further investigation. 
In the United States, the length of stay in the hospital after stroke averages 5.7 
days; within 30 days, all stroke survivors will have been discharged to home (31%), 
home with home-health services (15%), rehabilitation hospitals (20%) and/or skilled 
nursing facilities or other long-term care (34%; Kind, Smith, Frytak, & Finch, 2007). 
Given that caregivers need to assume their new role as informal caregivers in a relatively 
short period of time, they may experience uncertainty, stress and early signs of burden 
associated with these new caregiving experiences. A beginning literature review 
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suggested that burden may be present as early as 10 days to 30 days poststroke (Bugge, 
Alexander, & Hagen, 1999; Forsberg-Warleby et al., 2001, 2002). Not surprisingly, 
caregivers report physical and physiological health problems when measured months to 
years after their relative’s stroke event (Anderson et al., 1995; Berg, Palomaki, 
Lehtihalmes, Lonnqvist, & Kaste, 2003; Berg et al., 2005; White, Lauzon, Yaffe, & 
Wood-Dauphinee, 2004). 
Informal caregivers contribute “activities and experiences that provide help and 
assistance to relatives or friends who are unable to provide for themselves” (Pearlin, 
Mullan, Semple, & Skaff, 1990, p. 583). The general literature on caregiving 
demonstrates several stress-related outcomes including higher mortality rates in those 
with greater emotional strain (Schulz & Beach, 1999), increased risk for stroke in spousal 
caregivers reporting higher strain (Haley et al., 2010) and increased coronary heart 
disease in female spousal caregivers (S. Lee, Colditz, Berkman, & Kawachi, 2003). 
Perceived stress (self-reported) is typically reflected in physiological stress, 
including elevated neuroendocrine mediators such as cortisol and norepinephrine 
(Morgan et al., 2002). Acute stress is associated with a disruption in circadian rhythms 
(Feve-Montange et al., 1981) and, after exposure to acute stress, elevated levels of 
plasma and salivary cortisol (Morgan et al., 2002). In a laboratory study of caregivers 
whose spouses suffered from dementia, Cacioppo et al. (2000) found that when 
caregivers were exposed to a stressor, they had higher blood pressures and heart rates 
than noncaregivers. These results signify higher sympathetic activation (Cacioppo et al., 
2000), which is indicative of acute stress response. It is not known, however, whether 
stress hormones are elevated in caregivers experiencing acute stress in a natural or 
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clinical environment (vs. the laboratory) or in those caring for persons with disorders 
other than dementia, a question explored in the present study. 
Among psychological outcomes for stroke-survivor caregivers, prevalence of 
depression is known to be high (23% to 33%; Berg et al., 2005; Blake et al., 2003) and 
longer term outcomes include caregiver burden (Blake et al., 2003; Bugge et al., 1999; 
Forsberg-Warleby et al., 2001; Tooth, McKenna, Barnett, Prescott, & Murphy, 2005) and 
decreased health-related quality of life (HRQOL; White et al., 2004). 
A study of caregivers’ responses in the early poststroke period is critical to 
understanding the role of uncertainty and stress as potentially modifiable factors affecting 
caregiver health outcomes. There is currently little information that addresses the 
relationship between caregiver uncertainty and psychological outcomes. This study adds 
to the body of knowledge about the early period of caregiving by including, at two 
distinct time points, measures of uncertainty as well as perceived and physiological stress 
and caregiver psychological outcomes. 
Purpose 
The high levels of uncertainty about both the family member’s recovery following 
a stroke and the sudden assumption of a new caregiver role may be acutely stressful, and 
yet little is known about the caregivers’ experience in the first 2 to 6 weeks of caregiving 
or how it may contribute subsequently to caregivers’ health. Thus, the overall purpose of 
this study was to examine the effect of uncertainty on caregiver perceived and 
physiological stress and psychological outcomes (burden, HRQOL and depressive 
symptoms) within the first 6 weeks of caregiving following a sudden, serious health event 
in a family member: stroke. 
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Aims and Hypotheses 
I implemented a prospective, longitudinal observational study design during the 
time period immediately poststroke (within 2 weeks, T1) and 4 weeks later (when stroke 
survivors were at home, in rehabilitation hospitals or in nursing facilities, T2) to study the 
following aims: 
Aim 1: Determine at each time point if uncertainty (regarding stroke survivors’ 
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress. 
H1: At each time point, greater uncertainty scores will be positively associated 
with higher levels of perceived stress. 
Aim 2: Determine at each time point if uncertainty predicts levels of caregivers’ 
physiological stress (salivary cortisol). 
H2: At each time point, greater uncertainty scores will be positively associated 
with elevated levels of salivary cortisol. 
Aim 3: Examine at each time point the relationship of uncertainty to 
psychological outcomes (burden, HRQOL and depressive symptoms). 
At each time point, greater uncertainty scores will be positively associated with 
H3: greater burden, 
H4: poorer HRQOL and 
H5: greater depressive symptoms. 
Aim 4: Explore at each time point the mediator effect of stress (perceived stress 
and physiological stress) on the relationship between uncertainty and psychological 
outcomes (burden, HRQOL and depressive symptoms). 
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At each time point, perceived stress and salivary cortisol will mediate the 
relationship between uncertainty and 
H6: burden, 
H7: HRQOL and 
H8: depressive symptoms. 
Significance of the Study 
The uncertainty associated with the early caregiving experience (within the first 6 
weeks of the sentinel event) may predict the caregiver’s experience and its consequences 
over time. If uncertainty during this period is found to contribute significantly to stress, it 
may be possible to develop interventions to reduce uncertainty and thereby contribute to 
healthier outcomes for caregivers over time. For example, persons with higher levels of 
baseline uncertainty had higher levels of anxiety and depression and lower levels of 
perceived control and HRQOL 1 year after angiography compared to those with lower 
levels of baseline uncertainty (Eastwood, Doering, Roper, & Hays, 2008). Thus, the study 
results could inform early interventions that may have long-term impact. Further, the 
study contributes important information regarding perceived and physiological stress 
during the early caregiving experience and its association with uncertainty and with 
psychological outcomes of caregiving. 
In addition, it is not known whether stress hormones are elevated in caregivers of 
stroke survivors or, indeed, among any caregivers experiencing new, acute stress. By 
including direct measures of salivary cortisol as well as measures of caregiver 
psychological, behavioral and environmental factors that influence hypothalamic-
pituitary-adrenal reactivity (HPA) in the brain, any change that occurs in the early period 
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of caregiving can be further illuminated (Pearlin et al., 1990) and, perhaps, suggest areas 
for further intervention. For example, a stress-management program targeting areas 
related to stress revealed in this study may reduce caregiver perceived stress and elevated 
cortisol levels and prevent stress-related illnesses. 
Understanding the impact of caregiver uncertainty on perceived stress, 
physiological stress and psychological outcomes in the early weeks of caregiving is 
essential in designing a future intervention study aimed at preventing related morbidities 
in caregivers. Further, timely intervention resolving uncertainty and reducing caregiver 
stress may help family members better cope in their role as informal caregivers and result 
in better health outcomes for themselves and the stroke survivor. 
Given the high prevalence of stroke, efforts to shore up the informal-caregiving 
system, which may reduce healthcare costs by protecting the health of family caregivers, 
are vital to public health. These findings also may be salient in a variety of other 
caregiving situations when care recipients experience a sudden or serious health event, 
such as brain injury or myocardial infarction. 
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CHAPTER 2: REVIEW OF LITERATURE 
This chapter comprises a synthesis and evaluation of the existing literature on 
family caregivers of stroke survivors and suggests fruitful areas for confirmation or 
further exploration. The chapter is organized into four sections. Section one is the 
conceptual framework for this study. Section two is a discussion of each of the main 
variables in the study described from the perspective of existing literature: (a) uncertainty 
and its relationship to perceived and physiological stress and psychological outcomes 
including caregiver burden, health-related quality of life (HRQOL) and 
depression/depressive symptoms; (b) stress including perceived and physiological stress; 
(c) psychological outcomes including caregiver burden and HRQOL and 
depression/depressive symptoms; and (d) relevant caregiver and stroke-survivor 
characteristics. Section three provides a summary of known factors affecting caregiver 
outcomes. Finally, a summary of gaps in the literature and the current study solutions are 
presented. 
Conceptual Framework 
Mishel’s uncertainty-in-illness model (Mishel, 1988) and Schulz’s caregiver-
coping model (Schulz, Tompkins, & Rau, 1988) informed the conceptual framework 
proposed to explore how uncertainty may influence caregiver perceived stress, 
physiological stress and longer term psychological outcomes including burden, HRQOL 
and depressive symptoms. Mishel’s model explains that uncertainty occurs when decision 
makers cannot define meaning for illness-related events, predict what will happen next or 
predict the consequences from the event (Mishel, 1981). Uncertainty is a neutral concept 
that can be perceived either as danger or opportunity (Mishel, 1981, 1988). When 
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perceived as danger, people cope by trying to adapt to the situation and thereby resolve 
uncertainty (Mishel, 1997a). 
In addition to Mishel’s uncertainty-in-illness model (Mishel, 1988), Schulz’ 
caregiver-coping model, used with caregivers for stroke survivors (Schulz et al., 1988), 
suggested the majority of variables used in this study. Schulz’ caregiver-coping model 
identifies patient characteristics (e.g., functional status including independence in 
activities of daily living, patient affective state, manifestations of disability and 
prognosis) and caregiver characteristics (e.g., health, income, social support, satisfaction 
with social contacts and coping strategies) affecting both caregiver perceived stress and 
caregiver outcomes (psychological well-being, life satisfaction, depression and physical 
well-being) as responses to that stress. 
The resulting proposed conceptual framework (see Figure 1) specifies the 
relationships among the main variables of interest: uncertainty, caregiver stress 
(perceived and physiological stress) and psychological outcomes (burden, HRQOL and 
depressive symptoms). Uncertainty is directly associated with caregiver stress (perceived 
and physiological [salivary cortisol]). In addition, uncertainty is believed to directly 
affect psychological outcomes and also to have an indirect impact on these outcomes 
through their effects on caregiver stress, adjusting for covariates. Caregiver stress 
(perceived and physiological [salivary cortisol]) is also directly associated with 
psychological outcomes (burden, HRQOL and depressive symptoms), adjusting for 
covariates. Known covariates affecting stroke-survivor caregiver outcomes include 
caregiver characteristics (comorbidity, coping capacity, social support and 
sociodemographics) and stroke-survivor characteristics (severity of stroke, functional  
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status, comorbidity and sociodemographics). 
 
 
Figure 1. Conceptual framework. 
Note. Derived from Mishel’s Uncertainty-in-Illness Model (Mishel, 1988) and Schulz’s Caregiver-Coping 
Model (Schulz et al., 1988). 
Uncertainty 
According to the uncertainty-in-illness model, uncertainty is defined as the 
“inability to determine the meaning of illness-related events” (Mishel, 1988, p. 225) and 
includes four dimensions: (a) ambiguity about the illness state; (b) complexity regarding 
available information, treatment, the healthcare system and relationship with healthcare 
providers; (c) lack of information about the diagnosis, seriousness of the illness, 
treatment and symptoms; and (d) unpredictability of the illness course and prognosis 
(Mishel, 1988). When people perceive uncertainty as danger, they try to cope with the 
situation and resolve uncertainty, for example, by seeking knowledge or information or 
adopting health-promoting behavior (Mishel, 1997a). Caregivers of stroke survivors are 
not certain what to expect either in the disease trajectory or how fully the stroke survivor 
will recover (Brereton & Nolan, 2002; Forsberg-Warleby et al., 2001; Hunt & Smith, 
2004; O’Connell et al., 2003). Uncertainty arises when the decision maker cannot 
anticipate outcomes because of lack of resources or information (Mishel, 1997a). 
Caregivers’ uncertainty about stroke survivors’ outcomes from lack of information or 
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knowledge may be heightened because of the very real difficulty in the early poststroke 
period to predict just how much physical or cognitive impairment will remain (Forsberg-
Warleby et al., 2001; O’Connell et al., 2003). In contrast, by 1 year poststroke, recovery 
is relatively stable (Anderson et al., 1995). Because stroke has a sudden onset, family 
members need to adjust to a new relationship with stroke survivors and take on new 
responsibilities as informal caregivers, potentially without adequate support or 
knowledge (Coombs, 2007). Thus, in this study, uncertainty is defined as caregivers’ 
inability to determine the meaning of stroke survivors’ health outcomes and the new 
caregiver role. 
The concept of uncertainty in adults with chronic disease or cancer is well 
established and parents’ uncertainty about the prognosis of children with cancer has also 
been documented in the current literature. Few researchers, however, have systematically 
studied uncertainty in caregivers for persons with acute or chronic disorders. Northouse, 
Laten, and Reddy (1995) reported that caregivers of persons with breast cancer had 
greater uncertainty about the patients’ illness than did the patients themselves and also 
had difficulty adjusting to their new role. In another study, uncertainty in caregivers for 
persons with breast cancer was correlated with caregiver emotional distress and caregiver 
role adjustment (Northouse, Dorris, & Charron-Moore, 1995). Mitchell and Courtney 
(2004) reported that uncertainty in family caregivers around transfer from intensive care 
was significantly related to anxiety. As previously noted, persons with higher uncertainty 
at baseline had poorer health outcomes (e.g., higher levels of anxiety and depression and 
lower levels of perceived control and HRQOL) 1 year after angiography than those with 
lower uncertainty at baseline (Eastwood et al., 2008). Regardless, caregivers’ uncertainty 
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in the early weeks of caregiving, not only for stroke survivors, but also for patients with 
other disorders, has not been well explicated. 
Uncertainty and stress. 
Uncertainty and perceived stress. The impact of uncertainty on caregiver 
perceived stress has not yet been made clear. One study reported that a mother’s 
uncertainty about her infant’s HIV serostatus was related to the mother’s perceived stress 
(Shannon & Lee, 2008). Uncertainty in illness was also correlated with posttraumatic 
stress symptoms in young-adult childhood cancer survivors (Santacroce & Lee, 2006). 
This study did not control for other covariates that may affect posttraumatic-stress 
symptoms; the results, however, indicate that uncertainty may be a potential factor that 
influences perceived stress in caregivers and is, thus, a target for intervention. Further, 
the results of this study regarding posttraumatic-stress symptoms as mediators between 
uncertainty and health-promotion behavior support one of the proposed hypotheses in this 
study, i.e., that perceived stress will mediate the relationship between uncertainty and 
psychological outcomes (burden, HRQOL and depressive symptoms). 
Uncertainty and physiological stress. The relationship between uncertainty and 
physiological stress has not been investigated in the current literature. Mishel (1990) 
noted that chronically ill persons who are uncertain can develop symptoms related to 
pathological response to stressors. Caregivers for stroke survivors may have struggled 
with new responsibilities in their role as informal caregivers in the early poststroke period. 
Uncertainty regarding stroke survivors’ outcomes as well as the new caregiver role is 
likely to be stressful. Understanding the relationship between uncertainty and 
physiological stress will expand knowledge in the current literature and contribute to  
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development of a biobehavioral model to guide a future intervention study. 
Uncertainty and psychological outcomes. 
Uncertainty and burden. The impact of uncertainty on caregiver burden has not 
been documented in the current literature. In a related study, 30% of 44 caregivers for 
patients with Parkinson’s disease reported psychological distress, and uncertainty was a 
significant determinant for it (Sanders-Dewey, Mullins, & Chaney, 2001). In the existing 
literature, caregivers for stroke survivors conveyed caregiver burden beginning at least 1 
month poststroke (Bugge et al., 1999). Whether early uncertainty influences later 
caregiver burden is not clear, and a study in the early weeks of caregiving is, thus, 
required to reveal this relationship. If found, relieving some of this early uncertainty may 
be important to decreasing later caregiver morbidity and mortality associated with burden. 
Uncertainty and health-related quality of life. The relationship between 
uncertainty and HRQOL in caregivers for persons with recurrent breast cancer was 
studied by Northouse et al. (2002). Compared with estimated norms, caregivers for 
persons with breast cancer had lower (poorer) mean scores (mean 48.4, p = 0.03) in 
mental health dimensions of HRQOL, as measured by the Medical Outcomes Study SF-
36. Mean scores in physical health dimensions of HRQOL, however, were similar to 
norm values. In their study, caregiver uncertainty was associated with mental health 
dimensions of HRQOL, adjusting for caregiver characteristics (age, education, self-
efficacy, current concerns, family hardiness, social support and symptoms) as well as 
patient characteristics (symptom distress, stage of disease and length of the disease-free 
interval between stage of disease and recurrence). Eastwood et al. (2008) found worse 
HRQOL 1 year later in coronary angiography patients with high baseline uncertainty. 
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The influence of uncertainty on HRQOL in caregivers of stroke survivors, however, has 
not been documented in the current literature. 
Uncertainty and depression or depressive symptoms. Depression or depressive 
symptoms are common in caregivers of stroke survivors, but, there is little research 
linking caregiver uncertainty and depression. Sanders-Dewey et al. (2001) reported that 
uncertainty in caregivers for individuals with Parkinson’s disease was correlated with 
their depression, but no further predictive analysis was reported. Caregiver uncertainty 
about a family member’s transfer from intensive care was significantly associated with 
anxiety (Mitchell & Courtney, 2004). Patients with higher levels of uncertainty than those 
with lower levels of uncertainty had more anxiety and depression at 1 year after coronary 
angiography (Eastwood et al., 2008). Further study is required to identify the impact of 
uncertainty on caregiver depression while controlling for known risk factors for 
depression in caregivers of stroke survivors, including the survivors’ stroke severity and 
older age (Berg et al., 2005) and caregivers’ social support (Grant et al., 2006). 
Stress 
Perceived stress. Caregivers’ perceived stress includes “domestic upset, negative 
feelings toward the patient and personal distress in relation to the patient” (Draper et al., 
2007, p. 124).
 
Caregivers experience higher perceived stress than do noncaregivers 
(Bauer et al., 2000) due to exposure to complex stressors (Pearlin et al., 1990). The 
literature on caregiving reported (Pearlin et al., 1990) that caregiving stressors can be 
broadly divided into two categories: primary (i.e., patient characteristics and caregivers’ 
perspectives on these characteristics including cognitive status, behavioral symptoms and 
activities of daily living) and secondary (i.e., family conflict, job–caregiving conflict,  
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economic problems and constriction of social life). 
Stress from caregiving has been associated with effects on health and risk factors 
for mortality. Caregivers with greater emotional strain have 63% higher mortality rates 
than do noncaregivers (Schulz & Beach, 1999). Spousal caregivers with higher strain 
have increased risk for stroke (Haley et al., 2010) and female spousal caregivers are at 
higher risk for coronary heart disease (S. Lee et al., 2003). In caregivers of stroke 
survivors, significant stress was reported within the first year poststroke and one of its 
significant predictors was the functional status of the stroke survivor. Related caregiver 
factors include caregiver gender, age, caregiver health, time since providing care for 
stroke survivors, coping strategy/capacity, social support and preparedness for caregiving 
(Ostwald, Bernal, Cron, & Godwin, 2009). With stroke’s sudden onset, the early 
poststroke period may especially be acutely stressful for caregivers, but acute stress in 
caregivers during the early poststroke period has not yet been described. 
After stroke, caregivers need to address and become accustomed to patients’ 
functional deficits (Visser-Meily et al., 2009). In the acute stage of stroke, providers 
cannot anticipate exactly how much physical or cognitive impairment will remain 
(O’Connell et al., 2003), and the process of recovery from stroke is gradual. In the 
literature on family caregivers of stroke survivors, the concept of stress has been 
integrated with the explanation of caregiver burden. Little has been reported on perceived 
stress in the early weeks of caregiving. 
Physiological stress. Perceived stress is correlated with physiologic response, 
including elevated neuroendocrine mediators such as norepinephrine or cortisol (Morgan 
et al., 2002). As an allostatic response, that is, the ability to achieve stability during 
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change (McEwen, 1998), stress stimulates the sympathetic nervous system as well as 
activates the hypothalamic-pituitary-adrenal (HPA) axis. Sympathetic nervous-system 
stimulation results in norepinephrine (catecholamine neurotransmitter) release from 
sympathetic nerves into target tissues and epinephrine release from adrenal medulla into 
circulation. The activation of the HPA axis causes the adrenal cortex to release 
glucocorticoids, principally cortisol in humans. Salivary cortisol has often been measured 
to assess stress in caregivers, especially those caring for dementia patients; these 
caregivers have an increase in cortisol levels (Bauer et al., 2000; Da Roza Davis & 
Cowen, 2001; de Vugt et al., 2005; Vedhara et al., 1999). Receptor-mediated actions of 
cortisol cause immunosuppressive and anti-inflammatory effects on target immune 
tissues and cells (Elenkov, Webster, Torpy, & Chrousos, 1999), and the immune system 
is known to be suppressed in caregivers of dementia patients (Vitaliano et al., 2003). One 
study reported diurnal salivary-cortisol patterns in caregivers of stroke survivors; levels 
of salivary cortisol were lower across the day in caregivers with greater depressive 
symptoms than in those with less (Saban, Mathews, Bryant, O’Brien, & Janusek, 2012). 
This study found that younger age was associated with lower levels of cortisol on waking 
and 30 minutes postwaking. 
In the case of acute stress, a significant association with disrupted circadian 
rhythms, defined as a 24-hour cycle of physiological, biochemical and behavioral 
processes, was reported (Feve-Montange et al., 1981). After exposure to acute stress, 
levels of plasma and salivary cortisol and their ratios were significantly increased 
(Morgan et al., 2002) and acute stress also had long-term health implications (McEwen, 
1998). The activation of the sympathetic nervous system releases catecholamines 
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resulting in a broad physiologic response (Seeman, Singer, Rowe, Horwitz, & McEwen, 
1997): increased blood pressure, heart rate, breathing rate and blood-glucose level and 
intensifies muscle tension (Preville, Zarit, Susman, Boulenger, & Lehoux, 2008). To date, 
physiologic response from acute stress in caregivers has been measured only in 
experimental settings. When caregivers of demented spouses were asked to provide care 
for their spouses in the laboratory, they had higher blood pressure and heart rate than did 
noncaregivers, indicating they were experiencing acute stress and higher sympathetic 
activation (Cacioppo et al., 2000). 
In contrast to dementia, which is a chronic progressive disorder, stroke has a 
sudden onset and, thus, in the early poststroke period stroke-survivor caregivers are likely 
to experience acute stress. One study reported that levels of salivary cortisol were 
decreased across the day in caregivers with greater depressive symptoms compared with 
those with fewer depressive symptoms (Saban et al., 2012). It is not well known whether 
stress hormones are elevated, decreased or affected at all in caregivers of stroke survivors 
when they first confront their new role as a caregiver in a natural environment. 
Caregivers may also experience stress due to their own personal problems in addition or 
unrelated to their family members’ sudden onset of stroke or their new caregiving 
situation. Thus, in this study I attempted to capture these other precipitants by asking 
caregivers about their other potentially stressful life events in the past 3 months (e.g., 
death, moving, retirement and marriage). 
Salivary cortisol. Salivary cortisol has often been used as a biomarker of 
psychological stress. The salivary-cortisol level is reliable in assessing the variation in 
endocrine activity and response to acute stress (Feve-Montange et al., 1981). One 
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advantage of salivary cortisol is that one can measure the free unbound fraction of 
cortisol because it is the last output of the HPA axis that remains high in acute stress with 
its disruption of circadian rhythms (Feve-Montange et al., 1981; Hellhammer, Wust, & 
Kudielka, 2009). In addition, salivary cortisol acts independently of competition with 
other steroid hormones to bind cortisol globulin (Woods et al., 2008). Salivary cortisol is 
correlated with serum cortisol (Kirschbaum & Hellhammer, 1994; Shimada, Takahashi, 
Ohkawa, Segawa, & Higurashi, 1995) and contains up to 10% of serum cortisol (Woods 
et al., 2008). Assessing salivary-cortisol levels in caregivers of stroke survivors can 
contribute to a better understanding of caregiver stress. 
Psychological Outcomes 
Burden. Caregiver burden for stroke survivors refers to family members’ feelings 
of being overwhelmed and strained in assisting their care recipients (Elmstahl, Malmberg, 
& Annerstedt, 1996). The general concept of caregiver burden itself is dynamic. Zarit, 
Todd, and Zarit (1986) defined caregiver burden as “the extent to which caregivers 
perceived their emotional or physical health, social life and financial status as suffering as 
a result of caring for their relative” (p. 261). Although in the current literature the term 
“demand” has been recently used to describe caregiver burden, the majority of the 
literature on caregiving in stroke survivors continues to use the term “burden.” Thus, 
“caregiver burden” was used in this study. 
Objective burden is defined as “caregiving situations” such as “the caregiving 
tasks that are performed, like assistance with self-care, mobility, instrumental activities 
and financial management and the time spent on each task” (van Exel, Koopmanschap, 
van den Berg, Brouwer, & van den Bos, 2005, p. 12). One third of caregivers for stroke 
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survivors reported they were burdened by household responsibilities and caregiving 
(Thommessen, Wyller, Bautz-Holter, & Laake, 2001). 
Subjective burden is defined as “the psychological, social or emotional impact 
caregivers experience from the objective burden of caregiving” (van Exel et al., 2005, 
p. 12) or “the distress experienced” (Thommessen et al., 2002, p. 79). Few studies 
distinguish between objective burden and subjective burden, rather reporting on burden in 
general. 
As demonstrated in existing literature, caregivers reported a sense of burden from 
at least 1 month to 1 year poststroke (Blake et al., 2003; Bugge et al., 1999; Forsberg-
Warleby et al., 2001; Tooth et al., 2005). Of spousal caregivers of stroke patients, 34% 
reported burden at 3 months poststroke and 40% had burden at 6 months poststroke 
(Blake et al., 2003). Significant burden was reported in the first 12 months poststroke 
(Tooth et al., 2005). Some studies reported that burden of caregivers decreased over time, 
that is, baseline to 6 months (McCullagh et al., 2005; Vincent, Desrosiers, Landreville, 
Demers, & BRAD group, 2009), whereas others revealed that caregiver burden continued 
from 2 months to 6 months (Ilse, Feys, de Wit, Putman, & de Weerdt, 2008) or from 1 
month to 6 months (Blake et al., 2003; Bugge et al., 1999). 
Several caregiver sociodemographic factors are known predictors for burden: 
relationship to stroke survivors (Van Puymbroeck & Rittman, 2005), gender (Bugge et al., 
1999), age (Periard & Ames, 1993; Schulz et al., 1988; van Exel et al., 2005), time spent 
helping the survivors (Bugge et al., 1999) and coping capacity (Cameron & Gignac, 
2008; Forsberg-Warleby et al., 2001; Van Puymbroeck & Rittman, 2005; Visser-Meily et 
al., 2009). Stroke-survivor characteristics affecting burden include functional status (Ilse 
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et al., 2008), cognitive impairment (Thommessen et al., 2001) and communication 
loss/aphasia (Vincent et al., 2009). HRQOL of caregivers at 6 months poststroke is also 
strongly related to caregiver burden (van Exel et al., 2005). The effect of uncertainty on 
caregiver burden, however, has not yet been studied. 
Health-related quality of life. Quality of life is a broad concept that includes 
HRQOL. Quality of life can reference personal well-being or satisfaction with life. 
HRQOL focuses aspects on perceived health or illness. General caregiving literature 
reports that quality of life of caregivers is lower than that of noncaregivers (Roth, Perkins, 
Wadley, Temple, & Haley, 2009). Caregivers of stroke survivors also experienced 
decreased HRQOL from 1 month to several months poststroke (White et al., 2004). 
Increased caregiver burden was associated with decreased caregiver HRQOL (Larson et 
al., 2005; van Exel et al., 2005; Van Puymbroeck & Rittman, 2005), especially in the area 
of mental health (Morimoto et al., 2003). Caregiver HRQOL was predicted by caregiver 
age and gender (McCullagh et al., 2005). New caregivers of stroke survivors must 
confront issues of independence and managing comorbid conditions in stroke survivors, 
balance roles (e.g., caregiver, spouse and employee) and participate in physical therapy 
(Pierce et al., 2006). They must also deal with a number of factors affecting themselves 
and stroke survivors: emotions such as depression or anger, living with physical 
limitations and sleep problems (Pierce et al., 2006). These factors may affect their 
HRQOL. Uncertainty was associated with the mental health dimensions of HRQOL in 
caregivers for persons with recurrent breast cancer (Northouse et al., 2002). Whether 
uncertainty affects HRQOL in caregivers of stroke survivors, however, has not been  
studied. 
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Depression/depressive symptoms. Prevalence of depression is high among 
caregivers of stroke survivors; as many as 23% to 33% of caregivers experience 
depression during the 18-month follow-up period poststroke (Berg et al., 2005; Blake et 
al., 2003). Bakas, Kroenke, Plue, Perkins, and Williams (2006) reported that 18% of 
caregivers for stroke survivors had moderate depressive symptoms. In their study, an 
additional 18% of caregivers who were taking antidepressant medications showed no 
depressive symptoms, suggesting that approximately 36% of caregivers of stroke 
survivors may have symptoms of depression (Bakas, Kroenke, et al., 2006). Predictors 
for depression in caregivers include severity of stroke and older age of stroke survivors 
(Berg et al., 2005), caregiver social support (Grant et al., 2006), race, gender, hours spent 
providing care per day (Van Puymbroeck, Hinojosa, & Rittman, 2008) and younger age 
(Saban et al., 2012). Positive aspects of caregiving that protect against depression in 
caregivers of stroke survivors were also reported: a high sense of coherence at 1 month 
poststroke was associated with less depressive symptoms at 12 months poststroke (Van 
Puymbroeck et al., 2008). A longitudinal study reported moderate caregiver depression in 
2% of participants at baseline, 6% at 6 months poststroke and 9% at 18 months poststroke 
(Berg et al., 2005). Whether caregiver uncertainty influences depression, after adjusting 
for other known factors, has not been studied. 
Relevant Caregiver and Stroke-Survivor Characteristics 
Caregiver characteristics. 
Comorbidity and health status. Comorbidity is defined as the presence of  
coexisting diseases or conditions with reference to an initial diagnosis or the index  
condition that is the subject of study (Webster’s Online Dictionary, 2011). Caregivers of  
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stroke survivors have comorbidities (Hodgson, Wood, & Langton-Hewer, 1996) and 
confront new physical-health issues, comorbid issues and high numbers of illness-related 
symptoms including depression (Anderson et al., 1995; Bauer et al., 2000; Berg et al., 
2005; Blake et al., 2003; Burman, 2001; Cameron & Gignac, 2008; Forsberg-Warleby et 
al., 2002; McCullagh et al., 2005; Pierce et al., 2006; White et al., 2003). Of caregivers of 
stroke survivors, 54% already had preexisting medical conditions, including arthritis, 
vertigo or back problems that can influence their caregiving for stroke survivors over 
time (Hodgson et al., 1996). Caregivers studied during the first and second year 
poststroke reported a range of disorders including hypertension, arthritis, cataracts, 
bronchitis, angina, history of myocardial infarction, diabetes, asthma and ulcer disease 
(White et al., 2003). Reported psychological symptoms included depression, fear, 
frustration, resentment, impatience, guilt (Anderson et al., 1995), anxiety (Anderson et al., 
1995; McCullagh et al., 2005), worry, concern (Cameron & Gignac, 2008), anger (Pierce 
et al., 2006) and fear about the recurrence of stroke or other medical complications in 
their family members (Forsberg-Warleby et al., 2002). 
In addition to comorbidities, caregivers’ own perceived health status also affects 
their experience of burden (Bugge et al., 1999) and HRQOL (Morimoto et al., 2003). 
Comorbidity of caregivers is believed to influence the relationship between uncertainty, 
perceived stress and caregiver outcomes. Thus, in this study, the effect of comorbidity on 
outcomes was controlled. 
Coping capacity. Coping is defined as “one’s ability to respond to stressors by the 
appropriate use of adaptive coping resources” (Chumbler, Rittman, Van Puymbroeck, 
Vogel, & Qin, 2004, p. 944). When individuals confront stressful life events, they use 
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strategies to cope and adapt to the situation to decrease harmful effects that may arise 
from stress or to reduce emotional distress as a response to the event (Visser-Meily et al., 
2009). Coping capacity has been highly associated with burden (Cameron & Gignac, 
2008; Forsberg-Warleby et al., 2001; Van Puymbroeck & Rittman, 2005; Visser-Meily et 
al., 2009), quality of life (Visser-Meily et al., 2009) and depression (Visser-Meily et al., 
2009) in caregivers of stroke survivors. Thus, the effects of coping capacity on caregiver 
perceived and physiological stress and psychological outcomes (burden, HRQOL and 
depressive symptoms) in the early poststroke period were examined. 
Social support. Social support is defined as caregivers’ perceptions about the 
availability of relationships that provide help or support them and prevent negative 
outcomes from the stressful event (Sherbourne & Stewart, 1991). Less perceived 
availability of social support predicted depression in caregivers of stroke survivors (Grant, 
Bartolucci, Elliot, & Giger, 2000), whereas caregivers of stroke survivors who reported 
more perceived social support had less depression (Grant et al., 2006). Caregivers who 
reported greater satisfaction with social support had less caregiver strain (van den Heuvel, 
de Witte, Schure, Sanderman, & Meyboom-de Jong, 2001). Furthermore, social support 
was a significant determinant of better well-being and general health in caregivers (Grant 
et al., 2006). 
Sociodemographics. Caregivers’ burden has been shown to be associated with 
their sociodemographic characteristics. The relationship to patients with stroke was a 
predictor of caregiver burden: spousal caregivers at 1 month poststroke report higher 
levels of burden than nonspousal caregivers (Van Puymbroeck & Rittman, 2005). Gender 
also appeared to be important: the majority of caregivers are women, and female 
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caregivers experience greater caregiver burden than do male caregivers (Bugge et al., 
1999). Caregivers of stroke survivors spend significant time assisting patients with daily 
activities (Tooth et al., 2005): approximately 4.6 hours per day at 6 months poststroke 
and approximately 3.6 hours per day at 12 months poststroke (Tooth et al., 2005). The 
time spent helping stroke survivors was associated with caregiver strain at 1, 3 and 6 
months poststroke (Bugge et al., 1999). Age was also one of the predictors of caregiver 
burden at 6 (van Exel et al., 2005), 7 or 9 months after stroke (Schulz et al., 1988). In 
contrast, in at least one study, the caregiver-burden score decreased as the age of 
participants increased (Periard & Ames, 1993). Predictors of caregiver quality of life at 3 
months and 1 year poststroke have also been shown to include age and gender 
(McCullagh et al., 2005). Women caregivers had lower psychological well-being, which 
in turn, was related to lower quality of life (Larson et al., 2008). 
Stroke-survivor characteristics. 
Severity of stroke. Severity of stroke or resulting level of impairment also affects 
caregiver outcomes. In a study of 212 caregivers for stroke survivors, severity of stroke 
was found to be related to caregiver strain (van den Heuvel et al., 2001). Moderate 
impairment from stroke, together with a number of other factors, explained 56% of the 
variance in caregiver HRQOL (Berg et al., 2005; White et al., 2003). Berg et al. (2005) 
found that caregiver depression was predicted by severity of stroke in stroke survivors, 
whereas no such relationship was found in another study (Davis et al., 2009). Additional 
work to explore the association between severity of stroke and caregiver outcomes, 
including depressive symptoms, is required; these associations are clarified in the present  
study. 
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Functional status. In this study, functional status is defined as a stroke survivor’s 
motor and cognitive ability to perform activities of daily living. Stroke occurs when 
blood flow in the brain is interrupted by obstruction or hemorrhage of blood vessels 
(Nestler, Hyman, & Malenka, 2009). The specific lesions caused by stroke may predict 
the resulting types of neurological impairments. Broadly, physical performance, 
including motor or sensory performance, is affected by impairment of the sensorimotor 
cortex (Kunesch, Binkofski, Steinmetz, & Freund, 1995). Both location and size of 
damage as a result of stroke are related to resultant motor function (Chen, Tang, Chen, 
Chung, & Wong, 2000). Because of these neurological impairments and related impaired 
functional status, stroke survivors often require assistance from caregivers to perform 
activities of daily living (Forsberg-Warleby et al., 2002; Visser-Meily et al., 2009). Some 
investigators have reported that stroke survivors’ functional status predicts caregiver 
stress (Ostwald et al., 2009), burden (Ilse et al., 2008) and time spent providing care 
(Tooth et al., 2005), whereas others reported no such association with caregiver burden 
(Morimoto et al., 2003), emotional illness (Anderson et al., 1995)
 
or quality of life (White 
et al., 2003). 
The prevalence of cognitive impairment after stroke ranges from 30% to 40% (del 
Ser et al., 2005; Nestler et al., 2009; Patel, Coshall, Rudd, & Wolfe, 2002; Tatemichi et 
al., 1994). When patients’ stroke is located in the cerebellar region, more than 80% of 
survivors have cognitive deficits (Kalashnikova, Zueva, Pugacheva, Korsakova, & Zueva, 
2005). Stroke in the prefrontal cortex mainly affects cognitive function, emotion, decision 
making or behavior, but is not involved in motor, sensory or language function (Nestler et 
al., 2009). Poststroke cognitive impairment was associated with low functional status in 
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stroke survivors (Patel et al., 2002; Tatemichi et al., 1994) and, for their caregivers, with 
low quality of life (White et al., 2003) and higher burden (Thommessen et al., 2001). 
Communication. Of stroke survivors, 21 to 38% experience aphasia (loss of 
communicative ability), including impaired language understanding or expression 
(Berthier, 2005). Aphasia was associated with caregiver burden (Vincent et al., 2009) and 
decreased quality of life (White et al., 2003). Caregivers for stroke survivors with aphasia 
rated communication as the most upsetting factor to them (Bakas, Kroenke, et al., 2006). 
They also reported having more difficulty with caregiving tasks than did caregivers for 
stroke survivors without aphasia (Bakas, Kroenke, et al., 2006). Although communication 
is essential to overall functional status, it is not necessarily included as a specific item in 
functional-status assessment. Thus, I addressed communication separately in this study. 
Comorbidity. Comorbidity is defined as the presence of coexisting diseases with 
reference to an initial diagnosis or with reference to the index condition that is the subject 
of study (Webster’s Online Dictionary, 2011). Stroke survivors themselves often have 
comorbid diseases, as the major risk factors of stroke include hypertension, dyslipidemia, 
cigarette smoking, diabetes mellitus, carotid stenosis, arterial fibrillation and valvular 
heart disease (Hankey, 2006). Additionally, 95% of ischemic stroke survivors have 
medical complications (Johnston et al., 1998). Although few studies have reported any 
association between stroke-survivor comorbidity and caregiver outcomes, one recent 
investigation found that stroke survivors’ chronic medical conditions (as measured by the 
Charlson Index, a tool that does not include depression screening measures) were not 
significant factors influencing caregiver depression; however, stroke-survivor depression 
was highly associated with caregiver depression (Davis et al., 2009). 
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Sociodemographics. Caregivers experience more strain when stroke survivors are 
older (Berg et al., 2005). The present study focused exclusively on caregivers of stroke 
survivors aged 65 or older in an effort to reveal the impact of age (e.g., the oldest old, 
such as those 85 years of age or older) on caregiver outcomes. Other stroke-survivor 
sociodemographics have not been found to be significant factors affecting caregiver 
outcomes. This study further clarifies the relationship between stroke-survivor 
sociodemographics and caregiver outcomes. 
Summary of Known Factors Affecting Caregiver Outcomes 
Table 1 summarizes known factors affecting caregiver stress, burden, HRQOL 
and depression or depressive symptoms in caregivers of stroke survivors. (To my 
knowledge, with the exception of one study by Saban et al. (2012), direct measurement of 
physiological stress in caregivers of stroke survivors has not been studied.) What is not 
well known, however, is whether these same characteristics affect caregiver stress in the 
early poststroke period, nor is the role of uncertainty in caregiver perceived or 
physiological stress and these same psychological outcomes known. 
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Table 1 
Summary of Known Factors Influencing Caregiver Stress and Psychological Outcomes 
(Burden, Health-Related Quality of Life and Depressive Symptoms) in Caregivers of 
Stroke Survivors 
Outcomes Factors influencing Outcomes 
Stress  
Perceived  Caregiver gender, age, caregiver health, time since providing care 
for stroke survivors, coping strategy/capacity, social support, 
preparedness for caregiving and number of close friends and 
relatives; stroke-survivor function (Ostwald et al., 2009) 
Physiological  Caregiver younger age (Saban et al., 2012) 
Psychological Outcomes  
Burden Caregiver relationship to the stroke survivor (Van Puymbroeck & 
Rittman, 2005), age (Periard & Ames, 1993; Schulz et al., 1988; 
van Exel et al., 2005), gender, time spent helping the stroke 
survivor, health status (Bugge et al., 1999) and coping capacity 
(Cameron & Gignac, 2008; Forsberg-Warleby et al., 2001; Van 
Puymbroeck & Rittman, 2005; Visser-Meily et al., 2009); stroke-
survivor functional status (Ilse et al., 2008), cognitive impairment 
(Thommessen et al., 2001) and communication loss/aphasia 
(Vincent et al., 2009) 
Health-Related Quality of Life Caregiver age, gender (McCullagh et al., 2005), health status 
(Morimoto et al., 2003) and coping capacity (Visser-Meily et al., 
2009) 
Depression/Depressive 
Symptoms  
Caregiver social support (Grant et al., 2006), race, gender, hours 
spent providing care per day (Van Puymbroeck et al., 2008) and 
younger age (Saban et al., 2012); severity of stroke and older age of 
stroke survivors (Berg et al., 2005) 
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Gaps in the Literature and Current Study Solutions 
Although the literature on the long-term effects of caregiving is well developed, 
little is known about the immediate, early period after an acute event that precipitates 
assumption of the caregiver role by a family member or friend. Thus, this study 
incorporated prospective and longitudinal aspects to explore whether the level of 
uncertainty about stroke survivor’s health outcomes as well as uncertainty about 
assuming a new role predict caregiver perceived stress, physiological stress and 
psychological outcomes (burden, HRQOL and depressive symptoms) in the early 
poststroke period. 
The literature review confirmed that the effect of uncertainty on perceived stress 
has not been clearly differentiated. Researchers have studied mothers’ uncertainty about 
infant HIV serostatus (Shannon & Lee, 2008) and uncertainty in young-adult childhood-
cancer survivors (Y. L. Lee, 2006; Santacroce & Lee, 2006), and revealed the correlation 
between uncertainty and stress. These investigators failed, however, to control for other 
factors that may influence perceived stress. Further, to my knowledge, the relationship 
between uncertainty and perceived stress in caregivers of stroke survivors has not been 
documented. Thus, a study of caregivers’ responses in the early poststroke period is 
critical to understanding the role of uncertainty and stress as potential factors affecting 
caregiver outcomes. 
No studies regarding the influence of uncertainty on caregivers’ physiological 
stress have been found in the current literature. In studies of caregivers of stroke 
survivors, the concept of stress has more often been integrated with the operational 
definitions of caregiver burden or HRQOL, rather than treated as a separate concept, or 
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measured solely as perceived stress. Only one study was found that included direct 
measurement of physiological stress in caregivers of stroke survivors. The present study 
contributes to filling important gaps in the current literature. 
This study is innovative not only in measuring immediate physiological stress, but 
also by assessing the association of uncertainty with psychological outcomes (burden, 
HRQOL and depressive symptoms) 1 month after the first interview (around 6 weeks 
poststroke). There is limited information that addresses the relationship between 
uncertainty and caregiver psychological outcomes. Examining the mediating effect of 
caregiver stress (perceived and physiological [salivary cortisol]) on the relationship 
between uncertainty and psychological outcomes (burden, HRQOL and depressive 
symptoms) at each of these two time points is essential to begin to fill in these gaps. 
The robust biological and behavioral data collected are critical to prevention of 
untoward sequelae, resulting in better long-term health outcomes for caregivers. The 
findings may inform the development of a biobehavioral theoretical model that can serve 
as a foundation for future intervention studies. These intervention studies may result in 
supporting care-related decisions, preventing disease and promoting long-term health in 
caregivers. 
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CHAPTER 3: RESEARCH DESIGN AND METHODS 
Research Design and Study Overview 
A prospective, longitudinal observational study was conducted using a 
convenience sample of caregivers and their stroke-survivor relatives recruited from acute-
care settings in two Philadelphia academic health-science centers. Caregivers were 
enrolled and entered in the study within the first 2 weeks following their relatives’ stroke 
(T1) and revisited 4 weeks later (T2; ~ 6 weeks post stroke). This design enabled me to 
gain comprehensive information about the influence of uncertainty at two separate time 
periods during the early poststroke period. The study involved quantitative measures of 
caregiver and stroke-survivor characteristics and outcomes to allow the testing of 
hypotheses about relationships among the variables of interest (Burns & Grove, 1997). 
Participant enrollment and data collection for the entire study were completed over an 8-
month period; each participant was actively involved for approximately 4 weeks. Overall 
data analysis of study aims was conducted at the University of Pennsylvania School of 
Nursing. Salivary-cortisol assays were analyzed at the University of Pennsylvania 
Pearlman School of Medicine Clinical and Translational Research Center. The specific 
aims for the study were: 
Aim 1: Determine at each time point if uncertainty (regarding stroke survivors’ 
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress. 
Aim 2: Determine at each time point if uncertainty predicts levels of caregivers’ 
physiological stress (salivary cortisol). 
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Aim 3: Examine at each time point the relationship of uncertainty to 
psychological outcomes (burden, health-related quality of life [HRQOL] and depressive  
symptoms). 
Aim 4: Explore at each time point the mediator effect of stress (perceived stress 
and physiological stress) on the relationship between uncertainty and psychological 
outcomes (burden, HRQOL and depressive symptoms). 
Sample and Settings 
The convenience sample of caregivers, the primary participants for this study, and 
their stroke survivors were recruited from the large neurology and neurosurgery services 
at the Hospital of the University of Pennsylvania and the Thomas Jefferson University 
Hospital/Jefferson Hospital for Neurosciences in Philadelphia, PA. Caregivers’ relatives 
with stroke were also enrolled in order to collect relevant medical information from their 
medical records. 
To be included in the study, caregivers had to (a) self-identify as a family member, 
(b) self-identify as the expected primary caregiver for an older adult (age 65 or older) 
who was diagnosed within the past 2 weeks with new or recurrent ischemic or 
hemorrhagic stroke, (c) communicate in English, (d) demonstrate capacity for informed 
consent (see the consent capacity guide in Appendix N) and (e) be 21 years old or older. 
Given the higher incidence of stroke in older adults, this study enrolled only 
caregivers whose relatives were age 65 or older. In addition, all stroke survivors (a) had a 
family caregiver participating in the study, (b) had been diagnosed with new or recurrent 
stroke, (c) were within the first 2 weeks of stroke onset and (d) agreed (either self or 
surrogate) to a medical-chart review. 
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Power Analysis 
Because this study spans only 1 month per participant, I did not expect significant  
attrition. Originally, I proposed to enroll a total of 115 subjects to account for an attrition 
rate of 15% for a sample size of 100. In 2009, the Hospital of the University of 
Pennsylvania admitted approximately 1,000 adults over age 65 with stroke (ICD9 code 
range 430–438); thus, I expected little difficulty in enrolling 115 subjects. Power 
estimation was based on a sample size of 100 with the assumed ability to accrue 115 
caregivers and satisfy Aim 1, regressing caregiver perceived stress on uncertainty using 
multiple regression. Ostwald et al. (2009) published that predictors for caregiver 
perceived stress (perceived stress scale) were caregiver gender, caregiver age, caregiver 
health, time since providing care for stroke survivors, stroke-survivor function, coping 
strategy, social support, preparedness for caregiving and number of close friends and 
relatives. I ran a power analysis based on findings from a published study of uncertainty 
and distress in family caregivers for persons with Parkinson’s disease (Sanders-Dewey et 
al., 2001) and a series of values corresponding to variance in perceived stress in stroke-
survivor caregivers, explained by nine covariates (caregiver gender, caregiver age, 
caregiver health, time since providing care for stroke survivors, stroke-survivor function, 
coping strategy, social support, preparedness for caregiving and number of close friends 
and relatives). Using an F-test with 0.05 significance level, a sample size of 100 would 
achieve 98% power to detect an R-squared of 0.11 attributed to one independent variable, 
namely uncertainty, accounting for 20% of variance explained by the nine control 
variables in caregiver perceived stress. 
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I enrolled a total of 63 participants at T1, however, and 40 of these remained and 
completed the study at T2. Thus, I recalculated power, based on sample size 40 and 
revealed R-Squared of uncertainty as well as covariates for Aim 1 at T2, regressing 
caregiver perceived stress on uncertainty using multiple regression. Using an F-test with 
a significance level of 0.05, the achieved sample of 40 participants had 99.6% power to 
detect an R-squared of 0.26 attributed to one independent variable, namely uncertainty. 
The variables tested were adjusted for an additional two independent variables associated 
with perceived stress at T2 (social support and stroke-survivor income), with an R-
squared of 0.28. 
Study Variables and Instruments 
A paper and pencil survey was constructed that included instruments and items 
(see Appendices A–M) to measure each of the study variables. These are summarized in 
Tables 2 and 3. Additionally, participants self-collected and submitted samples of 
caregiver saliva at each time point. A chart abstraction form was used to obtain medical-
record information about each stroke patient. The study variables and their measures are 
described here. 
Uncertainty. The 31-item Perception of Uncertainty in Illness Scale for Family 
Members (Mishel, 1997b; see Appendix B) was used to measure caregivers’ degree of 
uncertainty (inability to determine the meaning of illness-related events) regarding stroke 
survivors’ health outcomes and the new caregiver role. Each of 31 items was scored on a 
scale of 1 (strongly disagree) to 5 (strongly agree). Total sum scores range from 31 to 
155; high scores indicate greater uncertainty. In the present study, total sum score 
measured on a continuum was used for statistical analysis. Construct validity of the 
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Parent Perception of Uncertainty Scale (the original scale used to measure parents’ 
perceptions of uncertainty by using the word child instead of him/her) is supported by 
correlation between factors and total scale (r = 0.50–0.89) as well as correlation between 
total score and the judged seriousness of their child’s illness (r = 0.16, p < 0.004; Mishel, 
1983). Internal consistency for the total scale is from 0.81 to 0.92 (Cronbach’s alpha) for 
family caregivers (Mishel, 1997b). In the present study, Cronbach’s alpha for the 31 
items was 0.92 at T1 and 0.95 at T2. 
Stress. 
Perceived stress. The Perceived Stress Scale (PSS) includes 14 items designed to 
assess symptoms of stress and global measures of the degree of stress experienced in the 
last month including today (see Appendix C). In the present study, the time parameter 
was modified to ask about stress experienced in the past day (24 hours). This 
modification was made because the period of “the last month” would actually precede the 
occurrence of the serious health event in the family member: stroke; the value of interest 
is the stress that participants have experienced since the event. The same language was 
used for the T2 interview (4 weeks later), as the more recent experience of stress was 
viewed as most relevant to the study outcomes and also most comparable to the T1 
measure. Items are related to how unpredictable, uncontrollable and overloaded 
respondents find their lives. Each item is scored from 0 (never) to 4 (very often) with total 
sum scores ranging from 0 to 56; higher scores indicate higher perceived stress. Total 
sum score measured on a continuum was used for statistical analysis in this study. One 
advantage of this instrument is that it has a normative value per age group (B. Cohen & 
Williamson, 1988) and the scale has been validated and correlated with depressive 
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(r = 0.65 – 0.76, p < 0.001) and physical symptomatology (r = 0.52 – 0.65, p < 0.001) 
and social anxiety (r = 0.37 – 0.46, p < 0.001) in college students (S. Cohen, Kamarck, & 
Mermelstein, 1983). Cronbach’s alpha of the PSS ranges from 0.84 to 0.86 (S. Cohen et 
al., 1983), and 0.91 in older African American and European American females 
(McCallum, Sorocco, & Fritsch, 2006), which represents the majority of participants in 
this study. Cronbach’s alpha for the PSS in the present study was 0.86 at T1 and 0.88 at 
T2, indicating good internal consistency at each time point. 
Physiological stress. Salivary-cortisol level is a reliable way to assess the 
variation in endocrine activity and response to acute stress (Feve-Montange et al., 1981). 
Salivary cortisol is highly correlated with serum cortisol: correlation coefficients range 
from 0.71 in patients with alpha-cholinergic medication to 0.96 in healthy older adults 
(Kirschbaum & Hellhammer, 1994). Sample collection was noninvasive, which can 
reduce the stress-inducing effects on cortisol levels by venipuncture (Stone et al., 2001) 
or burdensome 24-hour urine-specimen collection. 
Cortisol levels follow a circadian rhythm (Preville et al., 2008); levels normally 
reach their peak in the early morning, and the concentration is lower at night (Chernow et 
al., 1987). Woods et al. (2008) reported that cortisol levels measured in the morning 
(09:00) and afternoon (16:00) in some samples did not coincide with a normal circadian 
rhythm pattern, whereas peak levels on waking and lower levels in the evening were 
generally consistent across samples. Cortisol dysregulation is more likely to be detected 
in the evening (Woods et al., 2008). Thus, it is also important to observe for higher 
cortisol levels in the evening by comparing the findings with normal levels in the evening. 
To capture diurnal variations in cortisol concentration in this study, caregivers collected 
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saliva using Salimetrics oral swabs on waking and again at 2100 h (see Appendix D; 
McCallum et al., 2006). 
The Salimetrics salivary-cortisol kit is immunoassay designed and validated for 
detecting salivary-cortisol levels from .003 to 3.0 µg/dL using 25 µL of saliva per sample 
(Woods et al., 2008). The Salimetrics Kits’ sensitivity is < 0.003 μg/dL (Salimetrics, 
2011). Salivary cortisol using a Salimetrics enzyme immunoassay kit is highly correlated 
with serum (r = 0.91, p < 0.0001; Salimetrics, 2011). An inter-assay coefficient of 
variation is 6.41% across 12 runs and an intra-assay coefficient of variation is 3.65% 
(Woods et al., 2008). In the present study, an inter-assay coefficient of variation was 
6.56% and intra-assay coefficient of variation was 4.61%. The minimum detectable limit 
was 0.010 μg/dL. 
Psychological outcomes. 
Burden. The Zarit Burden Interview scale includes 22 items related to “problems 
including caregivers’ health, psychological well-being, finances, social life and the 
relationship between the caregiver and the impaired person” (Zarit, Reever, & Bach-
Peterson, 1980, p. 651; see Appendix E). The original Zarit Burden Interview had 25 
items (Zarit et al., 1980), but the revised version with 22 questions is more widely used 
(Whitlatch, Zarit, & von Eye, 1991). Each item is scored from 0 (never) to 4 (nearly 
always). Total scores range from 0 to 88 (severe burden 61–88; moderate to severe 
burden 41–60; mild to moderate burden 21–40 and little or no burden 0–21; Zarit & Zarit, 
1987). The sum score for two subscales—personal strain (six items) and role strain (12 
items)—together with four items not included in any factor are commonly used as an 
overall measure of burden (Whitlatch et al., 1991). Thus, the total score measured on a 
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continuum was used for statistical analysis. Construct validity for the Zarit Burden 
Interview score is high (Seng et al., 2010); the Zarit Burden Interview score is highly 
correlated with the Burden Assessment Scale score (r = 0.73, p < 0.0001), General Health 
Questionnaire score (r = 0.62, p < 0.0001), Dementia Management-Strategies Scale score 
(r = 0.53, p < 0.0001) and Revised Memory and Behavior Problems Checklist score 
(r = 0.53, p < 0.0001). Cronbach’s alpha ranges from 0.87 to 0.93 for caregivers of stroke 
survivors (Visser-Meily, Post, Riphagen, & Lindeman, 2004) and 0.89 for older 
caregivers of stroke survivors (Hartke & King, 2002). The test–retest reliability (Kappa) 
carries a value of 0.71 (Vitaliano, Young, & Russo, 1991). In the present study, 
Cronbach’s alpha ranged from 0.92 at T1 to 0.94 at T2. 
Health-related quality of life. The EQ5D of the EuroQol is a generic HRQOL 
measure that consists of five descriptive items (see Appendix F). Each question of the 
EQ5D investigates one of five concepts: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression, with scoring from 1 (no problems or symptoms) 
to 3 (serious problems or symptoms). Total score measured on a continuum was used for 
statistical analysis. The EuroQol has been demonstrated to be a valid and reliable 
measure of HRQOL in various populations (Dorman, Slattery, Farrell, Dennis, & 
Sandercock, 1998; Fransen & Edmonds, 1999; Hurst, Kind, Ruta, Hunter, & Stubbings, 
1997; Schweikert, Hahmann, & Leidl, 2006). The validity correlation coefficients with 
the 36-item short-form health-survey subscales and EQ5D index score range from 0.57 to 
0.74 in patients with acute coronary syndromes (Schweikert et al., 2006). The intraclass 
correlation coefficient is 0.70 (Fransen & Edmonds, 1999). Cronbach’s alpha in an 
evaluation of HRQOL in patients with cancer was 0.68 (Pickard, Neary, & Cella, 2007). 
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In the present study, Cronbach’s alpha was 0.48 at T1 and 0.59 at T2, which was 
minimally acceptable. 
Depressive symptoms. The Patient Health Questionnaire (PHQ-9) is a 9-item 
scale used as a diagnostic screening measure for major and minor depression (see 
Appendix G). The items in the PHQ-9 correspond with the full range of symptoms listed 
in the Diagnostic and Statistical Manual of Mental Disorders major depressive-disorder 
category (Kroenke & Spitzer, 2002). This scale assesses the frequency of symptoms such 
as disinterest, low mood, sleep disruption or tiredness over the last 2 weeks, and each 
item is scored from 0 (Not at all) to 3 (Nearly every day). Total score ranges between 0 
and 24 and severity of depression can be described as none (score 1 to 4), mild (5 to 9), 
moderate (10 to 14), moderately severe (15 to 19) and severe (20 to 27; Kroenke & 
Spitzer, 2002). Total sum score measured on a continuum was used for statistical analysis. 
This scale has demonstrated excellent internal consistency reliability (α = 0.86 to 0.89), 
test–retest reliability (r = 0.84) and construct validity (correlation coefficients range from 
0.33 to 0.73 between depression severity scores and worsening function with the subscale 
of the 20-item Short-Form General Health Survey; Kroenke, Spitzer, & Williams, 2001). 
Internal consistency reliability for caregivers of stroke survivors ranges from 0.80 to 0.86 
(Bakas, Champion, Perkins, Farran, & Williams, 2006; Bakas, Kroenke, et al., 2006). In 
the present study, reliability was demonstrated by Cronbach’s alpha of 0.84 at T1 and 
0.86 at T2. 
Caregiver characteristics: Covariates. 
Comorbidity. A modified version of the Cumulative Illness Rating Scale (CIRS; 
Miller et al., 1992) was used to measure comorbidity, that is, the presence of coexisting 
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diseases in caregivers (see Appendix H). The CIRS total scores (Miller et al., 1992) range 
from 0 (no impairment) to 56 (maximal impairment) across 14 systems. Scoring of each 
system followed the guidelines proposed by Hudon, Fortin, and Vanasse (2005). The 
total sum score measured on a continuum was used for statistical analysis. The CIRS is 
valid and reliable in measuring multimorbidity, a condition with more than one chronic 
disease, in a family practice (Hudon et al., 2005). There is correlation (r = 0.58, p < 0.02) 
between the CIRS scores and the Older American Activities of Daily Living Scale scores 
(Miller et al., 1992). The intraclass correlation coefficients to evaluate multimorbidity by 
interviewing patients in a family practice ranges from 0.70 to 0.89 (Hudon et al., 2005). 
In the present study, Cronbach’s alpha was not calculated because items (i.e., heart vs. 
lower gastrointestinal) are not necessarily closely related to others in the group. 
Health status. A single index on the EuroQol, a visual-analog scale (VAS), was 
used to measure health status (see Appendix F). The VAS evaluates current perceived 
health status on a scale of 0 to 100, with 100 indicating the best imaginable health status. 
In the present study, the self-rated score measured on a continuum was used for statistical 
analysis. The validity correlation coefficients with the 36-item Short form Health Survey 
subscales and the VAS score range from 0.21 to 0.72 in patients with acute coronary 
syndromes (Schweikert et al., 2006). See the previous HRQOL section for validity and 
reliability of the overall EuroQol. 
Coping capacity. A 13-item short-form version of the Sense of Coherence (SOC) 
tool (Antonovsky, 1987) was used to measure how well caregivers coped with stress 
associated with caregiving (see Appendix I). The SOC refers to “one’s ability to respond 
to stressors by the appropriate use of adaptive coping resources” (Chumbler et al., 2004, 
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p. 944). Each item is scored from 1 (never) to 7 (very often), with total scores ranging 
from 13 to 91 where higher scores indicate greater coping. Total score measured on a 
continuum was used for statistical analysis. Construct-validity correlations between the 
SOC scale and the Self-Esteem Scale, the Mastery Scale (used to measure perception of 
control) and the Life Orientation Test (used to measure dispositional optimism) are 0.61, 
0.54 and 0.53, respectively (Pallant & Lae, 2002). Internal consistency is 0.86 
(Cronbach’s alpha) for caregivers of stroke survivors (Chumbler et al., 2004). In the 
present study, Cronbach’s alpha was 0.81 at T1 and 0.83 at T2. 
Social support. Social support was measured using the Multidimensional Scale of 
Perceived Social Support (MSPSS; Zimet, Dahlem, Zimet, & Farley, 1988; see Appendix 
J). The MSPSS is a 12-item scale that assesses perceptions about support from family, 
friends and a significant other. Responses range from 1 (very strongly disagree) to 
7 (very strongly agree) and higher scores indicate better levels of perceived social 
support. Total score measured on a continuum was used for statistical analysis. This scale 
shows excellent internal consistency (α = 0.92), good test–retest reliability (r = 0.85) and 
moderate construct validity (r = –0.13 – –0.25 with anxiety and depression subscales of 
the Hopkins Symptom Checklist; Zimet et al., 1988). Internal consistency for caregivers 
of persons with traumatic brain injury is excellent (α = 0.95; Davis et al., 2009). In the 
present study, Cronbach’s alpha reliability scores were 0.94 at both T1 and T2. 
Sociodemographics. Sociodemographics were assessed using a standard set of 
investigator-developed items (see Appendix A). The items included age, gender, 
race/ethnicity, native language, relationship to the stroke survivor (e.g., spouse or child), 
perceived quality of relationship with the stroke survivor (on a scale of 1 = excellent to 
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4 = poor), duration of caregiving role for the stroke survivor (prior to as well as since 
stroke), hours spent caring each day (prior to and since stroke), length of time since the 
stroke survivor was diagnosed with stroke, perceived level of preparedness for caregiving 
(on a scale of 1 = well prepared to 4 = not at all prepared), insurance type including 
Medicare/Medicaid, number of close friends and relatives, distance between site of care 
(e.g., hospital) and caregiver’s home, education, employment status, income and other 
life events (e.g., death, moving, retirement or marriage) in the past 3 months (at T1). At 
T2, selected items including perceived quality of relationship with the stroke survivor, 
duration of caregiving role for the stroke survivor since stroke, hours spent caring each 
day since stroke, length of time since the stroke survivor was diagnosed with stroke, 
perceived level of preparedness for caregiving, distance between site of care and home 
and other life events since the first interview were assessed. 
Stroke-survivor characteristics: Covariates. 
Severity and description of stroke. Severity of stroke was operationalized by the 
National Institute of Health (NIH) Stroke Scale, a standard neurological examination tool 
that measures consciousness, language, neglect, visual-field
 
loss, extraocular movements, 
motor strength, ataxia, dysarthria
 
and sensory loss (see Appendix L). This scale has 13 
items and total scores range from
 
0 (not impaired) to 42 (fully impaired). Total score 
measured on a continuum was used for statistical analysis. This tool has been shown to be 
reliable overall (Cronbach’s alpha > 0.5) and highly validated (Brott et al., 1989; 
Goldstein, Bertels, & Davis, 1989; Lyden et al., 1994). The validity correlations between 
NIH Stroke Scale scores and stroke-lesion size and patient outcome are 0.68 and 0.79, 
respectively (Brott et al., 1989). The stroke survivor’s medical chart was reviewed to 
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assess severity of stroke; the intraclass correlation coefficient was 0.82 in assessing 
neurological impairment by medical-chart review (Kasner et al., 1999). In the present 
study, Cronbach’s alpha was 0.88. In addition, a chart-abstraction form was used to 
describe the type of stroke, area of the stroke, communication disability (yes/no) and time 
poststroke in days. 
Functional status. Caregiver perception of the survivor’s ability to perform 
activities of daily living was measured using the Barthel Index (Mahoney & Barthel, 
1965; see Appendix M). The Barthel Index has 10 items that assess activities of daily 
living: self-care, continence of bowel and bladder and mobility. Each is scored from 0 to 
15. Total scores range from 0 to 100 where higher scores indicate independence from any 
help. Total sum score measured on a continuum was used for statistical analysis. The 
Barthel Index has well-established validity and reliability in measuring the functional 
status of stroke patients (Wade & Hewer, 1987; White et al., 2003). The validity 
correlations between the Barthel Index and the Motricity Index arm, leg, and total scores 
range from 0.73 to 0.77 on stroke patients (Wade & Hewer, 1987). Cronbach’s alpha with 
patients with stroke is 0.93 (White et al., 2003). Internal consistency in patients with 
stroke ranges from 0.87 to 0.92 (Shah, Vanclay, & Cooper, 1989). The intraclass 
correlation for caregiver proxy measure is excellent: 0.71 (Saban et al., 2012). In the 
present study, Cronbach’s alpha was 0.94 at both T1 and T2. 
Comorbidity. The modified version of the CIRS (Miller et al., 1992, see 
Comorbidity section in Caregiver Characteristics: Covariates) was used to evaluate the 
stroke survivor’s comorbidity (the presence of coexisting or additional diseases) with 
reference to an initial diagnosis or with reference to the index condition, that is, stroke, 
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which is the subject of study (see Appendix H). Data were obtained by medical chart 
review. The scores of the CIRS (Miller et al., 1992), relative to its 14 systems, range from 
0 (no impairment) to 56 (maximal impairment). This scale has been shown to be valid 
and reliable in evaluating comorbidity among geriatric populations (Hudon et al., 2005) 
and
 
in institutionalized older adults (Parmelee, Thuras, Katz, & Lawton, 1995). There is a 
correlation (r = 0.58, p < 0.02) between the CIRS scores and the Older American 
Activities of Daily Living Scale scores (Miller et al., 1992). The intraclass correlation 
coefficients range from 0.66 to 0.87 and interrater reliability ranges from 0.80 to 0.89 in 
assessing comorbidity by medical-chart review in a family practice (Hudon et al., 2005). 
Total score measured on a continuum was used for statistical analysis. In the present 
study, Cronbach’s alpha for the CIRS was not calculated because items (i.e., heart vs. 
lower gastrointestinal) are not necessarily closely related to others in the group. 
Sociodemographics. Sociodemographic data were collected in the caregiver 
interview using a standard investigator-developed form (see Appendix K). At T1, 
caregivers provided stroke-survivor data: age, gender, race/ethnicity, education, 
employment status, income, insurance including Medicare/Medicaid and time in days 
since admission to the hospital. At T2, I obtained location (e.g., rehabilitation hospital, 
nursing facility or home) to which a stroke survivor was initially transferred after hospital 
discharge, site of current placement and time since admission to any facility or discharge 
to home. In addition, I assessed duration of rehabilitation including inpatient or outpatient, 
if relevant. 
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Table 2 
Summary of Main Variables and Measures 
Research 
variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
Uncertainty Inability to determine the 
meaning of illness-related 
events (i.e., stroke survivors’ 
health outcomes and the new 
caregiver role) 
Perception of 
Uncertainty in 
Illness Scale/             
31 items            
(Mishel, 1997b) 
Total Score  
(31 to 155)/ 
Continuous 
Correlation coefficient: 0.50–0.89 between 
factors and total scale/ 0.16 between total score 
and the judged seriousness of their child’s 
illness in the Parent Perception of Uncertainty 
Scale (Mishel, 1983) 
 
Cronbach’s alpha: 0.81–0.92 for family 
caregivers (Mishel, 1997b); 
Cronbach’s alpha in the present study: 0.92 to 
0.95 
Caregiver 
Interview    
T1, T2 
Perceived 
Stress 
Domestic upset, negative 
feelings toward the patient 
and personal distress in 
relation to the patient 
Perceived Stress 
Scale/ 
14 items                     
(S. Cohen et al., 
1983) 
Total Score    
(0 to 56)/ 
Continuous 
Correlation coefficient: 0.65–0.76 with 
depressive and 0.52–0.65 with physical 
symptomatology and 0.37–0.46 with social 
anxiety in college students (S. Cohen et al., 
1983) 
 
Cronbach’s alpha: 0.84–0.86 (S. Cohen et al., 
1983) and 0.91 in older African American and 
European American females (McCallum et al., 
2006); Cronbach’s alpha in the present study: 
0.86–0.88 
Caregiver 
Interview   
T1, T2 
    Table continues 
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Research 
variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
Physiological 
Stress  
Variation in endocrine 
activity and response to 
stressor 
Salivary Cortisol 
level; collection 
at awaking to 
capture peak 
levels and at 
2100h to capture 
lower levels using 
Salimetrics oral 
swabs            
(McCallum et al., 
2006) 
Cortisol in 
units: μg/dL/ 
Continuous 
Salivary cortisol reflects the variation in 
endocrine activity and response to acute stress 
(Feve-Montange et al., 1981) and is a reliable 
and valid reflection of cortisol in blood (Woods 
et al., 2008). 
 
Collecting salivary cortisol at awaking and in 
the evening can capture the circadian rhythm 
(Woods et al., 2008). 
 
Correlation between salivary cortisol using a 
Salimetrics Kit and serum cortisol: 0.91 
(Salimetrics, 2011)                                           
Salimetrics Kits’ Sensitivity: < 0.003 μg/dL; 
Inter-assay coefficient of variation (CV)          
across 12 runs: 6.41% (Woods et al., 2008)                         
Intra-assay CV: 3.65% (Woods et al., 2008) 
 
Inter-assay CV in the present study: 6.56% 
Intra-assay CV in the present study: 4.61% 
Minimum detectable limit in the present study : 
0.010 μg/dL 
Caregiver 
Self 
Collection 
T1, T2 
    Table continues 
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Research 
variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
Burden Caregivers’ feelings of being 
overwhelmed and strained in 
assisting their care recipients 
Zarit Burden 
Interview/ 
22 items                 
(Zarit & Zarit, 
1987) 
Total Score  
(0 to 88)/ 
Continuous 
Correlation coefficient: 0.73 with the Burden 
Assessment Scale score, 0.62 with the General 
Health Questionnaire score, 0.53 with the 
Dementia Management Strategies Scale score 
and 0.53 with the Revised Memory and 
Behavior Problems Checklist score (Seng et 
al., 2010) 
 
Cronbach’s alpha: 0.87–0.93 for caregivers of 
stroke survivors (Visser-Meily et al., 2004); 
0.89 for older caregivers of stroke survivors 
(Hartke & King, 2002); Test–retest reliability 
(Kappa): 0.71 (Vitaliano et al., 1991); 
Cronbach’s alpha in the present study: 0.92–
0.94 
Caregiver 
Interview  
T1, T2 
Health-
Related 
Quality of 
Life 
Personal well-being or 
satisfaction focusing on 
aspects of health or illness 
EuroQol: 
EQ5D/ 
5 items 
(EuroQol Group) 
Total Score             
(5 to 15)/ 
Continuous 
Valid and reliable to measure health-related 
quality of life in various populations (Dorman 
et al., 1998; Fransen & Edmonds, 1999; Hurst 
et al., 1997; Schweikert et al., 2006) 
 
Correlation coefficient: 0.57–0.74 with the 36-
item short-form health-survey subscales in 
patients with acute coronary syndromes 
(Schweikert et al., 2006) 
 
Intraclass correlation coefficient: 0.70 (Fransen 
& Edmonds, 1999); 
Cronbach’s alpha in the present study: 0.48–
0.59 
Caregiver 
Interview  
T1, T2 
    Table continues 
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Research 
variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
Depressive 
Symptoms  
Symptoms listed in the 
Diagnostic and Statistical 
Manual of Mental Disorders 
major depressive-disorder 
category such as disinterest, 
low mood, sleep disruption or 
tiredness  
Patient Health 
Questionnaire/ 
9 items            
(Kroenke & 
Spitzer, 2002) 
Total score                                
(0 to 27) 
Continuous 
Correlation coefficient: 0.33–0.73 with 
depression severity scores and worsening 
function with the subscale of the 20-item 
Short-Form General Health Survey (Kroenke et 
al., 2001) 
 
Excellent internal consistency reliability (α = 
0.86–0.89), test-retest reliability (r =0.84) and 
validity (Kroenke et al., 2001); Internal 
consistency reliability for caregivers of stroke 
survivors: 0.80–0.86 (Bakas, Champion, et al., 
2006; Bakas, Kroenke, et al., 2006); 
Cronbach’s alpha in the present study: 0.84–
0.86 
Caregiver 
Interview  
T1, T2 
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Table 3 
Summary of Covariates and Measures 
Caregiver covariates 
Research variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
Comorbidity Presence of coexisting diseases Cumulative Illness Rating 
Scale/ 
14 systems                       
(Miller et al., 1992) 
Total Score 
(0–56)/ 
Continuous 
Correlation coefficient: 0.58 with the 
Older American Activities of Daily 
Living Scale scores (Miller et al., 1992) 
Intraclass correlation: 0.70–0.89 (Hudon 
et al., 2005) 
Caregiver 
Interview 
T1, T2 
Health status Self-perceived level of overall wellness 
in the individual 
EuroQol: 
VAS/ 
1 item visual analogue 
scale 
(EuroQol Group) 
Self-rated    
Score  
VAS 
(0–100)/ 
Continuous 
Correlation coefficient: 0.21–0.72 with 
the 36-item Short-Form Health-Survey 
subscales in patients with acute coronary 
syndromes (Schweikert et al., 2006). 
Intraclass correlation coefficient: 0.70 
(Fransen & Edmonds, 1999) 
Caregiver 
Interview 
T1, T2 
Coping capacity One’s ability to respond to stressors by 
the appropriate use of adaptive 
resources 
Sense of Coherence/ 
13 items                        
(Chumbler et al., 2004) 
Total score 
(13–91)/ 
Continuous 
Correlation coefficient: 0.61 with the 
Self-Esteem Scale, 0.54 with the 
Mastery Scale (used to measure 
perception of control), 0.53 with the 
Life Orientation Test (used to measure 
dispositional optimism; Pallant & Lae, 
2002) 
 
Internal consistency; alpha = 0.9 
(Chumbler et al., 2004); 
Cronbach’s alpha in the present study: 
0.81–0.83 
Caregiver 
Interview 
T1, T2 
Table continues 
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Caregiver covariates 
Research variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
Social 
support  
Perceptions about the availability of 
relationships that provide help and 
prevent negative outcomes from the 
stressful event 
Multidimensional Scale 
of Perceived Social 
Support/ 
12 items                           
(Zimet et al., 1988) 
Total score 
(7–84)/ 
Continuous 
Correlation coefficient: –0.13 – –0.25 
with the anxiety and depression 
subscales of the Hopkins Symptom 
Checklist (Zimet et al., 1988) 
Excellent high internal consistency 
(α = 0.92) and good test–retest 
reliability (r = 0.85), correlated with the 
full version (Zimet et al., 1988); Internal 
consistency for caregivers of persons 
with traumatic brain injury: α = 0.95 
(Davis et al., 2009); 
Cronbach’s alpha in the present study: 
0.94–0.94 
Caregiver 
Interview 
T1, T2 
Sociodemographics At T1, age, duration of caregiving in 
days (prior to and since stroke), hours 
spent caring each day (prior to and 
since stroke), days since stroke, 
number of close friends and relatives, 
distance between site of care and home 
in miles, perceived quality of 
relationship with the stroke survivor, 
perceived level of preparedness for 
caregiving, other life events in the past 
3 months, gender, race/ethnicity, native 
language, relationship to the stroke 
survivor, health insurance, education, 
employment status and income 
Investigator Developed 
Form 
Continuous 
Ordinal 
Dichotomous 
or 
Categorical 
N/A Caregiver 
Interview 
T1, T2 
Table continues 
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Caregiver covariates 
Research variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/ 
data type Validity/reliability 
Source for 
data 
collection 
 At T2, hours spent caring each day 
since stroke, duration of caregiving 
role for the stroke survivor since stroke 
in days, days since stroke, distance 
between site of care and home in miles, 
perceived quality of relationship with 
the stroke survivor, perceived level of 
preparedness for caregiving and other 
life events occurring since the 1st 
interview 
    
Stroke-survivor covariates 
Research variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/                             
data type Validity/reliability 
Source for 
data 
collection 
Severity of stroke Measures of consciousness, language, 
neglect, visual-field
 
loss, extra-ocular 
movements, motor strength, ataxia, 
dysarthria
 
and sensory loss 
National Institutes of 
Health Stroke Scale/ 
13 items 
(Know Stroke, 2010) 
Total score 
(0–42)/ 
Continuous 
Correlation coefficient:  0.68 with 
stroke-lesion size and 0.79 with patient 
outcome (Brott et al., 1989) 
 
The intraclass correlation coefficient: 
0.82 by medical-chart review (Kasner et 
al., 1999); 
Cronbach’s alpha in the present study: 
0.88 
Chart 
Review 
T1 
Description of 
stroke 
Measures of communication disability 
(yes/no),type of stroke, area of stroke 
and time poststroke 
Investigator-developed 
form  
Dichotomous 
or  
Categorical 
 N/A Chart 
Review 
T1 
Table continues 
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Stroke-survivor covariates 
Research variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/              
data type Validity/reliability 
Source for 
data 
collection 
Functional 
status 
Ability to perform activities of daily 
living 
Barthel Index/ 
10 items                        
(Mahoney & Barthel, 
1965) 
Total score  
(0 to 15)/           
Continuous 
Correlation coefficient: 0.73–0.77 with 
the Motricity Index arm, leg and total 
scores range from on stroke patients 
(Wade & Hewer, 1987). 
Cronbach’s alpha: 0.93 (White et al., 
2003); 
Internal consistency: 0.87–0.92 (Shah et 
al., 1989) in stroke patients);               
Intraclass correlation for caregiver 
proxy measure: 0.71 (Saban et al., 
2012);                                                 
Cronbach’s alpha in the present study: 
0.94–0.94 
Caregiver 
Interview 
T1, T2 
Comorbidity Presence of coexisting diseases Cumulative illness 
rating scale/ 
14 systems                      
(Miller et al., 1992) 
Total Score     
(0 to 56)/  
Continuous 
Correlation coefficient: 0.58 with the 
Older American Activities of Daily 
Living Scale scores (Miller et al., 1992) 
Intraclass correlation coefficients; 0.66–
0.87;                                                          
Interrater reliability; 0.80–0.89 in 
assessing comorbidity by medical-chart 
review 
Chart 
review 
T1 
Table continues 
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Stroke-survivor covariates 
Research variable Theoretical definition 
Instrument/ 
items (source) 
Total score 
range/              
data type Validity/reliability 
Source for 
data 
collection 
Sociodemographics At T1, age, days since admission to the 
hospital, gender, race/ethnicity, 
education, employment status, income 
and health insurance 
 
At T2, duration of rehabilitation in 
days, if relevant, location to which a 
stroke survivor initially placed after 
hospital discharge and/or now currently 
placed and days since admission to any 
facility or discharge to home 
Investigator-developed 
form 
Continuous 
or 
Categorical 
     N/A  Caregiver 
interview 
T1, T2 
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Procedures 
Participant recruitment, screening and informed consent. Approval for the 
proposed study was obtained from the Institutional Review Boards (IRBs) at the 
University of Pennsylvania and Thomas Jefferson University. A member of the research 
team, either a research assistant or I (hereafter referred to as “research team member”), 
trained in the study protocol, visited each unit during weekdays and/or on weekends to 
identify, screen and enroll eligible participants. The research team member first inspected 
a daily list from the electronic medical records to identify patients admitted with stroke. 
Stroke survivors’ paper charts as well as electronic medical records were then reviewed 
by the research team member to identify eligible potential participants. In addition, 
nursing leaders on the units helped identify potential caregiver participants. As a 
recruitment strategy at the Hospital of the University of Pennsylvania, we posted IRB-
approved recruitment flyers in the units and added them to patient-education brochures 
that are routinely distributed to patients and caregivers by nursing staff when patients are 
admitted to the hospital (see Appendix X). At Thomas Jefferson University, IRB-
approved recruitment flyers were distributed to potential participants by a research team 
member. 
Ideally, a research team member tried to make first contact with caregivers for 
enrollment and T1 data collection while caregivers were visiting on the unit following 
their introduction by the nursing staff (See Appendix V). Alternatively, the research team 
member telephoned caregivers to explain the study and arrange a convenient meeting at 
the hospital or at their homes (See Appendix W). The research team member then talked 
with caregivers and determined their interest in study participation. 
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If caregivers met all of the inclusion criteria and expressed an interest in 
participating, a research team member obtained written informed consent. An effort was 
made to recruit caregivers within the first week of their relatives’ stroke since it was 
expected that this period would best capture caregivers’ acute stress in the natural 
environment. For caregivers who initially expressed being too overwhelmed to 
participate in an interview, the research team member sought their permission to 
approach them again up to 2 weeks poststroke. 
Informed consent. A research team member informed potential participants in 
lay language that participation was voluntary and the purpose of the study, potential risks, 
and what they would need to do if they chose to participate. The research team member 
also encouraged potential participants to discuss participation with their family, friends 
and/or healthcare providers. The research team member judged the decision-making 
capacity of caregivers to consent, based on the person’s ability to “understand, appreciate, 
compare and choose” (Ulrich & Karlawish, 2006, p. 57). The consent capacity guide used 
is found in Appendix N. 
After recruitment and obtaining informed consent from caregivers, the research 
team member also obtained from stroke survivors or their surrogates informed consent 
and Health Insurance Portability and Accountability Act of 1996 (HIPPA) authorization 
to access the stroke survivor’s medical record (see Appendices P, Q, S, T and U). Some 
stroke survivors who are cognitively impaired may or may not be able to demonstrate 
capacity for informed consent. For those lacking decision-making capacity, federal 
regulations require researchers to obtain written informed consent from their legally 
authorized representatives. For this study, we used the MacArthur Competency 
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Assessment for Clinical Research (MacCAT-CR; Appelbaum & Grisso, 2000) for 
situations in which it was not clear whether the stroke survivor did or did not demonstrate 
capacity for informed consent. The MacCAT-CR is a semistructured interview with 
open-ended questions and has been used to test capacity for decision making for consent 
in patients with Alzheimer’s disease (Kim, Caine, Currier, Leibovici, & Ryan, 2001; Kim, 
& Karlawish, 2003; Ulrich & Karlawish, 2006). The original MAcCAT-CR tool was 
developed for a clinical trial and some questions did not fit our study design. Thus, we 
modified relevant questions and a new cut-off point: 13 was used to determine capacity 
for informed consent in the group of stroke survivors with unclear capacity (see 
Appendix O). In cases when it was still unclear whether care recipients (stroke survivors) 
had the capacity to consent to the study, we used the “dual consent process” (see 
Appendix R), based on the recommendations of Barron, Duffey, Byrd, Campbell, and 
Ferrucci (2004, p. 82). 
Data collection. Data collection from caregiver participants occurred at two time 
points: within 2 weeks poststroke (T1) while stroke survivors were still in the hospital 
and then 4 weeks after the first interview (T2) (hereafter referred to as “6 weeks 
poststroke”). At each time point, participants completed a quantitative survey instrument 
and provided salivary specimens. Data from the stroke survivor’s medical record were 
collected only at T1; selected items were repeated with the proxy at T2. 
Survey instrument administration. After recruiting participants and obtaining 
informed consent, a research team member interviewed consenting caregivers in a quiet 
place at the hospital or in caregivers’ homes to provide privacy and protect 
confidentiality. With a few exceptions at T2, according to protocol, caregiver participants 
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were interviewed in person at each time point. The interviews required as much as 40–50 
minutes (including enrollment procedures) at T1 and as much as 30–40 minutes at T2. 
The research team member gave caregivers the option to stop the interview or take a 
break if needed. Quantitative paper and pencil survey instruments were administered by 
reading questions to participants and recording their answers. The participant was given a 
large print copy of the instrument to follow along to help overcome potential barriers in 
reading level or literacy in the study population. Alternatively, participants read and filled 
out the survey questions first and the research team member reviewed their answers for 
clarity and completeness. For T2 data collection (4 weeks after the first interview), the 
research team member contacted the caregiver participant by telephone to arrange to meet 
at a place convenient to them. For caregiver participants who were not available to meet 
in person at T2, we provided a copy of the survey instruments in advance, arranged a 
telephone interview and read questions aloud as necessary to enable participants to 
answer the survey questions by phone. Alternatively, some participants filled out the 
survey questions and collected the second saliva sample by themselves and mailed both 
to us. The research team member subsequently called the participants to review the 
survey answers for clarity and completeness. 
The research team member tried to minimize missing data by providing a quiet 
room for privacy, if the interview was conducted in a hospital or other healthcare setting. 
Missing data due to interviewer error was corrected in one of two ways. The research 
team member carefully reviewed the survey form for completeness before concluding 
each interview, or we telephoned participants to ask about any missing data and to 
confirm responses. 
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Chart review for stroke survivors. After having obtained informed consent and 
HIPAA authorization from patients or surrogates, a research team member reviewed the 
medical record of consenting stroke survivors at T1 to obtain information about their 
stroke severity, description of stroke and comorbidities. These data were subsequently 
reviewed for completeness and charts revisited to supply any missing data. 
Saliva-specimen collection. Caregivers were taught self-collection of saliva in an 
in-person demonstration at T1. On a day following the interview at T1 and before the 
interview at T2, caregivers were asked to collect their saliva samples. They were 
instructed to collect saliva at home at T1 and T2 using the same procedure. Written and 
diagrammatic instructions along with the collection kits were sent home with the 
caregiver and instructions were reviewed by telephone prior to the day they were to 
collect the samples at each time point. To capture diurnal variations in cortisol 
concentration, caregivers collected saliva on waking and again at 2100 h (McCallum et 
al., 2006). Caregivers were instructed not to eat food, drink liquid or brush teeth for 30 
minutes before collecting saliva and not to smoke for 60 minutes before collecting saliva. 
Caregivers put the Salimetrics oral swab under their tongue for 1 minute to collect saliva. 
They then inserted the oral swab into the tube, replaced the cap and filled out and placed 
the label on the storage tube. Saliva collection and labeling took up to 5 minutes each 
time. For each data collection (on waking and 2100 h), they placed the tube in a sealed 
plastic bag and placed the bag in the freezer overnight as instructed. The research team 
member picked up the samples and transported them in a cooler bag to the School of 
Nursing Biobehavioral Laboratory for storage. Alternatively (for those few caregivers 
living at extreme distance), caregivers placed the bags of tubes in a prepaid post office 
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envelope and mailed it to us. In either case, the sample was delivered, placed in a project-
labeled container and stored in a freezer at –80° C for later analysis. 
Retention. To avoid losing contact with participants, the research team member 
requested two telephone numbers (home phone and cellular phone) as well as street and 
e-mail addresses and an alternative contact for each participant. Every attempt was made 
to locate and contact the participant for the T2 data collection using this information. For 
participants who did not respond to our telephone calls, the research team member sent 
e-mail messages as well as letters via the U.S. Postal Service. 
As an additional strategy for retention, thank-you notes with a $10 gift card per 
participant were given after data collection was completed at each time point for a total 
maximum value of $20. The participant received the gift card in person or by U.S. mail 
upon completion of the quantitative interview and saliva data collection for each T1 and 
T2. If they withdrew from the study before T2, they kept the T1 gift card they had 
already received. If stroke survivors died following T1 data collection, an attempt to 
retain their caregiver participant for T2 data collection was made. 
Data Management 
All data were kept anonymous to protect the confidentiality of participants; 
identification numbers rather than names were assigned sequentially and were used on all 
paper and electronic materials that referenced participants. Paper forms were locked in a 
cabinet in a locked data-repository room at the University of Pennsylvania School of 
Nursing, separate from signed consent forms and lists of participants with code numbers. 
All data were entered into an electronic file. Double data entry was used and any 
discrepancy between the two data sets was compared and cleaned. Electronic data and 
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results of all analyses were stored and managed using a secure research server at the 
University of Pennsylvania School Nursing. 
The salivary-cortisol samples were kept in freezer storage at the Biobehavioral 
Laboratory at the University of Pennsylvania School of Nursing until data collection was 
complete, and then transported to the University of Pennsylvania Pearlman School of 
Medicine Clinical and Translational Research Center where the assays were completed 
all at one time by the trained laboratory staff. This updated 2,000-square-foot laboratory 
for biological research provides optimal –80° C freezer space and an established protocol 
for the assay of salivary cortisol using enzyme-linked immuno sorbent assay. 
Statistical Analysis 
Overall analysis. All data were analyzed using SPSS 20.0 for Windows and 
STATA 12. All variables were described using descriptive statistics and bivariate 
analysis. In addition, for participants with complete data at both time points, a paired 
t-test (for continuous variables) and Fisher’s exact test (for categorical variables) were 
used to explore any changes over time. For the development of multivariable models, 
multivariate stepwise regression was conducted to evaluate study hypotheses while 
adjusting for important covariates related to study outcomes for Aims 1, 2 and 3. For Aim 
4, univariate or multivariate regression in each Baron and Kenny (1986) step was used in 
establishing the mediator effect of perceived stress and salivary cortisol on the 
relationship between uncertainty and psychological outcomes (burden, HRQOL and 
depressive symptoms). The robust standard error was used to protect against violations in 
the homoscedasticity assumption in all regression analyses. 
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Preliminary analysis. Descriptive estimates of all measures were generated: 
frequencies and percents for categorical variables and estimates of central tendency 
(means and medians), measures of variability (standard deviations, interquartile ranges 
and ranges) and derived moments of skewness and kurtosis for continuous variables. An 
analysis of distributional properties using histograms and Shapiro-Wilk tests were 
performed to determine if variance stabilizing should be applied. Outliers were accessed 
via visual inspection of distributions and checked for accuracy. 
Comparison of study variables at T1 and T2. A paired t-test (for continuous 
variables) and Fisher’s exact test (for categorical variables) were used to examine 
differences in study variables measured at both time points in participants with complete 
datasets. 
Bivariate analysis. 
Correlations. I estimated correlations among caregiver or stroke-survivor 
characteristics and the main study variables—uncertainty, perceived stress, salivary 
cortisol, burden, HRQOL and depressive symptoms. I calculated Pearson’s correlation 
coefficient when two variables were normally distributed and Spearman’s correlation 
coefficient when one of the variables was not normally distributed or was ordinal. 
Differences in continuous variables by categories of caregiver and stroke-
survivor characteristics. Two-sample t-tests (for dichotomous variables) and one-way 
analysis of variance (ANOVA; for categorical variables having more than two levels) 
were used when comparing with continuous variables. For the positively skewed and not 
normally distributed variables, Mann-Whitney U test (for dichotomous variables) and the 
Kruskal-Wallis test (for categorical variables on more than two levels) were used to 
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examine differences in continuous variables between categories of caregiver and stroke-
survivor characteristics. 
Multivariate analysis. Multivariate stepwise regression and a p-value cut off 
point of 0.05 were used to determine the effect of uncertainty on perceived stress, 
salivary cortisol, burden, HRQOL and depressive symptoms (Aims 1, 2 and 3), 
controlling for covariates. Given the large number of covariates available and the limited 
sample size, only caregiver and stroke-survivor characteristics that were identified from 
bivariate analysis on the basis of a p-value less than or equal to 0.05 were entered in the 
multivariate stepwise regression models to test Aims 1, 2 and 3. Univariate or 
multivariate regression in each Baron and Kenny step (1986) was used in establishing the 
mediator effect of perceived stress and salivary cortisol on the relationship between 
uncertainty and psychological outcomes (burden, HRQOL and depressive symptoms; 
Aim 4). Covariates, which remained in the final stepwise models for each Aim 1, 2 and 3, 
were entered in the models to test Aim 4. The robust standard error was used to protect 
against violations in the homoscedasticity assumption in all analyses. For all analyses, a 
p-value of less than 0.05 in a two-sided test was considered statistically significant. 
Aim 1. Determine at each time point if uncertainty (regarding stroke survivors’ 
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress.  
The level of uncertainty measured continuously was modeled as an independent 
predictor of the dependent variable, perceived stress (total score measured on a 
continuum). Separate models were estimated for the dependent variable at T1 and at T2. 
Multivariate stepwise regression and a p-value cut off point of 0.05 were used to 
individually model the dependent variable as a function of the predictor of interest 
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(uncertainty) at T1 and at T2, while controlling for potential confounders or precision 
variables identified from bivariate analysis on the basis of a p-value less or equal to 0.05. 
To test the linearity assumption, a scatterplot matrix of all independent variables against 
the dependent measure in a pairwise manner was used. A bivariate correlation matrix of 
the independent variables combined with the computation of auxiliary R-squared values, 
tolerance and variance inflation factor were used to check for multicollinearity. Finally, 
the Huber-White robust sandwich variance estimator was used to protect against 
violations in the homoscedasticity assumption. 
Aim 2. Determine at each time point if uncertainty predicts levels of caregivers’ 
physiological stress (salivary cortisol).  
The level of uncertainty measured continuously was modeled as an independent 
predictor of the dependent variable, salivary cortisol. A multivariate stepwise regression-
analysis approach similar to that used for Aim 1 was used for Aim 2. Model assumptions 
were assessed as described for Aim 1. 
Aim 3. Examine at each time point the relationship of uncertainty to 
psychological outcomes (burden, HRQOL and depressive symptoms).  
Separate models were estimated for each dependent variable (burden, HRQOL 
and depressive symptoms) at T1 and at T2. Multivariate stepwise regression and a p-
value cut off point of 0.05 was used to individually model the dependent variable as a 
function of the predictor of interest (uncertainty) at T1 and at T2, while controlling for 
potential confounders or precision variables identified from bivariate analysis on the 
basis of a p-value less or equal to 0.05. Model assumptions were assessed as described 
for Aim 1. 
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Aim 4. Explore at each time point the mediator effect of stress (perceived stress 
and physiological stress) on the relationship between uncertainty and psychological 
outcomes (burden, HRQOL and depressive symptoms).  
To test the hypothesis of stress (perceived or salivary cortisol) as a mediator in the 
relationship between uncertainty and psychological outcomes (burden, HRQOL and 
depressive symptoms) at T1 and at T2, separate models were estimated for each mediator 
(perceived stress and salivary cortisol) and each dependent variable (burden, HRQOL and 
depressive symptoms) at T1 and at T2. According to Baron and Kenny (1986) and Judd 
and Kenny (1981), the following must hold to establish a mediational effect: (a) 
uncertainty must be significantly associated with each mediator (perceived stress or 
salivary cortisol); (b) each mediator (perceived stress or salivary cortisol) must reliably 
predict each psychological outcome (burden, HRQOL or depressive symptoms); and (c) 
the significant relationship between uncertainty and each psychological outcome should 
be attenuated when the mediator is added to the model. 
First, multiple regression analysis was used to assess the association between 
uncertainty and each potential mediator (perceived stress or salivary cortisol). Second, 
multiple regression analysis was used to assess the association between each dependent 
variable and each potential mediator. Third, uncertainty and the specific covariate were 
entered into a model estimated for each dependent variable, followed by the addition of 
the specific mediator. To demonstrate mediation, we observed a change in the 
relationship between uncertainty and the dependent variable from significant to 
nonsignificant or attenuated, after adjusting for perceived stress or salivary cortisol. 
Model assumptions were assessed as described in Aim 1. 
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Sensitivity analyses. 
Comparison of study completers and dropouts. A sensitivity analysis was 
conducted to compare baseline caregiver and stroke-survivor sociodemographics and 
stroke-related characteristics between participants who completed the study and those 
who were excluded in the data analysis at T2. 
Repeated-measures analysis for Aims 1, 2 and 3. Separate bivariate linear mixed 
models with repeated measures of each dependent variable were computed to additionally 
explore the overall effects of uncertainty or covariates on repeated measures of each 
dependent variable (perceived stress, salivary cortisol, burden, HRQOL and depressive 
symptoms). Restricted maximum likelihood was used. Restricted maximum likelihood 
“chooses as estimates those values that, if true, would maximize the probability of 
observing what has, in fact, been observed” (Allison, 2002, p. 13). Because restricted 
maximum likelihood compensates for missing data, all participants who were recruited at 
T1 were included in the analysis. For participants whose stroke survivor died after T1 
data collection, predeath recall of measures of uncertainty, burden or stroke-survivor 
functional status, as well as current (T2, postdeath) measures for perceived stress, 
salivary cortisol, HRQOL or depressive symptoms were included as data at T2, because 
these data are more likely to be similar to real than missing data. For participants who 
were lost to follow up or withdrew from the study, there were no available data at T2. 
First, separate bivariate linear mixed models with repeated measures of each 
dependent variable (perceived stress, salivary cortisol, burden, HRQOL and depressive 
symptoms) were computed to assess the overall effects of repeated measures of 
uncertainty on each dependent variable. The initial model included uncertainty, time and 
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the interaction between uncertainty and time to determine which factors were significant 
predictors of each dependent variable. If the interaction variable between uncertainty and 
time was not significant, this interaction variable was excluded in the final model. 
Second, separate bivariate linear mixed models with repeated measures of each 
dependent variable (perceived stress, salivary cortisol, burden, HRQOL and depressive 
symptoms) were computed to assess the overall effects of each covariate (that remained 
in the final stepwise regression model) on each dependent variable for Aims 1, 2 and 3. 
The initial model included each covariate, time and interaction between covariate and 
time to determine which factors were significant predictors of each dependent variable. If 
the interaction between covariate and time was not significant, the interaction variable 
was excluded from the final model. 
Third, the effects of time on repeated measures of each dependent variable 
(perceived stress, salivary cortisol, burden, HRQOL and depressive symptoms) were 
visually compared to the results from the paired t-test that was used to examine any 
differences in continuous variables measured at both time points for participants with 
complete datasets. 
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CHAPTER 4: RESULTS 
Introduction 
A total of 63 caregivers and stroke survivors agreed to participate in the study. At 
T1, all 63 caregivers were interviewed using a survey questionnaire; there were no 
missing data. Fifty seven of these caregivers provided saliva samples on waking and 56 
provided saliva samples in the evening. Of the evening samples, however, one lacked 
sufficient volume of saliva to detect cortisol and another was an extreme outlier when 
assayed, suggesting contamination; these two samples were excluded from data analysis. 
Thus, at T1, 57 saliva samples on waking and 54 evening saliva samples were included in 
the data analysis. Also at T1, the medical records of the 63 stroke survivors were 
reviewed to obtain information about severity of stroke, description of stroke and 
comorbidity with no missing data. At T2, 13 stroke survivors had died and their 
caregivers’ data were not included in the analyses of aims at T2; an additional seven 
caregivers were lost to follow up because we were unable to contact them, despite 
multiple attempts, and three caregivers withdrew from the study. The participants who 
withdrew from the study expressed that they could no longer participate due to their 
caregiving situation and/or personal problems. 
Thus, a total of 40 caregivers were included for data analysis at T2. There were no 
missing survey data for these 40 caregivers; 38 of them provided saliva samples on 
waking and in the evening, and all of these samples were available for assay. Comparing 
baseline characteristics of participants who completed the study (N = 40) and those who 
were not included in the data analysis at T2 (N = 23), there were no differences in values 
for caregiver or stroke-survivor characteristics with these exceptions: those who were not 
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included in data analysis at T2 had more social support at baseline (p = 0.036) and they 
and their stroke survivors were more likely of the non-Hispanic White race (p =  0.018 
for caregivers, p = 0.009 for stroke survivors). 
Descriptive Analysis for Sample Characteristics and Main Variables 
Caregiver characteristics. The sociodemographic characteristics of the 
caregivers are reported in Tables 4 and 5. The majority were female (67%) and largely 
non-Hispanic White (73%) or African American (22%). Caregivers’ ages ranged from 30 
to 89 years (Mean [M] ± Standard Deviation [SD]: 56.92 ± 13.81; median: 56.00, mode: 
41), and 30% were aged 65 years or older. Of caregivers, 60% were adult children and 
35% were spouses of stroke survivors. All caregivers had completed at least high school; 
most had either private, Medicare, or Medicare + supplemental health insurance plans 
(87%) and worked either full-time (43%) or part-time (11%). Just under half (48%) of 
caregivers felt comfortable financially and had more than enough funds to make ends 
meet. They reported an average of 18.37 (± 17.34) close friends and relatives. 
Table 5 shows caregiver characteristics measured at both T1 (N = 63) and T2 
(N = 40). In the year prior to the stroke, caregivers had provided help to their family 
member for an average of 201.75 (± 646.24) days, and time per day spent caring prior to 
the stroke was 2.90 (± 6.37) hours. At the T1 interview, the duration of caregiving for 
stroke survivors following the stroke was 4.19 (± 3.37) days and at T2, 36.03 (± 6.96) 
days. Time spent per day in caregiving since the stroke was 8.59 (± 6.64) hours at T1 and 
7.60 (± 6.59) hours at T2. Perceived quality of the relationship with the stroke survivor, 
on a scale of 1 (excellent) to 4 (poor), averaged 1.25 (± 0.60) at T1 and 1.5 (± 0.75) at T2. 
Perceived level of preparedness for caregiving on a scale of 1 (excellent) to 4 (poor) was 
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2.21 (1.11) at T1 and 2.25 (± 1.01) at T2. At T1, 40% of the caregivers had experienced 
other significant life events (e.g., a death, moving, retirement or marriage) in the 3 
months prior to the stroke in their family member and at T2, 23% reported similar life 
events that had occurred subsequent to the first interview. Distance between home and 
site of care was 39.35 miles (± 123.28) at T1 when stroke survivors were still 
hospitalized and 10.95 miles (± 20.26) at T2 when stroke survivors were at a 
rehabilitation hospital, a nursing facility or home. 
The average caregiver comorbidity score as measured by the Cumulative Illness 
Rating Scale (CIRS; higher score reflects greater severity) was 4.90 (± 4.20) at T1 
(N = 63) and 6.20 (± 4.69) at T2 (N = 40). Caregivers’ self-reported health status was also 
poorer at T2 (N = 40) with a mean EQ-Visual-Analog Scale (VAS) score of 74.68 
(± 15.68) compared to 80.57 (± 12.44) at T1 (N = 63). The mean coping capacity score as 
measured by the short-form version of the Sense of Coherence Scale (SOC; higher score 
reflects better coping) was 65.75 (± 11.71) at T1 (N = 63) and 67.25 (± 15.46) at T2 
(N = 40). On average, caregivers reported social-support scores of 73.57 (± 12.16) at T1 
(N = 63) and 63.88 (± 18.18) at T2 (N = 40) on the Multidimensional Scale of Perceived 
Social Support (MSPSS; higher score represents better social support). 
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Table 4 
Caregiver Sociodemographic Characteristics (N = 63) 
Variable M ± SD or N (%) 
Age (years) 56.92 ± 13.81 
Gender   
Female 42 (67%) 
Male  21 (33%) 
Race/Ethnicity  
Non-Hispanic White 46 (73%) 
African American 14 (22%) 
Asian  1 (< 2%) 
Hispanic  1 (< 2%) 
Other 1 (< 2%) 
Native Language  
English 60 (95%) 
Other 3 (5%) 
Relationship to the Stroke Survivor  
Spouse 22 (35%) 
Child 38 (60%) 
Grandchild 1 (2%) 
Sibling 2 (3%) 
Caregiver Insurance  
Private/Medicare/Medicare + Supplemental Health                
Insurance Plans 
55 (87%) 
Medicare + Medicaid/Medicaid/No insurance  8 (13%) 
Number of close friends and relatives 18.37 ± 17.34 
Education  
Less than High School 0 
High School 20 (32%) 
Vocational Training 6 (9.5%) 
College 23 (36.5%) 
Postgraduate 14 (22%) 
Table continues 
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Variable M ± SD or N (%) 
Employment  
Full Time 27 (43%) 
Part Tim  7 (11%) 
Homemaker 2 (3%) 
Unemployed  5 (8%) 
Retired  18 (29%) 
Leave of Absence  4 (6%) 
Income  
Comfortable 30 (48%) 
Adequate 26 (41%) 
Insufficient 7 (11%) 
Note. M = mean; SD = standard deviation; This information was collected only at T1. 
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Table 5 
Caregiver Characteristics Measured at T1 and T2 
 M ± SD or N (%) 
Variable T1 (N = 63) T2 (N = 40) 
Distance between site of care and home (miles) 39.35 ± 123.28 10.95 ± 20.26 
Duration of Caregiving (days)   
Prior to Stroke 201.75 ± 646.24  
Since Stroke 4.19 ± 3.37 36.03 ± 6.96 
Days Since Stroke 4.25 ± 3.36 36.45 ± 6.50 
Time Spent Caring per Day (hours)   
Prior to Stroke 2.90 ± 6.37  
Since Stroke 8.59 ± 6.64 7.60 ± 6.59 
Other significant life events in the past 3 months 
at T1 or since stroke at T2 (Yes) 
25 (40%) 9 (23%) 
Perceived Quality of Relationship with the  
Stroke Survivor 
[1=Excellent, 4=Poor] 
1.25 ± 0.60 1.50 ± 0.75 
Perceived Level of Preparedness for Caregiving 
[1=Excellent, 4=Poor] 
2.21 ± 1.11 2.25 ± 1.01 
Comorbidity Score 4.90 ± 4.20 6.20 ± 4.69 
Health Status 80.57 ± 12.44 74.68 ± 15.68 
Coping Capacity 65.75 ± 11.71 67.25 ± 15.46 
Social Support 73.57 ± 12.16 63.88 ± 18.18 
Note. M = mean; SD = standard deviation; Higher scores = poorer perceived quality of relationship with the 
stroke survivor, poorer perceived level of preparedness for caregiving, more comorbidities, better health 
status, better coping capacity and better social support. 
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Stroke-survivor characteristics. Table 6 summarizes stroke-survivor 
sociodemographic characteristics obtained from the caregivers. Just over half of stroke 
survivors were female (59%) and non-Hispanic White (71%), and most of the remainder 
were African American (24%). Stroke survivors’ ages ranged from 65 to 95 years (75.92 
± 7.82, median: 75.00, mode: 68), and 86% of them had completed high school or higher 
education. The majority had either private, Medicare, or Medicare + supplemental health 
insurance plans (84%). Most (75%) were retired, and their caregivers reported that only 
43% of them felt generally financially comfortable or had more than enough funds to 
make ends meet. 
Stroke-related information was obtained from a review of medical records, which 
was completed, on average, 4.22 (± 3.37) days poststroke (see Table 7). For the majority 
of stroke survivors (81%), this was a first stroke, whereas for 19% this was a recurrence 
(3% of 63 stroke survivors had a history of both stroke and transient ischemic attack) and 
11% had a history of transient ischemic attack. The average length of time since 
admission to the hospital at T1 was 4.49 (± 4.75) days at time of caregiver interview. The 
majority had either ischemic (51%) or hemorrhagic stroke (33%). For 43%, the stroke 
was located in the right hemisphere of the brain and for 44% in the left hemisphere. Of 
stroke survivors, 43% were unable to communicate verbally. The mean severity of stroke 
as measured by the National Institutes of Health (NIH) Stroke Scale was 12.98 (± 9.92; 
range 0–40, with higher scores reflecting greater severity) and the stroke-survivor 
comorbidity score, as measured by the CIRS, was 8.37 (± 4.37; higher scores represent 
greater severity). 
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Of the 40 stroke survivors remaining in the study at T2, 60% had been initially 
discharged from the acute-care hospital to a rehabilitation hospital (vs. 10% to a nursing 
facility; 22.5% to home and 7.5% to another place or remained in the same hospital). By 
the time of the T2 interview, only 17 (42.5%) of all stroke survivors were at home (vs. 
27.5% at a rehabilitation hospital, 12.5% at a nursing facility and 17.5% at another place). 
With regard to their rehabilitation experience, 80% had received in-patient rehabilitative 
therapy (in a rehabilitation hospital or skilled nursing facility) for a mean of 19.34 days 
(± 9.00) and 38% had received out-patient rehabilitative therapy for a mean of 18.71 days 
(± 10.80). Stroke-survivor functional status (see Table 7), as measured by the Barthel 
Index (higher scores reflect better function), was 23.17 (± 28.71) at T1 (N = 63)  
and 43.75 (36.56) at T2 (N = 40). 
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Table 6 
Stroke-Survivor Sociodemographic Characteristics (N = 63) 
Variable M ± SD or N (%) 
Age (years) 75.92 ± 7.82 
Gender   
Female  37 (59%) 
       Male  26 (41%) 
Race/Ethnicity  
Non-Hispanic White 45 (71%) 
African American 15 (24%) 
Asian 2 (3%) 
Hispanic  1 (2%) 
Education  
Less than High School 9 (14%) 
High School 22 (35%) 
Vocational Training 6 (10%) 
College 19 (30%) 
Postgraduate 7 (11%) 
Employment  
Full Time 6 (10%) 
Part Time 1 (2%) 
Homemaker 7 (11%) 
Unemployed 2 (3%) 
Retired 47 (75%) 
Leave of Absence 0 
Income  
Comfortable 27 (43%) 
Adequate 27 (43%) 
Insufficient 9 (14%) 
Insurance  
Private/Medicare/Medicare + Supplemental Health                   
Insurance Plans 
53 (84%) 
Medicare + Medicaid/Medicaid/No insurance 10 (16%) 
Note. M = mean; SD = standard deviation; This information was collected only at T1. 
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Table 7 
Stroke-Related Characteristics of Stroke Survivors (N = 63) 
Variable M ± SD or N (%) 
Days poststroke  4.22 ± 3.37 
Days since admission to hospital 
at time of caregiver interview  
4.49 ± 4.75 
Type of Stroke  
Ischemic 32 (51%) 
Intracerebral Hemorrhage 21 (33%) 
Subarachnoid Hemorrhage 10 (16%) 
Area of Stroke  
Right 27 (43%) 
Left 28 (44%) 
Right and Left or Other 8 (13%) 
Communication Disability  
Yes 27 (42.9%) 
No 30 (47.6%) 
Unclassified 6 (9.5%) 
Severity of Stroke 12.98 ± 9.92 
Comorbidity Score 8.37 ± 4.37 
Functional Status 23.17 ± 28.71 at T1 
43.75 ± 36.56 at T2 (N = 40) 
Note. M = mean; SD = standard deviation; With the exception of functional status, this information was 
collected only at T1; Higher scores = greater severity of stroke, more comorbidities and better functional 
status. 
Main study variables. Table 8 summarizes levels of caregiver uncertainty, 
perceived stress, salivary cortisol on waking and in the evening, burden, health-related 
quality of life (HRQOL) and depressive symptoms at T1 (N = 63) and T2 (N = 40). 
Average uncertainty score on the Mishel Uncertainty in Illness Scale for Family 
Members (higher scores reflect greater uncertainty) was 84.13 (± 19.93) at T1 and 85.23 
(± 23.94) at T2. Their average score on the Perceived Stress Scale (PSS; higher scores 
reflect higher perceived stress) was 24.21 (± 9.55) at T1 and 24.47 (± 10.74) at T2. 
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The mean salivary-cortisol level on waking was 0.41 (± 0.37) µg/dL at T1 and 
0.33 (± 0.21) µg/dL at T2 and the mean salivary-cortisol level in the evening was 0.13 
(± 0.11) µg/dL at T1 and 0.12 (± 0.10) µg/dL at T2 (see Figures 2 & 3). The average time 
of day participants collected waking saliva was 7.51 (±1.23) hours at T1 and 7.78 (±1.56) 
hours at T2. In the evening, caregivers collected saliva on average around 21.23 (± 1.05) 
hours at T1 and 21.20 (± 0.90) hours at T2. 
Caregivers reported mild to moderate burden with a mean Zarit Burden score of 
22.59 (± 16.56) at T1 and 26.90 (± 17.87) at T2. Caregivers reported reduced HRQOL at 
T2 with a mean EQ5D score of 6.58 (± 1.48) compared to 5.90 (± 1.12) at T1. On 
average, caregivers reported mild levels of depressive symptoms with a mean Patient 
Health Questionnaires (PHQ)-9 score of 6.67 (± 5.55) at T1 and 6.60 (± 5.96) at T2. At 
T1, 43% of caregivers and at T2 53% of caregivers reported no depressive symptoms. 
Table 8 
Summary of Main Study Variables at T1 and T2 
 T1 (N = 63) T2 (N = 40) 
Variable M ± SD 
   Minimum – 
Maximum M ± SD 
   Minimum – 
Maximum 
Uncertainty 84.13 ± 19.93 33–137 85.23 ± 23.94 43–140 
Perceived Stress 24.21 ± 9.55 0–43 24.47 ±10.74 5–46 
Salivary Cortisol AM 0.41 ± 0.37 
(N = 57) 
0.03–2.30 0.33 ± 0.21 
(N = 38) 
0.06–1.07 
Salivary Cortisol PM 0.13 ± 0.11 
(N = 54) 
0.02–0.58 0.12 ± 0.10 
(N = 38) 
0.03–0.46 
Burden 22.59 ± 16.56 2–71 26.90 ± 17.87 0–68 
Health-Related Quality of Life 5.90 ± 1.12 5–10 6.58 ± 1.48 5–9 
Depressive Symptoms 6.67 ± 5.55 0–22 6.60 ± 5.96 0–20 
Note. M = mean; SD = standard deviation; Higher scores = greater uncertainty, higher perceived stress, 
greater burden, poorer health-related quality of life and greater depressive symptoms.  
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Figure 2. Diurnal salivary cortisol pattern at T1. 
 
 
 
Figure 3. Diurnal salivary cortisol pattern at T2. 
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Comparisons of Study Variables at T1 and T2 
Among the 40 participants with data at both T1 and T2, paired t-tests were used to 
examine T1–T2 differences in main study continuous variables (uncertainty, perceived 
stress, salivary cortisol, burden, HRQOL and depressive symptoms) and continuous 
caregiver and stroke-survivor characteristics that were measured at both T1 and T2 
(perceived quality of relationship with the stroke survivor, hours spent caring per day, 
perceived level of preparedness for caregiving, caregiver comorbidity, coping capacity 
and social support and stroke-survivor functional status). Fisher’s exact test was used to 
examine differences in the only categorical variable, other life events, that was measured 
at both time points. 
Among the main study variables, salivary cortisol (at T1 and T2), burden (at T1), 
HRQOL (at T1 and T2) and depressive symptoms (at T1 and T2) were positively skewed 
due to variable floor effects. Thus, study variables at T1 and T2 were also compared 
using a Wilcoxon Signed Ranks Test. The results using paired t-tests and Wilcoxon 
Signed Ranks Test were similar; therefore, only the paired t-test results are reported. 
Table 9 summarizes descriptive analysis and comparison of study variables 
measured at both time points among 40 participants who completed the study. Compared 
to T1, caregivers at T2 had poorer HRQOL (t = –2.636, p = 0.012), poorer health status 
(t = 2.241, p = 0.031), higher comorbidity scores (t = –2.054, p = 0.047), better coping 
capacity (t = –2.061, p = 0.046) and less social support (t = 2.560, p = 0.014). Functional 
status of the stroke survivors improved from T1 to T2 (t = –3.266, p = 0.002). There were 
no statistically significant differences between T1 and T2 for caregiver uncertainty, 
perceived stress, salivary cortisol (on waking and evening), burden, depressive symptoms, 
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perceived quality of relationship with the stroke survivor, hours spent caring per day, 
perceived level of preparedness for caregiving or other life events. 
Table 9 
Comparison of Study Variables between T1 and T2 (N=40)  
Variable 
M ± SD or        
N (%)               
at T1  
M ± SD or      
N (%)                 
at T2  t statistic  p value 
Uncertainty 83.73 ± 23.47 85.23 ± 23.94 –0.713 0.480 
Perceived Stress 24.38 ± 10.15 24.48 ±10.74 –0.080 0.936 
Salivary Cortisol AM (N = 38) 0.39 ± 0.23 0.33 ± 0.21 1.308 0.199 
Salivary Cortisol PM (N = 37)  0.12 ± 0.10 0.12 ± 0.11 –0.061 0.952 
Burden 23.0 ± 17.64 26.90 ± 17.87 –1.880 0.068 
Health-Related Quality of Life 6.03 ± 1.25 6.58 ± 1.48 –2.636 0.012* 
Depressive Symptoms 7.25 ± 5.84 6.60 ± 5.96 0.891 0.379 
Perceived quality of relationship with 
the stroke survivor 
1.28 ± 0.64 1.50 ± 0.75 –1.940 0.060 
Hours spent caring per day 8.7 ± 6.29 7.6 ± 6.59 0.954 0.346 
Perceived level of preparedness for 
caregiving 
2.15 ± 0.98 2.25 ± 1.01 –0.561 0.578 
Caregiver Comorbidity 5.65 ± 4.37 6.20 ± 4.69 –2.054 0.047* 
Health Status 80.33 ± 12.68 74.68 ± 15.68 2.241 0.031* 
Caregiver Coping Capacity 63.85 ± 12.52 67.25 ± 15.46 –2.061 0.046* 
Caregiver Social Support 71.15 ± 13.14 63.88 ± 18.18 2.560 0.014* 
Stroke-Survivor Functional Status 26.25 ± 28.83 43.75 ± 36.56 –3.266 0.002** 
Other Life Event 17 (43%) 9 (23%)  0.134 
Note. M = mean; SD = standard deviation; *p < 0.05, two-tailed, **p < 0.01, two-tailed; Paired t-test was 
used for all variables except other life event for which Fisher’s exact test was calculated; Caregivers had 
poorer health-related quality of life, more comorbidities, poorer health status, better coping capacity and 
less social support at T2; Stroke-survivor functional status improved from T1 to T2.  
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Bivariate Analysis 
Correlations among the study variables. Correlations among caregiver or 
stroke-survivor characteristics and the main study variables at T1 were estimated. 
Pearson’s correlation coefficient was calculated when two variables were normally 
distributed and Spearman’s correlation coefficient was calculated when one of the 
variables was not normally distributed or was ordinal. Tables 10 and 11 report main study 
variables and characteristics of any statistically significant correlations. Variable 
correlations with each of the main variables are summarized here. 
Uncertainty. At T1, greater uncertainty was significantly correlated with poorer 
coping capacity (r = –0.424, p = 0.001), less social support (r = –0.307, p = 0.014), 
poorer perceived quality of relationship with the stroke survivor (r = 0.289, p = 0.022), 
poorer stroke-survivor functional status (r = –0.258, p = 0.041), higher perceived stress 
(r = 0.545, p < 0.001), greater burden (r = 0.439, p < 0.001), poorer HRQOL (r = 0.475, 
p < 0.001), poorer health status (r = –0.321, p = 0.01) and greater depressive symptoms 
(r = 0.487, p < 0.001). 
At T2, significant correlations persisted between greater uncertainty and the 
following variables: poorer coping capacity (r = –0.560, p < 0.001), poorer perceived 
quality of relationship with the stroke survivor (r = 0.359, p = 0.023), poorer stroke-
survivor functional status (r = –0.398, p = 0.011), higher perceived stress (r = 0.512, 
p = 0.001), greater burden (r = 0.586, p < 0.001), poorer HRQOL (r = 0.327, p = 0.039), 
poorer health status (r = –0.372, p = 0.018) and greater depressive symptoms (r = 0.413, 
p = 0.008). Greater uncertainty was also statistically correlated with caregiver older age 
(r = 0.350, p = 0.027) and elevated salivary-cortisol level in the evening (r = 0.418, 
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p = 0.009). The correlation between uncertainty and social support, however, was no 
longer significant. 
Perceived stress. At T1, higher perceived stress was significantly correlated with 
greater uncertainty (r = 0.545, p < 0.001), poorer coping capacity (r = –0.543, p < 0.001), 
greater burden (r = 0.479, p < 0.001), poorer HRQOL (r = 0.573, p < 0.001), poorer 
health status (r = –0.421, p = 0.001), greater depressive symptoms (r = 0.590, p < 0.001) 
and poorer stroke-survivor functional status (r = –0.278, p = 0.027). There was no 
significant correlation between perceived stress and salivary cortisol, either on waking or 
in the evening. 
At T2, higher perceived stress remained significantly correlated with the 
following variables: greater uncertainty (r = 0.512, p = 0.001), poorer coping capacity 
(r = –0.755, p < 0.001), greater burden (r = 0.680, p < 0.001), poorer HRQOL (r = 0.510, 
p = 0.001), poorer health status (r = –0.487, p = 0.001), greater depressive symptoms 
(r = 0.744, p < 0.001) and poorer stroke-survivor functional status (r = –0.419, p = 0.007). 
Higher perceived stress was also significantly correlated with elevated salivary-cortisol 
level in the evening (r = 0.520, p = 0.001). The relationship of higher perceived stress 
and lower social support approached significance (r = –0.310, p = 0.051). The 
relationship of higher perceived stress and more caregiver comorbidities also approached 
significance (r = 0.312, p = 0.050). There was no significant correlation between 
perceived stress and salivary cortisol on waking. 
Salivary cortisol. At T1, elevated salivary-cortisol level on waking was 
significantly correlated with greater burden (r = 0.262, p = 0.049), older caregiver age 
(r = 0.370, p = 0.005) and poorer perceived quality of relationship with the stroke 
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survivor (r = 0.420, p = 0.001). Salivary-cortisol level in the evening at T1 was not 
significantly correlated with any variable. 
At T2, decreased salivary-cortisol level on waking was significantly correlated 
with poorer HRQOL (r = –0.333, p = 0.041) and poorer health status (r = 0.383, 
p = 0.017). The correlations between salivary-cortisol level on waking and burden, 
caregiver age or poorer perceived quality of relationship with the stroke survivor were no 
longer significant. 
Elevated salivary-cortisol level in the evening at T2 was significantly correlated 
with higher uncertainty (r = 0.418, p = 0.009), poorer coping capacity (r = –0.433, 
p = 0.007), greater severity of stroke (r = 0.426, p = 0.008), higher perceived stress 
(r = 0.520, p = 0.001), poorer health status (r = –0.370, p = 0.022) and greater depressive 
symptoms (r = 0.502, p = 0.001). The relationship of elevated salivary-cortisol in the 
evening with poorer stroke-survivor functional status approached significance (r = –0.319, 
p = 0.051). 
Burden. At T1, greater burden was significantly correlated with greater 
uncertainty (r = 0.439, p < 0.001), poorer coping capacity (r = –0.427, p < 0.001), more 
caregiver comorbidities (r = 0.271, p = 0.032), poorer perceived quality of relationship 
with the stroke survivor (r = 0.403, p = 0.001), poorer perceived level of preparedness for 
caregiving (r = 0.411, p = 0.001), higher perceived stress (r = 0.479, p < 0.001), elevated 
salivary-cortisol level on waking (r = 0.262, p = 0.049), poorer HRQOL (r = 0.464, p < 
0.001), poorer health status (r = –0.446, p < 0.001) and greater depressive symptoms 
(r = 0.474, p < 0.001). There was no statistical correlation between burden and salivary 
cortisol in the evening. 
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At T2, greater burden was still significantly correlated with greater uncertainty 
(r = 0.586, p < 0.001), poorer coping capacity (r = –0.650, p < 0.001), higher perceived 
stress (r = 0.680, p < 0.001), poorer HRQOL (r = 0.447, p = 0.004), poorer health status 
(r = –0.523, p = 0.001) and greater depressive symptoms (r = 0.558, p < 0.001). At T2, 
however, burden failed to correlate significantly with caregiver comorbidity, perceived 
quality of relationship with stroke survivor, perceived level of preparedness for 
caregiving or salivary cortisol on waking. 
Health-related quality of life. At T1, poorer HRQOL was significantly correlated 
with greater uncertainty (r = 0.475, p < 0.001), poorer coping capacity (r = –0.470, p < 
0.001), more caregiver comorbidities (r = 0.482, p < 0.001), higher perceived stress 
(r = 0.573, p < 0.001), greater burden (r = 0.464, p < 0.001), poorer health status (r = –
0.646, p < 0.001) and greater depressive symptoms (r = 0.558, p < 0.001). 
At T2, poor HRQOL remained significantly correlated with greater uncertainty 
(r = 0.327, p = 0.039), poorer coping capacity (r = –0.556, p < 0.001), more caregiver 
comorbidities (r = 0.586, p < 0.001), higher perceived stress (r = 0.510, p = 0.001), 
greater burden (r = 0.447, p = 0.004), poorer health status (r = –0.564, p < 0.001) and 
greater depressive symptoms (r = 0.489, p = 0.001). In addition, poor HRQOL at T2 was 
statistically correlated with decreased salivary-cortisol level on waking (r = –0.333, 
p = 0.041) and more stroke survivor comorbidities (r = 0.380, p = 0.016). 
Depressive symptoms. At T1, greater depressive symptoms were significantly 
correlated with greater uncertainty (r = 0.487, p < 0.001), poorer coping capacity (r = –
0.467, p < 0.001), less social support (r = –0.305, p = 0.015), higher perceived stress 
(r = 0.590, p < 0.001), greater burden (r = 0.474, p < 0.001), poorer HRQOL (r = 0.558, 
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p < 0.001), poorer health status (r = –0.447, p < 0.001), poorer stroke-survivor functional 
status (r = –0.249, p = 0.049) and greater severity of stroke (r = 0.297, p = 0.018). 
At T2, greater depressive symptoms were still significantly correlated with greater 
uncertainty (r = 0.413, p = 0.008), poorer coping capacity (r = –0.744, p < 0.001), higher 
perceived stress (r = 0.744, p < 0.001), greater burden (r = 0.558, p < 0.001), poorer 
HRQOL (r = 0.489, p = 0.001), poorer health status (r = –0.409, p = 0.009) and poorer 
stroke-survivor functional status (r = –0.464, p = 0.003). Greater depressive symptoms 
were also significantly correlated with the following variables: fewer close friends and 
relatives (r = –0.406, p = 0.007) and elevated salivary-cortisol level in the evening 
(r = 0.502, p = 0.001). At T2, however, depressive symptoms were no longer 
significantly correlated with social support or severity of stroke. 
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Table 10 
Main Study Variables and Characteristics with Any Statistically Significant Correlations at T1 (N = 63) 
Variables 1 2 3 4 5 6 7 
1. Uncertainty  0.545** 0.172 0.070 0.439** 0.475** 0.487** 
2. Perceived Stress 0.545**  0.131 –0.104 0.479** 0.573** 0.590** 
3. Salivary Cortisol AM (N = 57) 0.172 0.131  0.113 0.262* –0.016 0.125 
4. Salivary Cortisol PM (N = 54)  0.070 –0.104 0.113  –0.157 –0.027 0.008 
5. Burden 0.439** 0.479** 0.262* –0.157  0.464** 0.474** 
6. Health-Related Quality of Life 0.475** 0.573** –0.016 –0.027 0.464**  0.558** 
7. Depressive Symptoms 0.487** 0.590** 0.125 0.008 0.474** 0.558**  
8. CG Comorbidity 0.119 0.124 0.064 0.066 0.271* 0.482** 0.147 
9. CG Health Status –0.321* –0.421** 0.043 0.240 –0.446** –0.646** –0.447** 
10. CG Coping Capacity –0.424** –0.543** –0.173 0.201 –0.427** –0.470** –0.467** 
11. CG Social Support –0.307* –0.205 –0.159 0.108 –0.202 –0.168 –0.305* 
12. CG Age 0.195 –0.105 0.370** 0.250 0.076 0.088 –0.116 
13. Perceived Quality of 
Relationship with the SS  
0.289* 0.176 0.420** 0.127 0.403** 0.185 0.125 
14. Perceived Level of Preparedness 
for Caregiving 
0.202 0.166 0.241 0.102 0.411** 0.180 0.120 
15. SS Severity of Stroke 0.201 0.224 –0.238 –0.057 –0.014 0.224 0.297* 
16. SS Functional Status –0.258* –0.278* 0.219 0.042 –0.040 –0.181 –0.249* 
Note. *p < 0.05, two-tailed, **p < 0.01, two-tailed; CG = caregiver; SS = stroke survivor. Higher scores = greater uncertainty, higher perceived stress, 
greater burden, poorer health-related quality of life, greater depressive symptoms, more comorbidities, better health status, better coping capacity, better 
social support, poorer perceived quality of relationship with the stroke survivor, poorer perceived level of preparedness for caregiving, greater severity of 
stroke and better functional status. 
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Table 11 
Main Study Variables and Characteristics with Any Statistically Significant Correlations at T2 (N = 40) 
Variables 1 2 3 4 5 6 7 
1. Uncertainty  0.512** 0.038 0.418** 0.586** 0.327* 0.413** 
2. Perceived Stress 0.512**  –0.212 0.520** 0.680** 0.510** 0.744** 
3. Salivary Cortisol AM (N = 38) 0.038 –0.212  0.072 –0.226 –0.333* –0.207 
4. Salivary Cortisol PM (N = 38) 0.418** 0.520** 0.072  0.205 0.267 0.502** 
5. Burden 0.586** 0.680** –0.226 0.205  0.447** 0.558** 
6. Health-Related Quality of Life 0.327* 0.510** –0.333* 0.267 0.447**  0.489** 
7. Depressive Symptoms 0.413** 0.744** –0.207 0.502** 0.558** 0.489**  
8. CG Comorbidity 0.248 0.312 –0.113 0.274 0.243 0.586** 0.112 
9. CG Health Status  –0.372* –0.487** 0.383* –0.370* –0.523** –0.564** –0.409** 
10. CG Coping Capacity –0.560** –0.755** 0.244 –0.433** –0.650** –0.556** –0.744** 
11. CG Social Support –0.034 –0.310 0.149 –0.052 –0.190 –0.194 –0.257 
12. CG Age 0.350* –0.088 0.135 –0.106 0.082 0.305 –0.102 
13. Perceived Quality of   
Relationship with the SS 
0.359* 0.199 0.159 –0.031 0.257 –0.010 0.089 
14. Number of close friends and 
relatives 
–0.056 –0.185 0.116 –0.106 –0.293 –0.162 –0.406** 
15. SS Severity of Stroke 0.143 0.205 0.071 0.426** –0.173 –0.007 0.248 
16. SS Functional Status –0.398* –0.419** –0.066 –0.319 –0.224 –0.193 –0.464** 
17. SS Comorbidity 0.156 0.246 0.083 –0.083 0.005 0.380* 0.210 
Note. *p < 0.05, two-tailed, **p < 0.01, two-tailed; CG = caregiver; SS = stroke survivor. Higher scores = greater uncertainty, higher perceived stress, 
greater burden, poorer health-related quality of life, greater depressive symptoms, more comorbidities, better health status, better coping capacity, better 
social support, poorer perceived quality of relationship with the stroke survivor, greater severity of stroke and better functional status. 
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Differences in main study variables by categories of caregiver and stroke-
survivor characteristics. I explored differences in main study variables by category of 
caregiver and stroke-survivor characteristics. Two sample t-tests (for dichotomous 
variables) and one-way analysis of variance (ANOVA: for categorical variables having 
more than two levels) were used to examine differences in uncertainty and perceived 
stress between categories of caregiver and stroke-survivor characteristics. The variables 
salivary cortisol (T1 and T2), burden (T1), HRQOL (T1 and T2) and depressive 
symptoms were positively skewed, due to the floor effects. Thus, the Mann-Whitney U 
test (for dichotomous variables) and the Kruskal-Wallis test (for categorical variables on 
more than two levels) were used to compare differences in these characteristics. 
Dichotomous/categorical variables and uncertainty. At T1, level of uncertainty 
differed significantly depending on stroke-survivor health insurance type (t = 2.610, 
p = 0.011; greater uncertainty found in those with private insurance/Medicare/Medicare + 
supplemental health insurance plans). At T2, uncertainty differed significantly by 
caregiver role (spouse vs. nonspouse; t = –2.343, p = 0.024), with greater uncertainty 
found among spousal caregivers. 
Dichotomous/categorical variables and perceived stress. At T1, degree of 
perceived stress differed significantly, depending on stroke-survivor communicative 
ability (t = –2.092, p = 0.041; higher stress, less communicative ability) and stroke-
survivor health insurance type (t = 2.197, p = 0.032; higher stress, private 
insurance/Medicare/Medicare + supplemental health insurance plans). At T2, perceived 
stress differed significantly depending on stroke-survivor gender (t = 2.266, p = 0.029 
with higher stress in men) and stroke-survivor income (F = 4.708, p = 0.015; higher  
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stress found in caregivers with adequate vs. comfortable income levels). 
Dichotomous/categorical variables and salivary cortisol. At T1, level of salivary 
cortisol on waking differed significantly depending on stroke-survivor health insurance 
type (p = 0.040; elevated salivary-cortisol level found in those with private 
insurance/Medicare/Medicare + supplemental health insurance plans) and other life 
events (p = 0.015; elevated salivary-cortisol level found in caregivers with no other life 
events). At T1, no statistically significant differences in salivary-cortisol level in the 
evening were found among categories of caregiver or stroke-survivor characteristics. At 
T1 and T2, the difference in level of salivary cortisol on waking among spousal and 
nonspousal caregivers approached significance (p = 0.050; elevated salivary-cortisol level 
in spouse at T1 and T2). At T2, salivary-cortisol level on waking differed significantly by 
caregiver race (elevated salivary-cortisol level in non-Hispanic White than non-White 
participants; p = 0.047) and salivary-cortisol level in the evening differed significantly by 
caregiver income (p = 0.032; elevated salivary-cortisol level found in caregivers with 
insufficient income compared with those reporting adequate or comfortable income). 
Dichotomous/categorical variables and burden. At T1, level of burden differed 
significantly depending on stroke-survivor health insurance type (p = 0.034; greater 
burden found in those with private insurance/Medicare/Medicare + supplemental health 
insurance plans). No statistically significant differences in burden were found among 
categories of caregiver or stroke-survivor characteristics at T2. 
Dichotomous/categorical variables and health-related quality of life. At T1 and 
T2, HRQOL differed significantly by caregiver income (p = 0.029 at T1 and p = 0.011 at 
T2; poorer HRQOL was found in caregivers with insufficient compared with comfortable  
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income). 
Dichotomous/categorical variables and depressive symptoms. At T1, depressive 
symptoms differed significantly by caregiver income (p = 0.014; greater depressive 
symptoms in those with insufficient income compared with those reporting adequate or 
comfortable income), stroke-survivor income (p = 0.041; greater depressive symptoms in 
those with adequate income compared with those whose income is comfortable), 
caregiver race (greater depressive symptoms in non-White; p = 0.015) and stroke-
survivor race (greater depressive symptoms in non-White; p = 0.018). At T2, no 
statistically significant differences in depressive symptoms were found among any 
categories of caregiver and stroke-survivor characteristics. 
Multivariate Analysis 
As discussed in Chapter 3, multivariate stepwise regression and a p-value cut off 
point of 0.05 were used to determine the effect of uncertainty on perceived stress, 
salivary cortisol, burden, HRQOL and depressive symptoms at each time point (Aims 1, 
2 and 3), controlling for covariates. Univariate or multivariate regression in each Baron 
and Kenny (1986) step was used in establishing the mediator effect of each perceived 
stress and salivary cortisol on the relationship between uncertainty and each 
psychological outcome (burden, HRQOL and depressive symptoms; Aim 4). The robust 
standard error was used to protect against violations in the homoscedasticity assumption 
in all analyses. Given the large number of covariates available and the limited sample 
size (N = 63 at T1 and N = 40 at T2), only caregiver and stroke-survivor characteristics 
that were identified from bivariate analysis on the basis of a p-value less than or equal to 
0.05 were entered in the multivariate stepwise regression models to test Aims 1, 2 and 3. 
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Due to multicollinearity between caregiver comorbidity and health status, caregiver 
comorbidity was used as a covariate and health status was excluded from the regression 
models. For Aim 4, covariates, which remained in the final stepwise models for each Aim 
1, 2 and 3, were entered in the multivariate regression models. For all analyses, a p-value  
of less than 0.05 in a two-sided test was considered statistically significant. 
Aim 1: Determine at each time point if uncertainty (regarding stroke survivors’ 
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress. 
H1: At each time point, greater uncertainty scores will be positively associated 
with higher levels of perceived stress. 
At T1, uncertainty and the covariates—coping capacity, stroke-survivor 
functional status, stroke-survivor health insurance type and stroke-survivor 
communicative ability, as identified from bivariate analysis on the basis of a p-value less 
than or equal to 0.05—were entered in the multivariate stepwise regression model. In the 
final regression model, uncertainty and all covariates except stroke-survivor functional 
status and health insurance remained. At T1, 48% of the variance in perceived stress was 
explained by uncertainty, coping capacity and stroke survivor’s inability to communicate. 
Greater uncertainty (p < 0.001), poorer coping capacity (p < 0.001) and stroke survivor’s 
inability to communicate (p = 0.025) were associated with higher perceived stress (see 
Table 12). 
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Table 12 
Multivariate Stepwise Regression of Perceived Stress at T1 (N = 63) 
Predictors β Robust SE t statistic p value 95% CI 
Uncertainty 0.163 0.042 3.89  < 0.001** [0.079, 0.246] 
Coping Capacity –0.338 0.086 –3.94 < 0.001** [–0.510, –0.166] 
SS Communicative Ability 4.000 1.743 2.30 0.025* [0.513, 7.487] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; SS = stroke 
survivor; F(3, 59) = 29.98; Prob > F = 0.000; R-squared = 0.48; *p < 0.05, two-tailed, **p < 0.01, two-
tailed. 
At T2, uncertainty and the covariates—caregiver comorbidity, social support, 
stroke-survivor functional status, stroke-survivor gender and stroke-survivor income, as 
identified from bivariate analysis on the basis of a p-value less than or equal to 0.05—
were entered in the multivariate stepwise regression model. Coping capacity mediated the 
relationship between uncertainty and perceived stress; thus, coping capacity was 
excluded from the model. In the final regression model, uncertainty and two covariates—
caregiver social support and stroke-survivor income—remained, explaining 49% of the 
variance in perceived stress. Greater uncertainty (p < 0.001), lower social support 
(p = 0.011) and stroke survivors’ adequate (compared to comfortable) income (p = 0.005) 
were associated with higher perceived stress (see Table 13). 
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Table 13 
Multivariate Stepwise Regression of Perceived Stress at T2 (N = 40) 
Predictors β Robust SE t statistic p value 95% CI 
Uncertainty 0.211 0.051 4.14  < 0.001**     [0.107, 0.314] 
Social Support –0.170 0.063 –2.68 0.011*  [–0.299, –0.041] 
SS Adequate Income# 8.000 2.681 2.98 0.005**        [2.554, 13.439] 
SS Insufficient income# 9.080 6.163 1.47 0.150 [–3.432, 21.592] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; SS = stroke 
survivor; F(4, 35) = 8.23; Prob > F = 0.0001; R-squared = 0.49; *p < 0.05, two-tailed, **p < 0.01, two-
tailed; #Reference category was stroke survivor comfortable income. 
At T1 and T2, greater uncertainty scores were positively associated with higher 
perceived stress, controlling for covariates (caregiver coping capacity and stroke 
survivor’s inability to communicate at T1 and social support and stroke-survivor income 
at T2). Thus, Hypothesis 1 was supported. 
Aim 2: Determine at each time point if uncertainty predicts levels of caregivers’ 
physiological stress (salivary cortisol). 
H2: At each time point, greater uncertainty scores will be positively associated 
with elevated levels of salivary cortisol. 
Uncertainty and salivary cortisol on waking. At T1, in univariate regression 
analysis, uncertainty was not significantly associated with salivary cortisol on waking 
(p = 0.103; see Table 14). 
Table 14 
Univariate Regression of Salivary Cortisol on Waking at T1 (N = 57) 
Predictor β Robust SE t statistic p value 95% CI 
Uncertainty 0.003 0.002 1.66 0.103 [–0.001, 0.006] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 55) = 2.75; 
Prob > F = 0.103; R-squared = 0.024. 
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At T1, the variables identified from bivariate analysis on the basis of a p-value 
less than or equal to 0.05—caregiver age, relationship to the stroke survivor (spousal vs. 
nonspousal), perceived quality of relationship with the stroke survivor, other life events 
and stroke-survivor health insurance type—were entered in the multivariate stepwise 
regression model. In the final regression model, caregiver age and other life events 
remained whereas relationship to the stroke survivor, perceived quality of relationship 
with the stroke survivor and stroke-survivor health insurance were excluded. At T1, 10% 
of the variance in salivary cortisol on waking was explained by caregiver age and other 
life events. Older caregiver age (p = 0.043) and having no other events in the period since 
the stroke (p = 0.048) were associated with elevated salivary-cortisol level on waking 
(see Table 15). 
Table 15 
Multivariate Stepwise Regression of Salivary Cortisol on Waking at T1 (N = 57) 
Predictors β Robust SE t statistic   p value      95% CI 
CG Age  0.005 0.002 2.07  0.043*          [0.000, 0.009] 
Other Life Events  –0.176 0.087 –2.03 0.048* [–0.351, –0.002] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; CG = caregiver; 
F(2, 54) = 4.61; Prob > F = 0.01; R-squared = 0.10; *p < 0.05, two-tailed.  
At T2, in univariate regression analysis, uncertainty was not significantly 
associated with salivary cortisol on waking (p = 0.570; see Table 16). 
Table 16 
Univariate Regression of Salivary Cortisol on Waking at T2 (N = 38) 
Predictor β Robust SE t statistic p value 95% CI 
Uncertainty 0.001 0.002 0.57 0.570 [–0.002, 0.004] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 36) = 0.33; 
Prob > F = 0.57; R-squared = 0.012. 
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At T2, the variables identified from bivariate analysis on the basis of a p-value 
less than or equal to 0.05 were caregiver race (non-Hispanic White vs. non-White), 
relationship to the stroke survivor (spousal vs. non-spousal). Caregiver race and 
relationship to the stroke survivor were entered in the multivariate stepwise regression 
model. In the final regression model, relationship to the stroke survivor remained. At T2, 
15% of the variance in the salivary-cortisol level on waking was explained by the 
relationship to the stroke survivor (see Table 17). A spousal relationship with the stroke 
survivor was associated with elevated salivary-cortisol level on waking (p = 0.035). 
Table 17 
Multivariate Stepwise Regression of Salivary Cortisol on Waking at T2 (N = 38) 
Predictors     β Robust SE t statistic       p value 95% CI 
Relationship to the SS  0.17 0.077 2.19 0.035* [0.012, 0.326] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; SS = stroke 
survivor; F(1, 36) = 4.78; Prob > F = 0.036; R-squared = 0.15; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
Uncertainty and salivary cortisol in the evening. At T1, uncertainty was not 
significantly associated with salivary cortisol in the evening in univariate regression 
analysis (p = 0.451; see Table 18). Salivary-cortisol level in the evening was not 
significantly correlated with any variable. In addition, no statistically significant 
differences in salivary-cortisol level in the evening were found among categories of 
caregiver or stroke-survivor characteristics.  
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Table 18 
Univariate Regression of Salivary Cortisol in the Evening at T1 (N = 54) 
Predictor β Robust SE t statistic p value 95% CI 
Uncertainty 0.000 0.001 0.76 0.451 [–0.001, 0.002] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 52) = 0.58; 
Prob > F = 0.451; R-squared = 0.006. 
In univariate regression analysis at T2, uncertainty was not significantly 
associated with salivary cortisol in the evening (p = 0.055; see Table 19). Uncertainty and 
the covariates—coping capacity, caregiver income, stroke-survivor functional status and 
severity of stroke, which were identified from bivariate analysis on the basis of a p-value 
less than or equal to 0.05—were entered in the multivariate regression model. No 
variables that were significantly associated with salivary cortisol in the evening remained 
in the final model. 
Table 19 
Univariate Regression of Salivary Cortisol in the Evening at T2 (N = 38) 
Predictor β Robust SE t statistic p value 95% CI 
Uncertainty 0.001 0.001 1.98 0.055 [–0.000, 0.002] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 36) = 3.93; 
Prob > F = 0.055; R-squared = 0.072. 
At neither T1 nor T2 was uncertainty significantly associated with salivary 
cortisol, either on waking or in the evening. Thus, Hypothesis 2 (which proposed that at 
each time point, greater uncertainty scores would be positively associated with elevated 
levels of salivary cortisol) was not supported. 
Aim 3: Examine at each time point the relationship of uncertainty to 
psychological outcomes (burden, HRQOL and depressive symptoms). 
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At each time point, greater uncertainty scores will be positively associated with 
H3: greater burden, 
H4: poorer HRQOL and 
H5: greater depressive symptoms. 
Uncertainty and burden. At T1, uncertainty and the covariates—perceived 
quality of relationship with the stroke survivor, perceived level of preparedness for 
caregiving, coping capacity, caregiver comorbidity and stroke-survivor health insurance 
type, as identified from bivariate analysis on the basis of a p-value less than or equal to 
0.05—were entered into the multivariate regression model. In the final regression model, 
uncertainty and the covariates perceived level of preparedness for caregiving and 
caregiver comorbidity remained; however, perceived quality of relationship with the 
stroke survivor, caregiver coping capacity and stroke-survivor health insurance were 
excluded. Of the variance in burden, 43% was explained by uncertainty, perceived level 
of preparedness for caregiving and caregiver comorbidity (see Table 20). Greater 
uncertainty (p < 0.001), less preparedness for caregiving (p = 0.009) and more caregiver 
comorbidities (p = 0.010) were associated with greater burden. 
Table 20 
Multivariate Stepwise Regression of Burden at T1 (N = 63) 
Predictors β Robust SE t statistic p value 95% CI 
Uncertainty 0.335 0.071 4.72 < 0.001** [0.193, 0.477] 
Preparedness for Caregiving 4.236 1.579 2.68 0.009** [1.076, 7.395] 
CG Comorbidity 1.026 0.384 2.67 0.010* [0.258, 1.794] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; CG = caregiver; 
F(3, 59) = 14.14; Prob > F = 0.000; R-squared = 0.43; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
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At T2, uncertainty and the covariate coping capacity as identified from bivariate 
analysis on the basis of a p-value less than or equal to 0.05 were entered into the 
multivariate regression model. Both uncertainty and coping capacity remained in the final 
model. Forty nine percent (49%) of the variance in burden was explained by uncertainty 
and coping capacity (Table 21). Greater uncertainty (p = 0.031) and poorer coping 
capacity (p = 0.006) were associated with greater burden. 
Table 21 
Multivariate Stepwise Regression of Burden at T2 (N = 40) 
Predictors β Robust SE t statistic p value 95% CI 
Uncertainty 0.242 0.108 2.24  0.031* [0.023, 0.461] 
Coping Capacity –0.542 0.185 –2.93 0.006** [–0.917, –0.167] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(2, 37) = 21.55; 
Prob > F = 0.000; R-Squared = 0.49; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
At T1 and T2, greater uncertainty scores were positively associated with greater 
burden, controlling for covariates (perceived level of preparedness for caregiving and 
caregiver comorbidity at T1 and caregiver coping capacity at T2). Thus, Hypothesis 3 
was supported. 
Uncertainty and health-related quality of life. At T1, uncertainty and the 
covariates—caregiver coping capacity, comorbidity and income, as identified from 
bivariate analysis on the basis of a p-value less than or equal to 0.05—were entered into 
the multivariate stepwise regression model. In the final regression model, uncertainty and 
covariates caregiver coping capacity and comorbidity remained; caregiver income, 
however, was excluded. Of the variance in HRQOL, 54% was explained by uncertainty, 
caregiver coping capacity and caregiver comorbidity (see Table 22). Greater uncertainty  
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(p < 0.001), poorer coping capacity (p = 0.026) and more caregiver comorbidities  
(p < 0.001) were associated with poorer HRQOL. 
Table 22 
Multivariate Stepwise Regression of Health-Related Quality of Life at T1 (N = 63) 
Predictors β Robust SE t statistic p value 95% CI 
Uncertainty 0.017 0.005 3.74  < 0.001** [0.008, 0.026] 
Coping Capacity –0.019 0.008 –2.29 0.026* [–0.036, –0.002] 
CG Comorbidity 0.130 0.032 4.00 < 0.001**  [0.065, 0.195] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(3, 59) = 13.95; 
Prob > F = 0.000; R-squared = 0.54; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
In the univariate regression model at T2, 11% of the variance in HRQOL was 
explained by uncertainty, and greater uncertainty (p = 0.023) was associated with poorer 
HRQOL (see Table 23). It was noted that coping capacity mediated the relationship 
between uncertainty and HRQOL. Thus, a multivariate stepwise regression model was 
conducted, omitting coping capacity to determine the effect of uncertainty on HRQOL, 
controlling for covariates (caregiver income, caregiver comorbidity and stroke-survivor 
comorbidity) identified from bivariate analysis on the basis of a p-value less than or equal 
to 0.05; uncertainty, however, failed to remain in the final model. 
Table 23 
Univariate Regression of Health-Related Quality of Life at T2 (N = 40) 
Predictor β Robust SE t statistic p value 95% CI 
Uncertainty 0.020 0.009 2.37 0.023* [0.003, 0.038] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 38) = 5.61; 
Prob > F = 0.023; R-squared = 0.11; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
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To further explore significant variables that might explain HRQOL at T2, 
HRQOL at T2 was regressed on the independent variables coping capacity, caregiver 
income, caregiver comorbidity and stroke-survivor comorbidity, as identified from 
bivariate analysis on the basis of a p-value less than or equal to 0.05 while omitting 
uncertainty. In the final regression model, all independent variables remained except 
stroke-survivor comorbidity. Of the variance in HRQOL, 57% was explained by coping 
capacity, caregiver comorbidity and caregiver income (see Table 24). Poorer coping 
capacity (p = 0.004), more caregiver comorbidities (p < 0.001) and caregivers’ income 
(p = 0.001; insufficient rather than comfortable) were associated with poorer HRQOL. 
Table 24 
Multivariate Stepwise Regression of Health-Related Quality of Life at T2 (N = 40) 
Predictors β Robust SE t statistic p value 95% CI 
Coping Capacity –0.036 0.011 –3.12  0.004** [–0.055, –0.012] 
CG Comorbidity 0.129 0.028 4.68 < 0.001** [0.073, 0.185] 
CG Adequate Income# 0.636 0.392 1.62 0.114   [–0.160, 1.431] 
CG Insufficient Income# 1.389 0.378 3.67 0.001** [0.622, 2.157] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(4, 35) = 27.29; 
Prob > F = 0.0000; R-squared = 0.57; *p < 0.05, two-tailed, **p < 0.01, two-tailed ; #Reference category 
was caregiver comfortable income. 
At T1, greater uncertainty scores were positively associated with poorer HRQOL, 
controlling for the covariates caregiver coping capacity and comorbidity. At T2, greater 
uncertainty scores were positively associated with poorer HRQOL only in the univariate 
regression model. Thus, Hypothesis 4 (that at each time point, greater uncertainty scores 
would be positively associated with poor HRQOL) was partially supported. 
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Uncertainty and depressive symptoms. At T1, uncertainty and the covariates— 
caregiver race, caregiver income, coping capacity, social support, stroke-survivor 
functional status and severity of stroke, as identified from bivariate analysis on the basis 
of a p-value less than or equal to 0.05—were entered in the multivariate stepwise 
regression model. In the bivariate analysis, depressive symptoms statistically differed  
depending on stroke-survivor race and stroke-survivor income. These variables, however, 
were excluded from the regression model due to multicollinearity between caregiver race 
and stroke-survivor race, as well as caregiver income and stroke-survivor income. In the 
final regression model, uncertainty and the covariates caregiver race and coping capacity 
remained, whereas caregiver income, social support, stroke-survivor functional status and 
severity of stroke were excluded. Of the variance in depressive symptoms, 40% was 
explained by uncertainty, coping capacity and caregiver race (see Table 25). Greater 
uncertainty (p = 0.002), poorer coping capacity (p = 0.042) and caregivers’ race (non-
White, p = 0.009) were associated with greater depressive symptoms. 
Table 25 
Multivariate Stepwise Regression of Depressive Symptoms at T1 (N = 63) 
Predictors β Robust SE t statistic p value 95% CI 
Uncertainty 0.111 0.033 3.31  0.002** [0.044, 0.178] 
Coping Capacity –0.112 0.054 –2.08 0.042* [–0.220, –0.004] 
CG Race 3.454 1.271 2.72 0.009**  [0.911, 5.997] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; CG = caregiver; 
F(3, 59) = 15.59; Prob > F = 0.000; R-squared = 0.40; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
At T2, uncertainty and the covariate number of close friends and relatives, as 
identified from bivariate analysis on the basis of a p-value less than or equal to 0.05, were 
entered in the multivariate stepwise regression model. Depressive symptoms were also 
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statistically correlated with caregiver coping capacity and stroke-survivor functional 
status in bivariate analysis. Coping capacity, however, mediated the relationship between 
uncertainty and depressive symptoms when controlling for number of close friends and 
relatives, whereas uncertainty mediated the relationship between stroke-survivor 
functional status and depressive symptoms when controlling for number of close friends 
and relatives. Thus, coping capacity and stroke-survivor functional status were omitted 
from the regression model. 
Of the variance in depressive symptoms, 22% was explained by uncertainty (see 
Table 26), and greater uncertainty was associated with greater depressive symptoms 
(p = 0.002). The number of close friends and relatives did not remain in the final model. 
Table 26 
Multivariate Stepwise Regression of Depressive Symptoms at T2 (N = 40) 
Predictor β Robust SE t statistic p value 95% CI 
Uncertainty 0.116 0.036 3.25 0.002** [0.044, 0.189] 
Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 38) = 10.59; 
Prob > F = 0.002; R-squared = 0.22; *p < 0.05, two-tailed, **p < 0.01, two-tailed. 
At T1, greater uncertainty scores were positively associated with greater 
depressive symptoms, controlling for caregiver coping capacity and race. At T2, greater 
uncertainty scores were positively associated with greater depressive symptoms, whereas 
the covariate, number of close friends and relatives, did not remain in the final regression 
model. Thus, Hypothesis 5 (that at each time point, greater uncertainty scores would be 
positively associated with greater depressive symptoms) was supported. 
Table 27 summarizes significant associations between uncertainty and perceived 
stress, salivary cortisol, burden, HRQOL and depressive symptoms at T1 and T2. 
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Table 27 
Significant Associations between Uncertainty and Perceived Stress, Salivary Cortisol, 
Burden, Health-Related Quality of Life and Depressive symptoms at T1 (N = 63) and T2 
(N = 40) 
 T1 T2 
Perceived Stress S (< 0.001**) S (< 0.001**) 
Salivary Cortisol AM NS (0.103)  
in univariate analysis 
(N = 57) 
NS (0.570) 
in univariate analysis 
(N = 38) 
Salivary Cortisol PM NS (0.451) 
in univariate analysis 
(N = 54) 
NS (0.055) 
in univariate analysis 
(N = 38) 
Burden S (< 0.001**) S (0.031*) 
Health-Related Quality of Life S (< 0.001**) S (0.023*) 
in univariate analysis 
Depressive Symptoms S (0.002**) S (0.002**) 
Note. S = significant; NS = nonsignificant; *p < 0.05, two-tailed, **p < 0.01, two-tailed.  
Repeated-measures sensitivity analysis for Aims 1, 2 and 3. Separate bivariate 
linear mixed models with repeated measures of each dependent variable (perceived stress, 
salivary cortisol, burden, HRQOL and depressive symptoms) were computed to further 
explore the overall effects of uncertainty or covariates on repeated measures of each 
dependent variable. 
Sensitivity analysis revealed that uncertainty was associated with repeated 
measures of perceived stress, burden, HRQOL and depressive symptoms. Uncertainty, 
however, was not associated with repeated measures of salivary cortisol either on waking 
or in the evening. The interactions between uncertainty and time were not associated with 
repeated measures of perceived stress, salivary cortisol either on waking or in the evening,  
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burden, HRQOL or depressive symptoms. 
The majority of covariates that remained in the final stepwise regression model at 
either at T1 and T2 were associated with repeated measures of each dependent variable. 
Stroke-survivor communication ability, which was associated with perceived stress at T1, 
was not significantly associated with repeated measures of perceived stress although it 
approached significance (p = 0.062). The relationship to the stroke survivor associated 
with salivary cortisol on waking at T2 was not significantly associated with repeated 
measures of salivary cortisol on waking (p = 0.064), but did approach significance. With 
these few exceptions, the results from the regression analysis at each time point were 
consistent with the findings from bivariate linear mixed models with repeated measures 
of each dependent variable. 
Time was not associated with repeated measures of perceived stress, salivary 
cortisol on waking or in the evening or depressive symptoms. Time, however, was 
associated with repeated measures of burden and HRQOL. In other words, perceived 
stress, salivary cortisol on waking or in the evening and depressive symptoms did not 
change, whereas caregivers demonstrated greater burden and poorer HRQOL by 6 weeks 
poststroke. With the exception of the effect of time on burden, these results were 
consistent with the findings from the paired t-tests using subjects with complete data at 
both time points (N = 40). The paired t-test showed that, although not statistically 
significant, the differences between T1 and T2 for burden in that smaller sample 
approached significance at p = 0.068. 
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Aim 4: Explore at each time point the mediator effect of stress (perceived stress 
and physiological stress) on the relationship between uncertainty and psychological 
outcomes (burden, HRQOL and depressive symptoms). 
At each time point, perceived stress and salivary cortisol will mediate the 
relationship between uncertainty and 
H6: burden, 
H7: HRQOL and 
H8: depressive symptoms. 
Mediator effect of perceived stress on the relationship between uncertainty 
and burden. At T1, uncertainty was a significant determinant of burden (β = 0.44, 
t = 5.14, p < 0.001) and of perceived stress (β = 0.26, t = 5.70, p < 0.001). When 
uncertainty and perceived stress were simultaneously regressed on burden, while 
controlling for perceived level of preparedness for caregiving and caregiver comorbidity, 
these four variables together explained 47% of the variance in burden; perceived stress 
remained a significant determinant (β = 0.43, t = 2.10, p = 0.040), and the significant 
relationship of uncertainty to burden was reduced (β = 0.23, t = 2.92, p = 0.005), 
indicating a partial mediator effect. 
Uncertainty (p = 0.031) and coping capacity (p = 0.006) were significant factors 
influencing burden at T2. Coping capacity mediated the relationship between uncertainty 
and stress; thus, coping capacity was excluded to test this aim, that is, the mediating 
effect of perceived stress in the relationship between uncertainty and burden. At T2, 
uncertainty was a significant determinant of burden (β = 0.44, t = 4.54, p < 0.001) and of 
perceived stress (β = 0.23, t = 3.76, p = 0.001). When uncertainty and perceived stress 
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were simultaneously regressed on burden, these two variables together explained 54% of 
the variance in burden; perceived stress remained a significant determinant (β = 0.86, 
t = 3.78, p = 0.001), and the significant relationship of uncertainty to burden was reduced 
(β = 0.24, t = 2.56, p = 0.015), indicating a partial mediator effect. 
Mediator effect of perceived stress on the relationship between uncertainty 
and health-related quality of life. At T1, uncertainty was a significant determinant of 
HRQOL (β = 0.029, t = 4.15, p < 0.001) and of perceived stress (β = 0.26, t = 5.70, 
p < 0.001). When uncertainty and perceived stress were simultaneously regressed on 
HRQOL, while controlling for caregiver comorbidity and coping capacity, these four 
variables together explained 55% of the variance in HRQOL; perceived stress was not a 
significant determinant (β = 0.017, t = 1.91, p = 0.062), and the significant relationship of 
uncertainty to HRQOL remained (β = 0.014, t = 2.85, p = 0.006), indicating no mediator 
effect. 
At T2, uncertainty was a significant determinant of HRQOL (β = 0.02, t = 2.37 
p = 0.023) and of perceived stress (β = 0.23, t = 3.76, p = 0.001). When uncertainty and 
perceived stress were simultaneously regressed on HRQOL, the two variables explained 
26% of the variance in HRQOL; perceived stress remained a significant determinant 
(β = 0.06, t = 2.58, p = 0.014), whereas uncertainty was no longer a significant 
determinant (β = 0.01, t = 0.67, p = 0.505), indicating a full mediator effect. 
Mediator effect of perceived stress on the relationship between uncertainty 
and depressive symptoms. At T1, uncertainty was a significant determinant of 
depressive symptoms (β = 0.14, t = 4.67, p < 0.001) and perceived stress (β = 0.26, 
t = 5.70, p < 0.001). When uncertainty and perceived stress were simultaneously 
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regressed on depressive symptoms, while controlling for coping capacity and caregiver 
race, these four independent variables together explained 46% of the variance in 
depressive symptoms; perceived stress remained a significant determinant (β = 0.19, 
t = 3.11, p = 0.003), and the significant relationship of uncertainty to depressive 
symptoms was attenuated (β = 0.08, t = 2.17, p = 0.034), indicating a partial mediator 
effect. 
At T2, uncertainty was a significant determinant of depressive symptoms 
(β = 0.12, t = 3.25, p = 0.002) and of perceived stress (β = 0.23, t = 3.76, p = 0.001). 
When uncertainty and perceived stress were simultaneously regressed on depressive 
symptoms, these two variables together explained 62% of the variance in depressive 
symptoms; perceived stress remained a significant determinant (β = 0.41, t = 7.48, 
p < 0.001), and the significant relationship of uncertainty to depressive symptoms became 
nonsignificant (β = 0.02, t = 0.70, p = 0.489), indicating a full mediator effect. 
Mediator effect of salivary cortisol on the relationship between uncertainty 
and psychological outcomes (burden, HRQOL and depressive symptoms). At neither 
time point—T1 or T2 —was uncertainty a significant determinant of salivary cortisol on 
either waking (p = 0.103 at T1 and p = 0.570 at T2) or in the evening (p = 0.451 at T1 
and p = 0.055 at T2). Thus, there were no mediating effects of salivary cortisol on waking 
or in the evening on the relationship of uncertainty to psychological outcomes (burden, 
HRQOL and depressive symptoms). 
Summary for Aim 4. Table 28 summarizes mediator effects of perceived stress 
on each relationship between uncertainty, burden, HRQOL and depressive symptoms. 
There was a partial mediator effect of perceived stress on the relationship between 
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uncertainty and burden, while controlling for perceived level of preparedness for 
caregiving and caregiver comorbidity at T1 and in univariate regression analysis without 
controlling for covariates at T2. There were, however, no mediating effects of salivary 
cortisol on waking or in the evening on the relationship of uncertainty to burden at either 
T1 or T2. Thus, Hypothesis 6 (that at each time point, perceived stress and salivary 
cortisol would each mediate the relationship between uncertainty and burden) was 
partially supported. 
There was no mediator effect of perceived stress on the relationship between 
uncertainty and HRQOL at T1. By T2, there was a full mediator effect of perceived stress 
on the relationship of uncertainty to HRQOL in univariate regression analysis without 
controlling for covariates. Prior to testing the mediator effect of perceived stress on the 
relationship between uncertainty and HRQOL, the association between uncertainty and 
HRQOL, however, was not strong. There were, however, no mediating effects of salivary 
cortisol on waking or in the evening on the relationship of uncertainty to HRQOL at 
either T1 or T2. Thus, Hypothesis 7 (that at each time point, perceived stress and salivary 
cortisol would mediate the relationship between uncertainty and HRQOL) was partially  
supported. 
There was a partial mediator effect of perceived stress on the relationship between 
uncertainty and depressive symptoms, while controlling for caregiver coping capacity 
and race at T1 and a full mediator effect of perceived stress on the relationship of 
uncertainty to depressive symptoms in univariate regression analysis without controlling 
for covariates at T2. There were, however, no mediating effects of salivary cortisol on 
waking or in the evening on the relationship of uncertainty to depressive symptoms at 
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both T1 and T2. Thus, Hypothesis 8 (that at each time point, perceived stress and salivary 
cortisol would mediate the relationship between uncertainty and depressive symptoms) 
was partially supported. 
Table 28 
Mediator Effects of Perceived Stress on the Relationship between Uncertainty, Burden, 
Health-Related Quality of Life and Depressive Symptoms at T1 (N = 63) and T2 (N = 40) 
 T1 T2 (in univariate analysis) 
Burden Partial Mediation Partial Mediation 
Health-Related Quality of Life No Mediation Full Mediation 
Depressive Symptoms Partial Mediation Full Mediation 
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CHAPTER 5: DISCUSSION 
Introduction 
I examined the effect of uncertainty on caregiver perceived and physiological 
stress and psychological outcomes (burden, health-related quality of life [HRQOL] and 
depressive symptoms) within the first 2 weeks (baseline) following a sudden health event 
(i.e., stroke) in a family member and again 4 weeks later (~6 weeks poststroke). In 
addition, I examined whether perceived or physiological stress influenced the relationship 
between uncertainty and psychological outcomes at each time point. This final chapter (a) 
summarizes principal findings, (b) discusses the meaning of study results and their 
relationship to existing literature, (c) identifies the strengths and limitations of the study, 
(d) specifies implications for clinical practice and health policy and (e) makes 
recommendations for future research. 
Summary of Principal Findings 
To the best of my knowledge, I believe I am the first to investigate the effect of 
uncertainty on perceived and physiological stress, burden, HRQOL or depressive 
symptoms in caregivers of stroke survivors in the very early phase poststroke. In addition, 
I explored the mediator effect of stress on the relationship between uncertainty and 
psychological outcome. Greater uncertainty was significantly associated with higher 
perceived stress in caregivers of stroke survivors, both immediately following the stroke 
and at 6 weeks poststroke. Uncertainty was not a significant predictor of physiological 
stress, however, at either time point. Greater uncertainty was significantly associated with 
greater burden, poorer HRQOL and greater depressive symptoms at both observations. 
By 6 weeks poststroke, however, uncertainty was significantly associated with poorer 
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HRQOL only in univariate analysis, indicating that the importance of uncertainty to 
HRQOL had waned. In addition, perceived stress partially mediated the relationship 
between uncertainty and depressive symptoms at baseline, and at 6 weeks poststroke it 
fully mediated that relationship; patients with greater uncertainty had more depressive 
symptoms as perceived stress levels increased. At both observations, perceived stress 
partially mediated the relationship between uncertainty and burden. 
Comparison with Findings in Existing Literature 
Uncertainty. The present study revealed that the level of uncertainty in caregivers 
of stroke survivors was consistent from baseline (Mean [M] ± Standard Deviation [SD]: 
84.13 ± 19.93, N = 63) to 6 weeks poststroke (M ± SD: 85.23 ± 23.94, N = 40); further, in 
the 40 caregivers with complete data at both time points, there was no statistically 
significant difference in level of uncertainty. The level was higher than that previously 
reported for several populations of family caregivers for persons living with, for example, 
dementia, prostate cancer and myocardial infarction (Mishel, 1997b). In addition, 
Mitchell and Courtney (2004) reported that average caregiver uncertainty levels, when a 
family member transferred from intensive care, ranged from 76.24 to 78.93. Nauser’s 
(2010) study of uncertainty in caregivers for patients with heart failure, using only a 30-
item version of the Perception of Uncertainty in Illness Scale for Family Member, also 
reported proportionally lower uncertainty scores than in the caregivers of stroke survivors 
in the present study. These findings suggest that caregivers of stroke survivors may have 
somewhat greater uncertainty. The average duration of providing care for patients with 
heart failure in the Nauser study was approximately 4 years, whereas the sampling 
interval for caregiving after stroke in the present study was shorter (within 2 weeks 
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poststroke to around 6 weeks poststroke). Caregivers of new stroke survivors must adjust 
to an altered relationship with their family member and also take on new responsibilities 
as informal caregivers; they may have great uncertainty in making meaning of their 
stroke survivors’ potential health outcomes and their own new caregiver role. 
Characteristics of caregivers or their stroke survivors that influence uncertainty in 
caregivers for stroke survivors have not been well documented in the existing literature. 
Although not the aim of the present study, it was notable that several of these were found 
related to uncertainty: caregiver coping capacity, caregiver health status, perceived 
quality of relationship with the stroke survivor and stroke-survivor functional status at 
both observations; and caregiver social support and stroke-survivor health-insurance type 
at baseline and caregiver age and relationship to the stroke survivor at 6 weeks poststroke. 
These observations add to the body of knowledge about factors that may influence 
caregiver uncertainty. 
Stress. 
Perceived stress. In this study, caregiver perceived stress was consistent from 
baseline (M ± SD: 24.21 ± 9.55, N = 63) to 6 weeks poststroke (M ± SD: 24.47 ± 10.74, 
N = 40), regardless of the current posthospital placement of the patient (rehabilitation 
hospital, nursing facility or other). By comparison, the mean perceived stress-scale levels 
in a probability sample of the United States (N = 2,355) was 19.62 (± 7.49; B. Cohen & 
Williamson, 1988) and 16.22 (±8.73) in caregivers of older adults with heart failure 
(Schwarz & Dunphy, 2003). Average perceived stress levels in caregivers of stroke 
survivors in the present study were higher than those reported in these other studies, 
suggesting that stroke-survivor caregivers are at high risk for the development of stress- 
 113 
related morbidity as found in the existing literature. 
The finding that greater uncertainty was associated with higher perceived stress in 
caregivers of stroke survivors is supported by studies on uncertainty in other populations. 
Shannon and Lee (2008) reported that a mother’s uncertainty about infant HIV serostatus 
was correlated with her perceived stress. In their study, however, there was no adjustment 
for other factors that may have influenced perceived stress, whereas in the present study, 
uncertainty was a main predictor for perceived stress when adjusting for other caregiver 
and stroke-survivor characteristics, both at baseline and at 6 weeks poststroke. These 
results indicate that caregiver uncertainty is likely a key factor associated with stress 
during the first 6 weeks of caregiving. 
Previous research identified several factors affecting perceived stress: caregiver 
gender, age, health status, time since beginning to provide care for stroke survivors, 
coping strategies/capacity, social support, preparedness for caregiving, stroke-survivor 
functional status and severity of stroke (Ostwald et al., 2009). With the exception of 
coping capacity and social support, none of these factors was supported in the present 
study. One possible reason for these differences may be that the time period we explored, 
the first 6 weeks of caregiving, represents only a relatively early period of caregiving, 
whereas Ostwald et al. (2009) investigated perceived stress in caregivers on hospital 
discharge and then up to 12 months postdischarge. Another possibility affecting 
differences in study outcomes is the larger sample size in the Ostwald et al. study, which 
included 159 stroke survivors and their caregivers. 
In the present study, in addition to uncertainty, factors associated with perceived 
stress were caregiver coping capacity and stroke survivor’s inability to communicate at 
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baseline and social support and stroke survivor’s income at 6 weeks poststroke. Of stroke 
survivors, 43% were unable to communicate verbally. Other researchers have reported 
that communication loss or aphasia was the most upsetting factor to caregivers and was 
related strongly to caregiver burden (Bakas, Kroenke, et al., 2006; Vincent et al., 2009). 
When stroke survivors were in the acute stage, their caregivers experienced stress from 
the stroke survivor’s inability to communicate. At 6 weeks poststroke, caregivers 
reported significantly less perceived social support from family, friends and significant 
others compared to baseline. Although stroke survivors had recovered much function, 
other issues such as economic strain and reduction in perceived social support surfaced as 
important aspects affecting caregiver perceived stress. In addition, although caregivers 
spent significant time in caregiving during the first 6 weeks of caregiving, this factor did 
not affect perceived stress. Time spent per day in caregiving was consistent from 8.59 
(± 6.64, N = 63) at baseline to 7.60 (± 6.59, N = 40) at 6 weeks poststroke. Tooth et al. 
(2005) reported that caregivers of stroke survivors spent approximately 4.6 hours per day 
at 6 months poststroke and approximately 3.6 hours per day at 12 months to assist 
patients with daily activities. 
Poorer caregiver coping capacity was associated with higher perceived stress at 
baseline and mediated the relationship between uncertainty and stress at 6 weeks 
poststroke; it is noteworthy that coping capacity consistently influenced perceived stress 
during the first 6 weeks of caregiving. Even with a relatively small sample size at 6 
weeks poststroke, uncertainty and coping capacity remained significant predictors of 
perceived stress. After the stroke survivor’s discharge from the hospital, caregivers with 
greater uncertainty experienced higher levels of perceived stress, which may have  
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contributed to difficulty adjusting to their new role. Those with higher coping capacity at  
6 weeks poststroke, however, had lower perceived stress. 
Physiological stress. No studies investigating the relationship between 
uncertainty and physiological stress response were found in the current literature. In the 
present study, uncertainty was not a predictor of physiological stress at either time point. 
There was, however, a significant correlation between caregiver uncertainty and evening 
salivary-cortisol level at 6 weeks poststroke. Although caregivers were uncertain 
regarding the outcomes of the stroke and their new caregiver role at baseline, there was 
no measurable influence on physiological stress in the first few days after the stroke. 
Their greater uncertainty by 6 weeks poststroke, however, may have influenced their 
physiological regulatory mechanisms. At that same observation point, there was also a 
significant correlation between perceived stress and salivary-cortisol level in the evening, 
whereas this relationship was not significant at baseline. One possible explanation is that 
while physiologic homeostasis may have been maintained even in the face of perceived 
stress at baseline, the body’s failure to compensate longer term led to a physiological 
stress response by 6 weeks poststroke. 
In addition, acute stress response, which would be represented by an increase in 
salivary cortisol among caregivers of stroke survivors, may be more likely to be detected 
in salivary cortisol in the evening. Woods et al. (2008) also reported that cortisol 
dysregulation for residents with advanced dementia is more likely to be detected in the 
evening. In the present study, salivary-cortisol levels on waking, however, were not 
correlated with uncertainty or perceived stress at either time point. A 12-month self-
management intervention in patients with irritable bowel syndrome, including cognitive-
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behavioral strategies, reduced perceived stress over time, but did not diminish urinary 
salivary cortisol in the morning (Deechakawan, Cain, Jarrett, Burr, & Heitkemper, 2013). 
In the present study, the mean salivary-cortisol levels on waking and in the 
evening at each time point were in normal ranges, based on the salivary cortisol expected 
ranges provided by the enzyme-linked immuno sorbent assay kit manufacturer, although 
salivary-cortisol levels in a few participants were above or below normal ranges. Further 
exploration is required with a larger sample size. One study reporting salivary-cortisol 
levels in female caregivers of stroke survivors found that younger age was associated 
with lower levels of cortisol on waking and 30 minutes postwaking (Saban et al., 2012). 
In the present study, at baseline, older caregiver age was associated with elevated 
salivary-cortisol level on waking, and experiencing other life events was associated with 
a lower salivary-cortisol level on waking; these significant associations had, however, 
disappeared by 6 weeks poststroke. Instead, at the second time point, a spousal 
relationship with stroke survivors was associated with elevated waking levels of salivary 
cortisol. The inconsistency found for study variables that were related to salivary-cortisol 
levels (correlations and associations) at both time points—and either on waking or in the 
evening—in the present study is puzzling and warrants further research on salivary 
cortisol with repeated measures in a larger sample to better understand the mixed results. 
Saban et al. (2012) reported that salivary-cortisol levels were lower across the day 
in caregivers with higher versus lower depressive-symptom scores. Another study 
reported that patients with relapsed major depression had higher cortisol levels than 
patients in stable remission (Zobel et al., 2001). At 6 weeks poststroke in the present 
study, having greater depressive symptoms was correlated with elevated salivary-cortisol 
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level in the evening, but not with the levels on waking at either time period. The present 
study measured salivary-cortisol levels at two time points during the first 6 weeks of 
caregiving, whereas Saban et al. (2012) measured them at approximately 8 months of 
caregiving. One possible explanation for these differences may be that when caregivers 
initially are exposed to stressors, e.g., within 2 weeks poststroke, their physiologic 
homeostasis may have been maintained, as suggested previously. By 6 weeks poststroke, 
as in the present study, stressors had induced an increase in hypothalamic-pituitary-
adrenal (HPA)-axis activity, which caused elevated cortisol level. By 8 months poststroke, 
however, HPA-axis activity may have decreased or overadjusted, resulting in lower 
levels of cortisol (Fries, Hesse, Hellhammer, & Hellhammer, 2005; Saban et al., 2012). 
Another difference between the present study and that of Saban et al. (2012) is 
gender differences in the study samples; the present study included both male and female 
caregivers, whereas their study was limited to women. The present study, however, found 
no significant gender differences for salivary-cortisol levels. Women with irritable-bowel 
syndrome had slightly higher urinary cortisol levels than did men; however, this 
difference was not statistically significant (Deechakawan et al., 2013). Thus, gender 
differences between study samples would not likely be a reason affecting the relationship 
between salivary-cortisol levels and depressive symptoms. 
Psychological outcomes. 
Burden. In this study, caregivers reported mild to moderate burden on average 
during the first 6 weeks of caregiving; this observation is consistent with results of a 
study by Bugge et al. (1999) in which caregivers experienced “strain” at least 1 month 
poststroke. In the present study, 14% to 20% of caregivers experienced burden at 
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moderate-to-severe or severe levels. One possible reason for the inconsistent findings 
between the present study and the study by Tooth et al. (2005), in which 44% caregivers 
reported considerable burden at 6 months and 42% reported burden at 12 months 
poststroke, may be the effect of time on burden. I studied caregiver burden during the 
first 6 weeks of caregiving whereas Tooth et al. studied burden from 6 months to 12 
months poststroke; the experience of burden may be cumulative and worsen over time 
and certainly burden in caregivers is reported to be at much higher levels at 1 year. Some 
studies reported that caregiver burden continued to increase from 2 months to 6 months 
(Ilse et al., 2008) or from 1 month to 6 months (Blake et al. 2003; Bugge et al., 1999). 
Two other studies, however, reported that burden of caregivers decreased over time, that 
is, baseline to 6 months (McCullagh et al., 2005; Vincent et al., 2009). Additional studies 
that encompass multiple measurements over longer periods from the stroke event to 
several years, as well as inclusion of comparable risk factors and measures, are required 
to understand the mixed results in the existing literature. 
No previous studies were found that explored the direct relationship between 
uncertainty and burden in caregivers. In a study of caregivers for patients with 
Parkinson’s disease, Sanders-Dewey et al. (2001) reported that uncertainty was a 
significant factor affecting psychological distress. In the present study, uncertainty was a 
significant predictor for burden. I found that burden in caregivers increased slightly from 
baseline (within 2 weeks poststroke) to 6 weeks poststroke, although there was no 
statistical difference based on paired t-tests in the smaller sample of those who completed 
the study. In addition, at both observations, perceived stress partially mediated the 
relationship between uncertainty and burden. Although the mediator effect of perceived 
 119 
stress on the relationship between uncertainty and burden was weak, this result suggests 
that caregiver uncertainty may lead to a stressful caregiving situation, which eventually 
induces greater burden. 
Uncertainty, perceived level of preparedness for caregiving and caregiver 
comorbidity at baseline, and uncertainty and caregiving coping capacity at 6 weeks 
poststroke were significant factors influencing burden in the present study. The findings 
that caregiver comorbidity was associated with burden at baseline and that coping 
capacity was associated with burden 6 weeks poststroke are supported by other studies 
(Cameron & Gignac, 2008; Van Puymbroeck & Rittman, 2005). Ostwald et al. (2009) 
reported that preparedness for caregiving influenced perceived stress in caregivers for 
stroke survivors. The significant effect of perceived level of preparedness for caregiving 
on burden found in the present study, however, has not been shown in previous studies. 
Another interesting finding in the present study was that perceived level of preparedness 
for caregiving was associated with burden only at baseline; further, there was no 
significant difference in perceived level of preparedness for caregiving at baseline and 6 
weeks poststroke (from M ± SD: 2.21 ± 1.11, N = 63 to M ± SD: 2.25 ± 1.01, N = 40 on 
scale of 1 [excellent] to 4 [poor]), suggesting that although there was greater uncertainty 
among caregivers, time in caregiving experience did not affect sense of preparedness and 
average preparedness level did not improve. Perceived level of preparedness for 
caregiving may be an important factor in acute stages of stroke, such as within the first 2 
weeks poststroke, but over time, other factors such as uncertainty and coping capacity 
may be more important influences on burden than preparedness for caregiving. This 
factor warrants further exploration. 
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Health-related quality of life. Northouse et al. (2002) reported that uncertainty 
was associated with mental health dimensions of HRQOL (while adjusting for caregiver 
and patient characteristics) in caregivers for persons with recurrent breast cancer. In the 
present study, uncertainty was associated with HRQOL at baseline. By 6 weeks 
poststroke, uncertainty had lost its significant association with HRQOL, while adjusting 
for other caregiver and stroke-survivor characteristics, although there was a significant 
association in univariate regression analysis. The study by Northouse et al. (2002) was a 
cross-sectional study with a sample of 189. In the present study, only 40 caregivers 
remained at 6 weeks poststroke to explore the relationship between uncertainty and 
HRQOL. Our dissimilar result could, thus, be related to the limited sample size; at 6 
weeks poststroke, the 40 remaining caregivers, on average, had significantly poorer 
HRQOL and poorer health status than they had at baseline (based on a paired t-test with 
the sample of 40 caregivers), whereas uncertainty levels among these remaining 
caregivers was consistent over time. Another possibility is that a relativity lower 
reliability and fewer items (only 5) of the EQ5D instrument used to measure HRQOL 
may have impeded the detection of the effect of uncertainty on HRQOL. Although 
caregiver HRQOL and health status each declined from baseline to 6 weeks poststroke, 
other factors, including caregiver coping capacity and comorbidity, appeared to have a 
stronger influence on HRQOL than did uncertainty at 6 weeks poststroke. Neither age of 
caregiver nor that of stroke survivor influenced HRQOL or health status in caregivers in 
the short time period of the present study; it should be noted, however, that 30% of 
caregivers were aged 65 years or older, placing them at higher longer term risk for 
morbidity and mortality from caregiving. 
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Our finding of a continuous effect of caregiver coping capacity and comorbidity 
on HRQOL over time does support results of previous studies (Morimoto et al., 2003; 
Visser-Meily et al., 2009). McCullagh et al. (2005) revealed that increasing caregiver age 
and male gender were associated with their poorer quality of life, whereas these same 
caregiver characteristics were not associated with HRQOL in the present study. Possible 
explanations for this difference may include the variation between studies in operational 
definitions and measures for quality of life and HRQOL. The McCullagh et al. study used 
EQ-Visual-Analog Scale (VAS) to measure quality of life, whereas the present study 
used EQ5D to measure HRQOL. In addition, caregivers in this sample were much 
younger (M ± SD: 56.92 ± 13.81 years) compared to those in the study by McCullagh et 
al. (2005; M ± SD: 65.7 ± 12.5 years). 
One of the noteworthy findings of the present study is that caregiver HRQOL, 
health status and comorbidity each got worse, even while stroke-survivor functional 
status improved. Caregiving outcomes in stroke survivors is reported to be related to 
physical and psychological health as well as related morbidities (Anderson et al., 1995; 
Bauer et al., 2000; Berg et al., 2005; Blake et al., 2003; Burman, 2001; Forsberg-Warleby 
et al., 2002; McCullagh et al., 2005; Pierce et al., 2006; White et al., 2003). Stroke has a 
sudden onset. Thus, while caregivers were trying to adjust to their new caregiver role in 
the early weeks of caregiving, their own health status had already begun to deteriorate, 
underscoring the importance of monitoring caregivers during this critical period. 
Perceived stress mediated the relationship between uncertainty and HRQOL at 6 
weeks poststroke but not at baseline. This relationship is limited to univariate regression 
analysis without adjusting for other caregiver and stroke-survivor characteristics. In 
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addition, prior to testing the mediator effect, the association between uncertainty and 
HRQOL was not strong. This result, however, may be clinically meaningful. Uncertainty 
was associated with HRQOL in patients with cancer and their caregivers (Northouse et al., 
2002) and patients with gynecological cancer (Padilla, Mishel, & Grant, 1992). 
Compared to noncaregivers, caregivers of patients with Alzheimer’s disease had elevated 
allostatic load (measures of blood pressure, BMI, total/HDL, HDL cholesterol, plasma 
norepinephrine and epinephrine; Roepke et al., 2011). Uncertainty in caregivers of stroke 
survivors during the early weeks is likely a key factor associated with caregiver stress, 
leading to poorer HRQOL. 
Depressive symptoms. Although in the present study caregivers, on average, 
reported mild levels of depressive symptoms, approximately 30% of caregivers had 
moderate, moderate-to-severe or severe depressive symptoms. This finding is consistent 
with previous reports that as many as 23% to 33% of caregivers experience depression 
during an 18-month poststroke follow-up period (Berg et al., 2005; Blake et al., 2003), 
yet is nearly twice as high as the 18% of caregivers with moderate, moderate-to-severe or 
severe depressive symptoms reported in the Bakas, Kroenke, et al. study (2006). 
The finding of a significant effect of uncertainty on depressive symptoms is 
consistent with earlier findings of a correlation between uncertainty and depression in 
caregivers for persons with Parkinson’s disease (Sanders-Dewey et al., 2001). In that 
study, however, other predictors that may influence caregiver depression were not 
analyzed, whereas in this study, uncertainty, caregiver coping capacity and race were 
each found to be associated with depressive symptoms at baseline. At 6 weeks poststroke, 
uncertainty and the covariate number of close friends and relatives were entered in the 
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multivariate stepwise regression model, but number of close friends and relatives did not 
remain in the final model. Thus, uncertainty itself was related to depressive symptoms. In 
the existing literature, a number of factors were found to influence depressive symptoms 
but mixed results between studies also have been reported. One result of the present study, 
that caregiver race and coping capacity were associated with depressive symptoms at 
baseline, is supported a study by Van Puymbroeck et al. (2008). Caregiver race was no 
longer associated with depressive symptoms at 6 weeks poststroke, but coping capacity 
mediated the relationship between uncertainty and depressive symptoms. 
Although uncertainty and coping capacity were each significant predictors for 
depressive symptoms in caregivers for stroke survivors, over time the effect of coping 
capacity on depressive symptoms proved stronger than that of uncertainty. Caregivers 
may have mixed emotions about their caregiving situation because they may have daily 
caregiving tasks that disturb their own lifestyles or jobs. Chumbler, Rittman, and Wu 
(2008) reported that higher coping capacity was associated with lower levels of 
depression in caregivers of stroke survivors across 2 years of follow-up. They suggested 
that caregivers be encouraged to cope with their situations by finding meaning in 
caregiving rather than by focusing on negative demands or burden, and that this strategy 
may prevent depressive symptoms (Chumbler et al., 2008). 
The current findings show that the degree of influence of perceived stress in the 
relationship between uncertainty and depressive symptoms was strengthened at 6 weeks 
poststroke. In other words, patients with greater uncertainty had greater depressive 
symptoms as perceived stress levels increased. In patients with multiple sclerosis, 
uncertainty about the illness was an important mediator of the relationship between the 
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present state of the illness and depression (Kroencke, Denney, & Lynch, 2001). Perceived 
stress as a mediator of the relationship between uncertainty and depressive symptoms is 
not clear in the current literature. Caregivers of stroke survivors may experience stress 
because they are not certain of the extent to which stroke survivors will worsen or 
recover, as well as how involved they will need to be in longer term care for the stroke 
survivor and the commensurate impacts on employment, economics, family life and so on. 
This uncertainty is highly associated with stress, which eventually leads to greater 
depressive symptoms. Stress-management behavioral therapy has been shown to decrease 
the prevalence of depression in patients with early-stage breast cancer (Antoni et al., 
2001). Cognitive-behavioral therapies, including stress management related to 
uncertainty, may have utility in decreasing depressive symptoms in caregivers of stroke 
survivors as well. 
Strengths of This Study 
The present study exhibits several strengths. First, the prospective longitudinal 
design captured the effects of uncertainty on perceived and physiological stress, burden, 
HRQOL and depressive symptoms at two time points within the first 6 weeks poststroke: 
within 2 weeks poststroke and again at ~6 weeks poststroke. In addition, this is the first 
study to examine the role of uncertainty on these outcomes in caregivers of stroke 
survivors or to investigate caregiver experiences in the very early period poststroke. By 
including physiologic measures of stress, the early time period of caregiving was further 
illuminated. Although the follow-up period was relatively short, I was able to examine 
the influence of uncertainty on outcomes at each time point. As there was no intervention 
for caregivers between baseline and 6 weeks poststroke, I, thus, observed the “natural 
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history” of this relationship. The effects of uncertainty on perceived stress, burden, 
HRQOL and depressive symptoms were consistently important over time and explained a 
large amount of their variance. Different caregiver and stroke-survivor characteristics, 
however, affected outcomes at each time point: when stroke survivors were still in the 
hospital (baseline) and at 6 weeks poststroke (after discharge). These results are clinically 
meaningful because they facilitate the ability to target factors and key time points for 
potential intervention. 
Second, I used multiple statistical methods to confirm the validity of the findings. 
I used either a parametric or nonparametric method for bivariate analysis based on 
distributions of the variables (Pearson’ correlation vs. Spearman’s correlation, two 
sample t-test vs. Mann-Whitney U test and analysis of variance [ANOVA] vs. Kruskal-
Wallis test). The results from paired t-tests used to examine changes from baseline to 6 
weeks poststroke in continuous variables among 40 participants were compared with 
those of Wilcoxon Signed ranks test. In addition, as sensitivity analyses, separate 
bivariate linear mixed models with repeated measures of each dependent variable to 
compare the effects of uncertainty or covariates were computed to affirm confidence in 
the results in the present study. The findings from the bivariate linear mixed models were 
very similar to those resulting from the conservative statistical analyses used to test the 
hypotheses, thereby increasing my confidence in the results. 
Limitations of This Study 
This study has some limitations that should be acknowledged. First, 
generalizability is potentially limited because of the study’s design, convenience 
sampling, single geographic region and relatively small sample size. For instance, the 
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present study did not include age/gender-matched noncaregivers or caregivers of persons 
with other conditions as control subjects. The literature on caregivers for patients with 
dementia, for example, indicates that they have elevated levels of salivary cortisol across 
the day and higher stress than do noncaregivers (Gallagher-Thompson et al., 2006). It 
would be difficult, however, to compare measures such as caregiver uncertainty or 
burden between caregivers and noncaregivers or even among those caring for persons 
with other conditions with nonacute onset; examining differences in perceived stress, 
salivary cortisol, HRQOL and depressive symptoms between caregivers for stroke 
survivors and either of these other groups, however, would increase current knowledge of 
stroke-survivor caregivers. 
Furthermore, caregivers who did not agree to participate in the study or who were 
lost to follow up at 6 weeks poststroke may have had more caregiving responsibilities and 
higher stress levels. The main reason given for declining to participate in the study was 
“feeling overwhelmed with their current situation.” Some study participants who 
withdrew from the study expressed they could not continue to participate due to their 
caregiving situation and/or personal problems. Thus, there is a possibility that some 
caregivers with greater uncertainty or more severe levels of stress were not included in 
the present study. By 6 weeks poststroke, 13 stroke survivors had died and their caregiver 
data were excluded in analyses for that observation. Another 10 caregivers were lost to 
follow up or withdrew from the study. The majority of the baseline values in caregiver 
and stroke-survivor characteristics between these 23 caregivers who were not included in 
the data analysis at 6 weeks poststroke and 40 caregivers who completed the study were 
similar, pointing to overall homogeneity in the sample. The 40 caregivers who completed 
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the study, however, did report less social support at baseline than did the 23 who were 
excluded in the data analysis at 6 weeks poststroke; the sample of 40 caregivers at 6 
weeks poststroke also contained a slightly larger proportion of non-White participants. 
Although these two differences were statistically significant, they are not believed to be 
clinically meaningful; however, there is a possibility that the findings at 6 weeks 
poststroke could be influenced by characteristics in the retained sample. 
Second, the time period for follow up was limited. Extending the follow-up period 
to include multiple time points over a longer period of time after caregivers assume their 
caregiver role is required to further examine how uncertainty may change “naturally” and 
to determine its effect on long-term perceived stress, diurnal salivary cortisol and 
psychological outcomes. Still, the study results shed light on a previously unexplored 
period in the development of untoward caregiver outcomes. 
Third, there is the possibility that participants were noncompliant with the 
protocol for saliva collection. Although caregivers were taught self-collection of saliva in 
a personal demonstration at baseline, I was unable to verify whether they actually 
followed directions. For example, some salivary-cortisol levels in the evening were 
higher than those on waking, an unusual finding that held even after reanalysis. It is 
possible that caregivers mislabeled the sample vials with an incorrect time of day. 
Salivary-cortisol levels in a few participants were similar between on waking and in the 
evening. A possible interpretation for these flatter salivary slope patterns in a few 
caregivers could be depression. Stroke-survivor caregivers with depression were found to 
have lower salivary levels across the day than did caregivers without depression (Saban 
et al., 2012). 
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Fourth, due to the small sample size and limited power in the present study, I 
chose as covariates to enter into the multivariate stepwise regression models for testing 
Aims 1, 2 and 3 only caregiver and stroke-survivor characteristics that were identified 
from bivariate analysis on the basis of a p-value less than or equal to 0.05. There is a 
possibility that some covariates that were not significant in the bivariate analysis could 
have been important factors affecting outcomes in a multivariate analysis. Because of the 
mediation effects between uncertainty and covariates, testing the mediator effect of 
perceived stress on the relationship between uncertainty and psychological outcomes 
including burden, HRQOL and depressive symptoms at 6 weeks poststroke was limited 
to univariate regression analysis. With a larger sample size, many more covariates could 
be controlled to better examine any mediating effect of stress on the relationship between 
uncertainty and psychological outcomes including burden, HRQOL and depressive 
symptoms. 
Finally, although not proposed for this study, sophisticated methods such as 
mixed models with repeated-measures analysis would be statistically more powerful 
because this analysis accounts for missing data if the data are missing at random. No 
previous studies, however, had examined the effect of uncertainty on perceived and 
physiological stress, burden, HRQOL and depressive symptoms in caregivers of stroke 
survivors. Therefore, as the first step, it was important in this study to explore whether 
uncertainty, as well as other caregiver and stroke-survivor characteristics, affect these 
outcomes at each time point—while stroke survivors are in the hospital and after 
discharge to home, rehabilitation hospitals or nursing facilities—using participants with 
complete data at each time point. Conducting separate regression analyses with complete 
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data at each time point in the present study was, thus, appropriate for the aims of the 
present study. Further, existing longitudinal studies on caregivers of stroke survivors 
have used a separate regression analysis to reveal factors that affected outcomes at each 
time point (Bugge et al., 1999; McCullagh et al., 2005; Tooth et al., 2005). Hence, my 
design permits important comparisons with existing reports and also fills gaps to 
contribute importantly to a story about the evolution of caregiver outcomes, including 
burden, over time. 
Further, in the present study, there was no intervention for caregivers between 
baseline and 6 weeks poststroke. In a natural environment without any intervention and in 
the absence of previous study results, it is difficult to hypothesize whether perceived and 
physiological stress, burden, HRQOL and depressive symptoms change significantly or 
remain consistent over time. The paired t-tests using data from participants with complete 
datasets (N = 40) in the present study showed that perceived stress, salivary cortisol, 
burden and depressive symptoms were consistent from baseline to 6 weeks poststroke, 
whereas bivariate linear mixed models with repeated measures of each dependent 
variable using the entire available sample (63 at baseline, 53 [40 participants who 
completed the study and 13 participants whose stroke survivor died after baseline data 
collection] at 6 weeks poststroke) revealed that caregivers had greater burden and poorer 
HRQOL at 6 weeks poststroke compared to baseline. The difference from baseline to 6 
weeks poststroke for burden based on the paired t-test in the present study approached 
statistical significance (p = 0.068), suggesting lack of power due to the small sample size 
at 6 weeks poststroke (N = 40). Using a larger sample size in future studies may reveal 
significant differences from baseline to 6 weeks poststroke. With a few exceptions (2 
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covariates [stroke-survivor communication ability for perceived stress at baseline and 
relationship to the stroke survivor for salivary cortisol on waking at 6 weeks poststroke] 
that approached significance in bivariate linear mixed models with repeated measures), 
the results from the regression analysis at each time point were consistent with the 
findings from bivariate linear mixed models with repeated measures of each dependent 
variable, adding further support for the study findings. 
Implications for Clinical Practice and Health Policy 
The findings from the current study have several implications for clinical practice 
with caregivers of stroke survivors. First, healthcare providers in neuroscience must 
become sensitized to caregiver uncertainty in the early period of caregiving. It is 
important for clinicians to help caregivers identify specific areas where they are uncertain 
(e.g., re: stroke-survivor outcome, the recovery process or caregiver role) and provide 
appropriate support. Using uncertainty as a predictor may help identify caregivers at risk 
for stress, burden, poor HRQOL or depressive symptoms—that is, those in need of 
additional support. In addition, the present study revealed that by 6 weeks poststroke, 
caregivers with greater uncertainty had greater depressive symptoms as perceived stress 
levels increased. Acting on these critical insights has the potential to improve clinical 
outcomes. Using early detection of uncertainty as a trigger to initiate caregiver 
intervention in the early period of caregiving, such as consultation or stress-management 
behavioral therapy, may lead to decreased depressive symptoms and reduced morbidity 
and mortality in this population. 
Second, greater caregiver involvement in discharge planning for stroke 
survivors—by providing anticipatory guidance and information about care needs and care 
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options and enhancing caregiver preparedness—may also help reduce early uncertainty, 
support decision making in care planning and attenuate stress in the complex and often-
alienating healthcare-delivery system during a critical period. Caregivers for patients with 
heart failure have better caregiving experiences and health outcomes when they are 
involved in hospital-discharge planning (Bull, Hansen, & Gross, 2000). The results from 
the present study indicated that caregiver uncertainty remained consistent from within 2 
weeks poststroke to 6 weeks poststroke. Stroke-survivor functional status was correlated 
with uncertainty at both times in the present study. Stroke survivors who were discharged 
directly to home with their caregivers had had less severe strokes and fewer 
complications, but at 6 weeks poststroke, there was no difference in caregiver uncertainty 
regardless of posthospital discharge placement (i.e., rehabilitation hospital, nursing 
facility or homes) of the stroke survivor. Involvement in discharge planning, especially 
for stroke survivors who will be discharged directly home, could immeasurably help 
caregivers adjust to their new caregiver role, increase preparedness for caregiving and 
reduce their uncertainty. In the present study, less preparedness for caregiving in 
caregivers was associated with greater burden at baseline. In a related study (Ostwald et 
al., 2009), spousal caregivers who reframed their situation and prepared for caregiving 
had lower stress throughout the year after discharge. 
Third, policymakers need to make better informed investments in caregivers to 
effectively reduce healthcare costs. The majority of new or recurring strokes occurs 
among the older population (Stephenson, 2001). The U.S. 65 years and older population 
comprised 35 million people in 2000 and will increase to 71 million by 2030 (U.S. 
Census Bureau, 2004); thus, it is expected that the numbers of caregivers for older adults 
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with stroke will increase commensurately. A policy improving informal family 
caregiving, especially for caregivers of stroke survivors, could result in cost savings in 
the formal long-term-care system. For example, in the present study, it was noted that 
caregivers reported lowered social support at 6 weeks poststroke compared to baseline. 
Social support (including instrumental and informational as well as emotional and 
companionship support) is an important buffer known to decrease stress in stroke 
survivors and their caregivers (Glass, Matchar, Belyea, & Feussner, 1993; Jonsson, 
Lindgren, Hallstrom, Norrving, & Lindgren, 2005; Ostwald et al., 2009; Pierce et al., 
2004; Secrest, 2000). Efforts to enhance social support and discharge planning for stroke 
survivors and for their caregivers, as well as provide direct interventions for caregivers 
such as consultation or stress-management behavioral therapy, may prevent stress-related 
health problems in caregivers, decrease their burden and depressive symptoms and 
eventually reduce their healthcare costs by preventing or forestalling untoward outcomes. 
Therefore, provision of these services as a covered benefit under Medicare/Medicaid and 
other health insurances should be seriously considered. 
Recommendations for Future Research 
Replication studies are required that use a larger sample size in which many 
factors that have been viewed in previous studies as influencing outcomes can be 
successfully controlled. These include perceived stress, salivary cortisol, burden, 
HRQOL and depressive symptoms. Longitudinal designs that encompass longer periods 
(from the initial stroke event to several years poststroke) and multiple time points are also 
needed. Because of the relatively small sample size in the present study, it was difficult to 
examine the influence on outcomes of variables that changed over time. Such studies, 
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which can better employ multilevel mixed linear-regression analyses and explore the 
effects of time, interactions between time and uncertainty and interactions between time 
and other covariates, will further elucidate the overall effects of uncertainty on short- and 
long-term outcomes for caregivers. In the present study, salivary-cortisol levels were 
measured on waking and in the evening to decrease data-collection burden in caregivers. 
Longitudinal studies with saliva collection on waking, 30 minutes postawakening, 
afternoon and evening (4 measures per day) over 2 consecutive days at each 
measurement point would provide greater reliability and validity of the measure (Saban et 
al., 2012; Woods et al., 2008). Such longitudinal studies may reveal diurnal variation in 
salivary cortisol when caregivers for stroke survivors experience chronic stress. Further 
investigation is required to verify whether, over time, cortisol levels increase, similar to 
those in caregivers for patients with dementia (Bauer et al., 2000; Da Roza Davis & 
Cowen, 2001; de Vugt et al., 2005; Vedhara et al., 1999) or lower, similar to those in a 
previous study of caregivers for stroke survivors (Saban et al., 2012). In addition, daily 
self-reported stress reflecting how study participants feel when collecting saliva would 
enhance an interpretation regarding the finding of lack of correlation between perceived 
stress and salivary cortisol in the present study. 
Future intervention studies that incorporate components of uncertainty into a 
problem-solving approach are required. In one study, social problem-solving telephone 
interventions with family caregivers of stroke survivors after hospital discharge enhanced 
mental health, caregiver preparedness and social functioning, and decreased depression, 
although there was no effect on burden (Grant, Elliott, Weaver, Bartolucci, & Giger, 
2002). The steps for problem-solving therapy suggested by Grant et al. (2002) are to 
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(a) identify and define the problem, (b) decide what needs to be accomplished and list 
possible solutions to the problems, (c) choose and test best solution(s) and (d) evaluate 
outcomes of problem solving. Applying similar steps with caregivers to identify and 
define uncertainty for the individual; find possible solutions to resolve uncertainty; 
choose, test and evaluate the best problem-solving solutions and evaluate outcomes may 
increase effective communication between caregivers and healthcare providers to resolve 
uncertainty and enhance caregiver outcomes including stress, burden, HRQOL and 
depressive symptoms. 
Conclusions 
The purpose of the present study was to examine the effect of uncertainty on 
perceived and physiological stress, burden, HRQOL and depressive symptoms in 
caregivers of stroke survivors within 2 weeks and 6 weeks poststroke. The results of 
these analyses indicate that greater uncertainty was associated with higher perceived 
stress immediately following the stroke and also at 6 weeks poststroke. Uncertainty, 
however, was not a significant predictor of physiological stress at either time point. 
Overall, greater uncertainty was associated with greater burden, poorer HRQOL and 
greater depressive symptoms at both times. By 6 weeks poststroke, however, the 
influence of uncertainty on HRQOL had diminished. In addition, at 6 weeks poststroke, 
perceived stress fully mediated the relationship between uncertainty and depressive 
symptoms and mediated the effect of uncertainty on HRQOL. Prior to testing the 
mediator effect of perceived stress on the relationship between uncertainty and HRQOL, 
however, the association between uncertainty and HRQOL was not strong. At both times, 
perceived stress partially mediated the relationship between uncertainty and burden. 
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Healthcare providers in neuroscience must become sensitized to caregiver uncertainty in 
the early period of caregiving, helping them identify specific areas where they are 
uncertain (e.g., stroke-survivor outcome, the recovery process and/or caregiver role) and 
provide appropriate support. Further research on the observed rapid decline in caregiver 
health is warranted, and studies of the effect of uncertainty on long-term caregiving 
would be useful to explore its consequences over time. 
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APPENDIX A. SOCIODEMOGRAPHICS OF CAREGIVERS 
Date: _____________________________________ 
Identification Number: ________________________ 
 
1.    Age: _____(years) 
2.    Gender: a) Male b) Female 
3.    Race/Ethnicity: 
    a) Caucasian b) African American c) Asian d) Latino/Hispanic e) Other: 
4.      Native Language: a) English b) Spanish c) Other: 
5.      Relationship to the stroke survivor: 
    a) Spouse b) Child c) Grandchild d) Sibling e) Friend f) Other: 
6.      Perceived quality of relationship with the stroke survivor 
   on a scale of 1 = excellent, 4 = poor  
1 2 3 4 
7.      Duration of caregiving for the stroke survivor: prior to stroke _____days 
        since stroke _____days 
8.    Time spent caring per day:        prior to stroke _____hours 
        since stroke _____hours 
    (It included time spent with stroke survivors in a hospital.) 
9.    Length of time since the stroke survivor was diagnosed with stroke: _____days 
10.    Perceived level of preparedness for caregiving 
    On a scale of 1 = well prepared, 4 = not at all prepared  
1 2 3 4 
11.    Your (caregiver) insurance including Medicare/Medicaid: 
    a) Private insurance b) Medicare c) Medicaid d) No Insurance e) Other: 
12.    Number of close friends and relatives: _____ 
13.    Distance between the hospital (or facility) and your home: 
          _____miles or not applicable _____ 
14.    Education (highest level of education completed): 
    a) Less than high school b) High school c) Vocational training d) College 
    e) Postgraduate 
15.    Employment Status: 
    a) Full-time work b) Part-time work c) Homemaker d) Unemployed e) Retired 
    f) Leave of Absence 
16.    Considering how well your household lives on its income, financially, would you       
         say you are: 
    a) Comfortable, have more than enough to make ends meet 
    b) Adequate, have enough to make ends meet 
    c) Do Not have enough to make ends meet 
17.    Other life events in the past 3 months: e.g., death, moving, retirement, marriage 
    a) Yes, specify _____________ b) No 
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Sociodemographics of Caregivers for the Second Interview 
Date: _____________________________________ 
Identification Number: ________________________ 
 
1.      Perceived quality of relationship with the stroke survivor 
    on a scale of 1=excellent, 4=poor  
1 2 3 4 
 
2.    Duration of caregiving for the stroke survivor: since stroke _____days 
 
3.    Time spent caring per day:       since stroke _____hours 
    (It includes time spent with your loved one with stroke in a hospital, rehabilitation 
    center or nursing home.) 
 
4.    Length of time since the stroke survivor was diagnosed with stroke: _____days 
 
5.    Perceived level of preparedness for caregiving 
    On a scale of 1= well prepared and 4 = not at all prepared  
1 2 3 4 
 
6.    Distance between the hospital or facility (rehabilitation center or nursing home) 
    and your home: ____miles or N/A _____ 
 
7.    Other life events since the first interview: e.g., death, moving, retirement, marriage 
    a) Yes, specify _____________ b) No 
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APPENDIX B. MISHEL UNCERTAINTY IN ILLNESS SCALE—FAMILY 
MEMBER FORM 
 
Date: _____________________________________ 
Identification Number: ________________________ 
 
INSTRUCTIONS: 
Please read each statement. Take your time and think about what each statement 
says. Then place a “X” under the column that most closely measures how you 
are feeling about your family member TODAY. If you agree with a statement, 
then you would mark under either “Strongly Agree” or “Agree”. If you 
disagree with a statement, then mark under either “Strongly Disagree” 
or “Disagree”. If you are undecided about how you feel about him /her, then 
mark under “Undecided” for that statement. Please respond to every statement. 
 
1.      I don’t know what is wrong with him/her. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
2.      I have a lot of questions without answers. 
  
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
3.    I am unsure if his/her illness is getting better or worse. 
  
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
4.  It is unclear how bad his/her pain will be. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
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5. The explanations they give about him/her seem hazy to me. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
6. The purpose of each treatment for him/her is clear to me. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
7. I do not know when to expect things will be done to him/her. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
8. His/her symptoms continue to change unpredictably. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
9. I understand everything explained to me. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
10. The doctors say things to me that could have many meanings. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
11. I can predict how long his/her illness will last. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
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12. His/her treatment is too complex to figure out. 
 
            Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
    
13. It is difficult to know if the treatment or medications he/she is getting are 
helping. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
   
14. There are so many different types of staff; it’s unclear who is responsible for 
what. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
15. Because of the unpredictability of his/her illness, I cannot plan for the future. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
16. The course of his/her illness keeps changing. He/she has good and bad days. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
17. It’s vague to me how I will manage the care of him/her after he/she leaves the 
hospital. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
18. It is not clear what is going to happen to him/her. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
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19. I usually know if he /she is going to have a good or bad day. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
 
20. The results of his/her test are inconsistent. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
21. The effectiveness of the treatment is undetermined. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
22. It is difficult to determine how long it will be before I can care for him/her by 
myself. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
23. I can generally predict the course of his/her illness. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
24. Because of the treatment, what he/she can do and cannot do keeps changing. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
25. I ‘m certain they will not find anything else wrong with him/her. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
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26. They have not given him/her a specific diagnosis. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
     _______           ______          ______            ______                 ______ 
 
 
27. His/her physical distress is predictable; I know when it is going to get better or 
worse. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
28. His/her diagnosis is definite and will not change. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
29. I can depend on the nurses to be there when I need them. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
30. The seriousness of his/her illness has been determined.   
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
31. The doctors and nurses use everyday language so I can understand what they 
are saying. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
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APPENDIX C. PERCEIVED STRESS SCALE 
Date: _____________________________________ 
Identification Number: ________________________ 
The questions in this scale ask you about your 
feelings and thoughts in the past day (24 hours). In 
each case, you will be asked to indicate by circling 
how often you felt or thought a certain way. 
0 = 
Never 
1 = 
Almost 
Never 
2 = 
Some-
times 
3 = 
Fairly 
Often 
4 = 
Very 
Often 
1. In the past day, how often have you been upset 
because of something that happened unexpectedly?  
     
2. In the past day, how often have you felt that you 
were unable to control the important things in your 
life?  
     
3. In the past day, how often have you felt nervous 
and “stressed”?  
     
4. In the past day, how often have you dealt 
successfully with irritating life hassles?  
     
5. In the past day, how often have you felt that you 
were effectively coping with important changes that 
were occurring in your life? 
     
6. In the past day, how often have you felt confident 
about your ability to handle your personal problems? 
     
7. In the past day, how often have you felt that 
things were going your way? 
     
8. In the past day, how often have you found that 
you could not cope with all the things that you had 
to do? 
     
9. In the past day, how often have you been able to 
control irritations in your life? 
     
10. In the past day, how often have you felt that you 
were on top of things? 
     
11. In the past day, how often have you been 
angered because of things that happened that were 
outside of your control? 
     
12. In the past day, how often have you found 
yourself thinking about things that you have to 
accomplish?  
     
13. In the past day, how often have you been able to 
control the way you spend your time? 
     
14. In the past day, how often have you felt 
difficulties were piling up so high that you could not 
overcome them? 
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APPENDIX D. SALIVA COLLECTION INSTRUCTIONS 
Supplies Needed: Swab, cap, storage tube and sample ID labels. 
 
1. Do not eat food or drink liquid for 30 minutes before collecting saliva. 
2. Do not brush your teeth for 30 minutes before collecting saliva. 
3. Do not smoke for 60 minutes before collecting saliva. 
4. Do not have any major dental work within 3 days before collecting saliva. 
5. Using pre-prepared label, mark date and time. 
6. Wash your hands. 
7. Remove the oral swab from the tube (see the picture). . 
8. Put the oral swab under the tongue for 1 full minute. The oral swab can be 
moved around in the mouth to take advantage of saliva pooling under the 
tongue. This may help increase collection volume. If after 1 full minute the 
oral swab appears dry, then repeat the process. 
9. Return the oral swab into tube insert and replace the cap. 
10. Place the label on the storage tube. 
11. Wash your hands. 
12. After collecting each sample, please mark the time below. 
                  (Dates will be marked on the form ahead time for you). 
13. Place all two tubes in a plastic sealed bag and place in the freezer overnight. 
14. After collecting samples, the research team members will pick up the samples. 
 
Schedule for Salivary Cortisol Sampling 
 
Collect 2 salivary samples per day after the first interview.  
First Samples 
Date: 
Waking 9 pm 
Actual Time:  Actual Time: 
 
Collect 2 salivary samples per day before or after the second interview (1 month after the 
first interview). 
Second Samples (1 month after the first interview) 
Date: 
Waking 9 pm 
Actual Time:  Actual Time: 
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SAMPLE PREPARATION 
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APPENDIX E. ZARIT BURDEN INTERVIEW 
Date: _____________________________________ 
Identification Number: ________________________ 
 
 
Please circle the response the best describes how you feel. 
 Never Rarely Sometimes 
Quite 
Frequently 
Nearly 
Always 
1. Do you feel that your relative asks for 
more help than he/she needs? 
0 1 2 3 4 
2. Do you feel that because of the time 
you spend with your relative that you 
don’t have enough time for yourself? 
0 1 2 3 4 
3. Do you feel stressed between caring for 
your relative and trying to meet other 
responsibilities for your family or work? 
0 1 2 3 4 
4. Do you feel embarrassed over your 
relative’s behavior? 
0 1 2 3 4 
5. Do you feel angry when you are 
around your relative? 
0 1 2 3 4 
6. Do you feel that your relative currently 
affects our relationships with other family 
members or friends in a negative way? 
0 1 2 3 4 
7. Are you afraid what the future holds 
for your relative? 
0 1 2 3 4 
8. Do you feel your relative is dependent 
on you? 
0 1 2 3 4 
9. Do you feel strained when you are 
around your relative? 
0 1 2 3 4 
10. Do you feel your health has suffered 
because of your involvement with your 
relative? 
0 1 2 3 4 
11. Do you feel that you don’t have as 
much privacy as you would like because 
of your relative? 
0 1 2 3 4 
12. Do you feel that your social life has 
suffered because you are caring for your 
relative? 
0 1 2 3 4 
13. Do you feel uncomfortable about 
having friends over because of your 
relative? 
0 1 2 3 4 
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 Never Rarely Sometimes 
Quite 
Frequently 
Nearly 
Always 
14. Do you feel that your relative seems 
to expect you to take care of him/her as if 
you were the only one he/she could 
depend on? 
0 1 2 3 4 
15. Do you feel that you don’t have 
enough money to take care of your 
relative in addition to the rest of your 
expenses? 
0 1 2 3 4 
16. Do you feel that you will be unable to 
take care of your relative much longer? 
0 1 2 3 4 
17. Do you feel you have lost control of 
your life since your relative’s illness? 
0 1 2 3 4 
18. Do you wish you could leave the care 
of your relative to someone else? 
0 1 2 3 4 
19. Do you feel uncertain about what to 
do about your relative? 
0 1 2 3 4 
20. Do you feel you should be doing 
more for your relative? 
0 1 2 3 4 
21. Do you feel you could do a better job 
in caring for your relative? 
0 1 2 3 4 
22. Overall, how burdened do you feel in 
caring for your relative? 
0 1 2 3 4 
© 1983 Steven Zarit 
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APPENDIX F. EUROQOL 
Date: _____________________________________ 
Identification Number: ________________________ 
 
A. EQ5D 
 
By placing a checkmark in one box in each group below, please indicate which 
statements best describe your own health state today. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
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B. EuroQol-VAS (visual-analog scale) 
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APPENDIX G. PATIENT HEALTH QUESTIONNAIRE 
Date: _____________________________________ 
Identification Number: ________________________ 
 
 
Over the last 2 weeks, how often have you been 
bothered by any of the following problems? 
Not 
at 
all 
Several 
days 
More 
than half 
the days 
Nearly 
every 
day 
1. Little interest or pleasure in doing things.     
2. Feeling down, depressed, or hopeless.     
3. Trouble falling or staying asleep, or sleeping too 
much. 
    
4. Feeling tired or having little energy.     
5. Poor appetite or overeating.     
6. Feeling bad about yourself – or that you are a failure 
or have let yourself or your family down. 
    
7. Trouble concentrating on things, such as reading the 
newspaper or watching television. 
    
8. Moving or speaking so slowly that other people could 
have noticed. Or the opposite – being so fidgety or 
restless that you have been moving around a lot more 
than usual. 
    
9. Thoughts that you would be better off dead or of 
hurting yourself in some way. 
    
 
10. If you checked off any problem on this questionnaire so far, how difficult have these 
problems made it for you to do your work, take care of things at home, or get along 
with other people? 
 
Not difficult at all Somewhat difficult Very difficult     Extremely difficult 
      _______                        _______                  _______                  _______ 
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APPENDIX H. CUMULATIVE ILLNESS RATING SCALE 
 
Date: _____________________________________ 
Identification Number: ________________________ 
 
0: No problem 
1: Current mild problem or past significant problem 
2: Moderate disability or morbidity / requires “first line” therapy 
3: Severe / constant significant disability / “uncontrollable” chronic problems 
4: Extremely severe / immediate treatment required / end organ failure / severe       
    impairment of function 
Score Notes: Conditions, treatments, etc. 
 
1: Heart ……………………….. 
 
2: Vascular ……………...…….. 
 2a: Hypertension ……….… 
 
3: Hematopoieric …..………… 
 
4: Respiratory ……………..… 
 
5: Eyes, ears, nose, throat, 
 and larynx ………..….. 
 
6: Upper gastrointestinal……... 
 
7: Lower gastrointestinal…….. 
 
8: Liver and biliary ……..…… 
 
9: Renal …………………..….. 
 
10: Genito-urinary …………... 
 
11: Musculo-skeletal / 
 integument ………..….. 
 
12: Neurological ……………… 
 
13: Endocrine/metabolic 
 and breast……………..…. 
 
14: Psychiatric ………………… 
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APPENDIX I. SHORT-FORM VERSION OF SENSE OF COHERENCE 
 
Date: _____________________________________ 
Identification Number: ________________________ 
 
Here is a series of questions relating to various aspects of your lives. Each question has 
seven possible answers. Please mark the number, which expresses your answer, with 
number 1 and 7 being the extreme answers. If the words under 1 are right for you, circle 
1: if the words under 7 are right for you, circle 7. If you feel differently, circle the number 
which best expresses your feeling. Please give only one answer to each question. 
1. Do you have feeling that you don’t really care about what goes on around you? 
 
1 2 3 4 5 6 7 
very seldom very often 
or never 
2. Has it happened in the past that you were surprised by the behavior of people whom 
you thought you knew well? 
 
1 2 3 4 5 6 7 
never happened always happened 
3. Has it happened that people whom you counted on disappointed you? 
 
1 2 3 4 5 6 7 
never happened always happened 
4. Until now your life has had: 
 
1 2 3 4 5 6 7 
no clear goals very clear 
or purpose at all goals and purpose 
5. Do you have the feeling that you’re being treated unfairly? 
 
1 2 3 4 5 6 7 
very often very seldom or 
 never 
6. Do you have the feeling that you are in an unfamiliar situation and don’t know what to 
do? 
 
1 2 3 4 5 6 7 
very often very seldom or 
 never 
 153 
7. Doing the thing you do every day is: 
 
1 2 3 4 5 6 7 
a source of deep a source of 
pleasure and pain and 
satisfaction boredom 
8. Do you have very mixed-up feelings and ideas? 
 
1 2 3 4 5 6 7 
very often very seldom or 
 never 
9. Does it happen that you have feelings inside you would rather not feel? 
 
1 2 3 4 5 6 7 
very often very seldom or 
 never 
10. Many people – even those with a strong character – sometimes feel like sad sacks 
(losers) in certain situations. How often have you felt this way in the past? 
 
1 2 3 4 5 6 7 
never very often 
11. When something happened, have you generally found that: 
 
1 2 3 4 5 6 7 
you overestimated you saw 
or underestimated things in the 
its importance right proportion 
12. How often do you have the feeling that there’s little meaning in the things you do in 
your daily life? 
 
1 2 3 4 5 6 7 
very often very seldom or 
 never 
13. How often do you have feelings that you’re not sure you can keep under control? 
 
1 2 3 4 5 6 7 
very often very seldom or 
 never 
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APPENDIX J. MULTIDIMENSIONAL SCALE OF PERCEIVED SOCIAL 
SUPPORT 
Date: _____________________________________ 
Identification Number: ________________________ 
 
I am going to read several statements about how much help you receive from others. 
Please use the following scale to indicate how much you agree or disagree with each 
statement. The responses range from very strongly disagree to very strongly agree, 
with neither agree nor disagree in the middle. You can answer with either a number or 
the words.  
very 
strongly 
disagree 
strongly 
disagree 
mildly 
disagree neutral 
mildly 
agree 
strongly 
agree 
very 
strongly 
agree 
1 2 3 4 5 6 7 
 1 2 3 4 5 6 7 
1. There is a special person who is around when I am in need.  ○ ○ ○ ○ ○ ○ ○ 
2. There is a special person with whom I can share my joys and sorrows.  ○ ○ ○ ○ ○ ○ ○ 
3. My family really tries to help me. ○ ○ ○ ○ ○ ○ ○ 
4. I get the emotional help and support I need from my family.  
 
○ ○ ○ ○ ○ ○ ○ 
5. I have a special person who is a real source of comfort to me.  
 
○ ○ ○ ○ ○ ○ ○ 
6. My friends really try to help me. ○ ○ ○ ○ ○ ○ ○ 
7. I can count on my friends when things go wrong. ○ ○ ○ ○ ○ ○ ○ 
8. I can talk about my problems with my family. ○ ○ ○ ○ ○ ○ ○ 
9. I have friends with whom I can share my joys and sorrows.  
 
○ ○ ○ ○ ○ ○ ○ 
10. There is a special person in my life who cares about my feelings.  
 
○ ○ ○ ○ ○ ○ ○ 
11. My family is willing to help me make decisions. ○ ○ ○ ○ ○ ○ ○ 
12. I can talk about my problems with my friends. ○ ○ ○ ○ ○ ○ ○ 
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APPENDIX K. SOCIODEMOGRAPHICS OF STROKE SURVIVORS 
 
Date: _____________________________________ 
Identification Number: ________________________ 
 
1.     Age: _____(years) 
2.     Gender: a) Male b) Female 
3.     Race/Ethnicity: 
        a) Caucasian b) African American c) Asian d) Latino/Hispanic e) Other: 
4.     Education (highest level of education completed): 
        a) Less than high school b) High school c) Vocational training d) College 
        e) Postgraduate 
5.     Employment Status: 
        a) Full-time work b) Part-time work c) Homemaker d) Unemployed e) Retired 
        f) Leave of Absence 
6.     Considering how well your household lives on its income, financially, would 
        you say you are: 
        a) Comfortable, have more than enough to make ends meet 
        b) Adequate, have enough to make ends meet 
        c) Do Not have enough to make ends meet 
7.     Insurance including Medicare/Medicaid: 
        a) Private insurance b) Medicare c) Medicaid d) No Insurance e) Other: 
8.     Time since admission to hospital _____days 
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Sociodemographics of Stroke Survivors for the Second Interview 
Date: _____________________________________ 
Identification Number: ________________________ 
 
1.     A facility or home where a stroke survivor was initially placed after hospital 
        discharge 
        a) Rehabilitation center b) Nursing Home c) Home d) Other: _____ 
 
 Time since admission to facility _____ days 
 Or 
 Time since discharge to home _____ days 
 
2.     A facility or home where a stroke survivor is now currently placed 
        a) Rehabilitation center b) Nursing Home c) Home d) Other: _____ 
 
 Time since admission to facility _____ days 
 Or 
 Time since discharge to home _____ days 
 
3.      Duration of rehabilitation including Inpatient _____ days 
  Outpatient _____ days 
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APPENDIX L. NIH STROKE SCALE & DESCRIPTION OF STROKE 
Date: _____________________________________ 
Identification Number: ________________________ 
 
Instructions Scale definition Score 
1a. Level of Consciousness: The investigator must 
choose a response, even if a full evaluation is 
prevented by such obstacles as an endotracheal tube, 
language barrier, orotracheal trauma/bandages. A 3 is 
scored only if the patient makes no movement (other 
than reflexive posturing) in response to noxious 
stimulation. 
0 = Alert; keenly responsive. 
1 = Not alert, but arousable by minor 
stimulation to obey, answer, or 
respond. 
2 = Not alert, requires repeated 
stimulation to attend, or is obtunded 
and requires strong or painful 
stimulation to make movements (not 
stereotyped). 
3 = Responds only with reflex motor 
or autonomic effects or totally 
unresponsive, flaccid, areflexic. 
 
1b. LOC Questions: The patient is asked the month 
and his/her age. The answer must be correct—there is 
no partial credit for being close. Aphasic and stuporous 
patients who do not comprehend the questions will 
score 2. Patients unable to speak because of 
endotracheal intubation, orotracheal trauma, severe 
dysarthria from any cause, language barrier or any 
other problem not secondary to aphasia are given a 1. It 
is important that only the initial answer be graded and 
that the examiner not “help” the patient with verbal or 
non-verbal cues. 
0 = Answers both questions correctly. 
1 = Answers one question correctly. 
2 = Answers neither question 
correctly.  
 
1c. LOC Commands: The patient is asked to open and 
close the eyes and then to grip and release the non-
paretic hand. Substitute another one step command if 
the hands cannot be used. Credit is given if an 
unequivocal attempt is made but not completed due to 
weakness. If the patient does not respond to command, 
the task should be demonstrated to them (pantomime) 
and score the result (i.e., follows none, one or two 
commands). Patients with trauma, amputation, or other 
physical impediments should be given suitable one-
step commands. Only the first attempt is scored. 
0 = Performs both tasks correctly. 
1 = Performs one task correctly. 
2 = Performs neither task correctly. 
 
Table continues 
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Instructions Scale definition Score 
2. Best Gaze: Only horizontal eye movements will be 
tested. Voluntary or reflexive (oculocephalic) eye 
movements will be scored but caloric testing is not 
done. If the patient has a conjugate deviation of the 
eyes that can be overcome by voluntary or reflexive 
activity, the score will be 1. If a patient has an isolated 
peripheral nerve paresis (CN III, IV or VI) score a 1. 
Gaze is testable in all aphasic patients. Patients with 
ocular trauma, bandages, pre-existing blindness or 
other disorder of visual acuity or fields should be tested 
with reflexive movements and a choice made by the 
investigator. Establishing eye contact and then moving 
about the patient from side to side will occasionally 
clarify the presence of a partial gaze palsy. 
0 = Normal 
1 = Partial gaze palsy. This score is 
given when gaze is abnormal in one or 
both eyes, but where forced deviation 
or total gaze paresis are not present. 
2 = Forced deviation, or total gaze 
paresis not overcome by the 
oculocephalic maneuver. 
 
3. Visual: Visual fields (upper and lower quadrants) 
are tested by confrontation, using finger counting or 
visual threat as appropriate. Patient must be 
encouraged, but if they look at the side of the moving 
fingers appropriately, this can be scored as normal. If 
there is unilateral blindness or enucleation, visual fields 
in the remaining eye are scored. Score 1 only if a clear-
cut asymmetry, including quadrantanopia is found. If 
patient is blind from any cause score 3. Double 
simultaneous stimulation is performed at this point. If 
there is extinction patient receives a 1 and the results 
are used to answer question 11. 
0 = No visual loss 
1 = Partial hemianopia 
2 = Complete hemianopia 
3 = Bilateral hemianopia (blind 
including cortical blindness)  
 
4. Facial Palsy: Ask, or use pantomime to encourage 
the patient to show teeth or raise eyebrows and close 
eyes. Score symmetry of grimace in response to 
noxious stimuli in the poorly responsive or non-
comprehending patient. If facial trauma/bandages, 
orotracheal tube, tape or other physical barrier obscures 
the face, these should be removed to the extent 
possible. 
0 = Normal symmetrical movement 
1 = Minor paralysis (flattened 
nasolabial fold, asymmetry on smiling) 
2 = Partial paralysis (total or near total 
paralysis of lower face) 
3 = Complete paralysis of one or both 
sides (absence of facial movement in 
the upper and lower face) 
 
Table continues 
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Instructions Scale definition Score 
5 & 6. Motor Arm and Leg: The limb is placed in the 
appropriate position: extend the arms (palms down) 90 
degrees (if sitting) or 45 degrees (if supine) and the leg 
30 degrees (always tested supine). Drift is scored if the 
arm falls before 10 seconds or the leg before 5 seconds. 
The aphasic patient is encouraged using urgency in the 
voice and pantomime but not noxious stimulation. 
Each limb is tested in turn, beginning with the non-
paretic arm. Only in the case of amputation or joint 
fusion at the shoulder or hip may the score be “9” and 
the examiner must clearly write the explanation for 
scoring as a “9”. 
0 = No drift, limb holds 90 (or 45) 
degrees for full 10 seconds. 
1 = Drift, Limb holds 90 (or 45) 
degrees, but drifts down before full 10 
seconds; does not hit bed or other 
support. 
2 = Some effort against gravity, limb 
cannot get to or maintain (if cued) 90 
(or 45) degrees, drifts down to bed, but 
has some effort against gravity. 
3 = No effort against gravity, limb 
falls. 
4 = No movement 
9 = Amputation, joint fusion, explain 
______________________ 
5a. Left Arm 
5b. Right Arm 
 
  0 = No drift, leg holds 30 degrees 
position for full 5 seconds. 
1 = Drift, leg falls by the end of the 5 
second period but does not hit bed. 
2 = Some effort against gravity; leg 
falls to bed by 5 seconds, but has some 
effort against gravity. 
3 = No effort against gravity, leg falls 
to bed immediately. 
4 = No movement 
9 = Amputation, joint fusion, explain 
______________________ 
6a. Left Leg 
6b. Right Leg 
 
7. Limb Ataxia: This item is aimed at finding 
evidence of a unilateral cerebellar lesion. Test with 
eyes open. In case of visual defect, insure testing is 
done in intact visual field. The finger-nose-finger and 
heel-shin tests are performed on both sides, and ataxia 
is scored only if present out of proportion to weakness. 
Ataxia is absent in the patient who cannot understand 
or is paralyzed. Only in the case of amputation or joint 
fusion may the item be scored “9”, and the examiner 
must clearly write the explanation for not scoring. In 
case of blindness test by touching nose from extended 
arm position. 
0 = Absent 
1 = Present in one limb 
2 = Present in two limbs 
If present, is ataxia in 
Right arm 1 = Yes 2 = No 
9 = amputation or joint fusion, explain 
___________________ 
Left arm 1 = Yes 2 = No 
9 = amputation or joint fusion, explain 
___________________ 
Right leg 1 = Yes 2 = No 
9 = amputation or joint fusion, explain 
___________________ 
Left leg 1 = Yes 2 = No 
9 = amputation or joint fusion, explain 
___________________  
 
Table continues 
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Instructions Scale definition Score 
8. Sensory: Sensation or grimace to pin prick when 
tested, or withdrawal from noxious stimulus in the 
obtunded or aphasic patient. Only sensory loss 
attributed to stroke is scored as abnormal and the 
examiner should test as many body areas [arms (not 
hands), legs, trunk, face] as needed to accurately check 
for hemisensory loss. A score of 2, “severe or total,” 
should only be given when a severe or total loss of 
sensation can be clearly demonstrated. Stuporous and 
aphasic patients will therefore probably score 1 or 0. 
The patient with brain stem stroke who has bilateral 
loss of sensation is scored 2. If the patient does not 
respond and is quadriplegic score 2. Patients in coma 
(item 1a=3) are arbitrarily given a 2 on this item. 
0 = Normal; no sensory loss. 
1 = Mild to moderate sensory loss; 
patient feels pinprick is less sharp or is 
dull on the affected side; or there is a 
loss of superficial pain with pinprick 
but patient is aware he/she is being 
touched. 
2 = Severe to total sensory loss; patient 
is not aware of being touched in the 
face, arm, and leg.  
 
9. Best Language: A great deal of information about 
comprehension will be obtained during the preceding 
sections of the examination. The patient is asked to 
describe what is happening in the attached picture, to 
name the items on the attached naming sheet, and to 
read from the attached list of sentences. 
Comprehension is judged from responses here as well 
as to all of the commands in the preceding general 
neurological exam. If visual loss interferes with the 
tests, ask the patient to identify objects placed in the 
hand, repeat, and produce speech. The intubated patient 
should be asked to write. The patient in coma (question 
1a=3) will arbitrarily score 3 on this item. The 
examiner must choose a score in the patient with stupor 
or limited cooperation but a score of 3 should be used 
only if the patient is mute and follows no one step 
commands.  
0 = No aphasia, normal 
1 = Mild to moderate aphasia; some 
obvious loss of fluency or facility of 
comprehension, without significant 
limitation on ideas expressed or form 
of expression. Reduction of speech 
and/or comprehension, however, 
makes conversation about provided 
material difficult or impossible. For 
example in conversation about 
provided materials examiner can 
identify picture or naming card from 
patient’s response. 
2 = Severe aphasia; all communication 
is through fragmentary expression; 
great need for inference, questioning, 
and guessing by the listener. Range of 
information that can be exchanged is 
limited; listener carries burden of 
communication. Examiner cannot 
identify materials provided from 
patient response. 
3 = Mute, global aphasia; no usable 
speech or auditory comprehension.  
 
10. Dysarthria: If patient is thought to be normal an 
adequate sample of speech must be obtained by asking 
patient to read or repeat words from the attached list. If 
the patient has severe aphasia, the clarity of articulation 
of spontaneous speech can be rated. Only if the patient 
is intubated or has other physical barrier to producing 
speech, may the item be scored “9”, and the examiner 
must clearly write an explanation for not scoring. Do 
not tell the patient why he/she is being tested. 
0 = Normal 
1 = Mild to moderate; patient slurs at 
least some words and, at worst, can be 
understood with some difficulty. 
2 = Severe; patient’s speech is so 
slurred as to be unintelligible in the 
absence of or out of proportion to any 
dysphasia, or is mute/anarthric. 
9 = Intubated or other physical barrier, 
explain 
 
Table continues 
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Instructions Scale definition Score 
11. Extinction and Inattention (formerly Neglect): 
Sufficient information to identify neglect may be 
obtained during the prior testing. If the patient has a 
severe visual loss preventing visual double 
simultaneous stimulation, and the cutaneous stimuli are 
normal, the score is normal. If the patient has aphasia 
but does appear to attend to both sides, the score is 
normal. The presence of visual spatial neglect or 
anosagnosia may also be taken as evidence of 
abnormality. Since the abnormality is scored only if 
present, the item is never untestable. 
0 = No abnormality. 
1 = Visual, tactile, auditory, spatial, or 
personal inattention or extinction to 
bilateral simultaneous stimulation in 
one of the sensory modalities. 
2 = Profound hemi-inattention or 
hemi-inattention to more than one 
modality. Does not recognize own 
hand or orients to only one side of 
space.  
 
 
Description of Stroke 
1.     Type of stroke: 
  a) Ischemic ______ b) Intracerebral Hemorrhage ______ 
  c) Subarachnoid Hemorrhage ______ 
  d) Unclassified ______ 
2.     Area of stroke: 
  a) Right______ b) Left ______ c) Cerebellar ______ d) Brain Stem ______ 
  e) Other ______ f ) Unclassified ______ 
3.     Communication disability: a) Yes ______ b) No ______ c) Unclassified ______ 
4.     Time poststroke: ______ days 
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APPENDIX M. BARTHEL INDEX 
Date: _____________________________________ 
Identification Number: ________________________ 
 
Instructions: Choose the scoring point for the statement that most closely corresponds to 
the patient’s current level of ability for each of following 10 items. Record actual, not 
potential, functioning. 
 
Activity Score Scores 
FEEDING 
0 = unable 
5 = needs help cutting, spreading butter, etc., or requires modified diet 
10 = independent  
 
BATHING 
0 = dependent 
5 = independent (or in shower)  
 
GROOMING 
0 = needs to help with personal care 
5 = independent face/hair/teeth/shaving (implements provided)  
 
DRESSING 
0 = dependent 
5 = needs help but can do about half unaided 
10 = independent (including buttons, zips, laces, etc.)  
 
BOWELS 
0 = incontinent (or needs to be given enemas) 
5 = occasional accident 
10 = continent  
 
BLADDER 
0 = incontinent, or catheterized and unable to manage alone 
5 = occasional accident 
10 = continent  
 
TOILET USE 
0 = dependent 
5 = needs some help, but can do something alone 
10 = independent (on and off, dressing, wiping)  
 
TRANSFERS (BED TO CHAIR AND BACK) 
0 = unable, no sitting balance 
5 = major help (one or two people, physical), can sit 
10 = minor help (verbal or physical) 
15 = independent  
 
MOBILITY (ON LEVEL SURFACES) 
0 = immobile or < 50 yards 
5 = wheelchair independent, including corners, > 50 yards 
10 = walks with help of one person (verbal or physical) > 50 yards 
15 = independent (but may use any aid; for example, stick) > 50 yards  
 
STAIRS 
0 = unable 
5 = needs help (verbal, physical, carrying aid) 
10 = independent  
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APPENDIX N. CONSENT CAPACITY GUIDE FOR CAREGIVERS 
Identification Number: ________________________ 
 
Interviewer: I am going to ask you some true/false questions now. 
Before each statement state: True or False read statement Correct 
1) The goal of this study is to describe caregiver experience in response to a loved 
one’s health event. (T)  
Yes  No 
2) If I do not participate in this study, my relative or friend’s medical care will still 
be provided. (T)  
Yes  No 
3) If I participate in this study, it will cost me a lot of money. (F) Yes  No 
4) I can decide I do not want to participate at any time. (T) Yes  No 
5) If I participate, I will have to answer questions about how I am feeling and 
collect saliva samples to measure level of stress. (T) 
Yes  No 
 
Assessment: _______________________________________________________ 
__________________________________________________________________ 
 
Considering the risks and benefits we have discussed, what have you decided about 
participating in this study? 
 
____to participate ___not to participate- 
 
why?:________________________________________ 
 
A subject must have a perfect score of 5 for being eligible to provide informed consent 
for this study. If a subject gets a lower score, the information on the items missed may be 
repeated, and the specific question/s asked again. This may be done for a total of 3 trials. 
If a subject fails to obtain a score of 5 after 3 such attempts, he/she is not eligible to 
participate in the study. 
 
____Does____Does not demonstrate adequate decision-making capacity. 
 
________________________ ___________________________ ________ 
Printed name of assessor  Signature of assessor          Date 
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APPENDIX O. MACCAT-CR RECORD FORM FOR STROKE SURVIVORS 
Understanding (Each item is rated 2–0) 
Understanding Rating 
2: Subject recalls the content of the item and offers a fairly clear version of it. 
1: Subject shows some recollection of the item content, but describes it in a way that 
renders understanding uncertain, even after the interviewer has made efforts to obtain 
clarification from the subject. 
0: Subject (a) does not recall the content of the item, or (b) describes it in a way that is 
clearly inaccurate, or (c) describes it in a way that seriously distorts its meaning, even 
after the interviewer has made efforts to obtain clarification from the subject, or offers a 
response that is unrelated to the question or is unintelligible. 
1. Nature of project 
Description and Interview Questions: “The purpose of the research project is to 
learn more about the experience of caregivers of older adults with stroke in the 
first 6 weeks of caregiving. You are being asked to participate in this study 
because you have been diagnosed with stroke and your family caregiver is 
participating in the study. The entire study is expected to be completed within one 
year. Your agreement to allow us to review your hospital records will be a one-
time permission to get information about your health and stroke. You will not be 
asked to do anything. A member of the research team will review your hospital 
medical record to get selected information about your health, type of stroke, and 
severity of stroke.” Can you tell me your understanding of what I just said? [If 
subject fails to mention spontaneously, ask:] 
a) What is the purpose of the research project I described to you? 
Expected Answer: To learn more about the experience of caregivers of older 
adults with stroke in the first 6 weeks of caregiving. 
b) How long will the research project last? 
Expected Answer: The entire study is expected to be completed within one 
year. My agreement to allow us to review my hospital records will be a one-
time permission to get information about my health and stroke. 
c) What sorts of things will be done with people who agree to be in the study? 
Expected Answer: I will not be asked to do anything. A member of the 
research team will review my hospital medical record to get selected 
information about my health and stroke. 
Score 
a) _______________ 
b) _______________ 
c) _______________ 
 
Subtotal: _______________ 
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2. Primary purpose is research 
Description and Interview Questions: “It is important for you to understand that 
the project in which you have been asked to participate is a research project. This 
study is not treatment. The main purpose of the study is to help researchers figure 
out caregiver experiences in response to a loved one’s stroke.” Can you tell me 
your understanding of what I just said? 
Expected Answer: The project in which I have been asked to participate is for 
research, and not treatment/care. 
 
Score 
Subtotal: _______________ 
 
3. Effects on individualized care 
Description and Interview Questions: 
a) “If you do not choose to participate in the research study, your medical care 
will still be provided.” Can you tell me your understanding of what I just said? 
Expected Answer: If I do not participate in this study, my medical care will 
still be provided. 
 
b) “What will you be asked to do if you agree to participate in this research  
project?” 
Expected Answer: If I participate in this study, a member of the research 
team will review my hospital record. I will not need to do anything. 
 
Score 
a) _______________ 
b) _______________ 
 
Subtotal: _______________ 
 
4. Benefits and risks/discomfort 
Description and Interview Questions: “No major risks are anticipated from this 
study and your privacy and confidentiality will be protected. An identification 
code number will be assigned to you and the number, and not your name, will be 
used to identify all the information. There is no benefit to you. This study will 
guide future research and promote improved clinical practice and education for 
caregivers of survivors.” Can you tell me your understanding of what I just said? 
[If subject fails to mention spontaneously, ask:] 
 
a) What are the risks? 
 Expected Answer: No major risks are anticipated from this study. 
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b) Will confidentially be maintained and your privacy be protected? 
 Expected Answer: My privacy and confidentiality will be protected. An 
identification code number will be assigned to me. 
 
c)   How will you benefit from the study? 
 Expected Answer: There is no benefit to me. 
 
c) Will this study guide future research and promote improved clinical practice 
and education for caregivers of survivors? 
 Expected Answer: This study will guide future research and promote 
improved clinical practice and education for caregivers of survivors. 
 
Score 
a) _______________ 
b) _______________ 
c) _______________ 
d) _______________ 
 
Subtotal: _______________ 
5. Ability to withdraw 
Description and Interview Questions: “No one has to be in this study. People 
who agree to be in this research project can change their minds at any time. You 
can leave the study before the study ends. Nothing will happen to you, if you 
decide not to be in the study.” Can you tell me your understanding of what I just 
said? 
Expected Answer: If I change my mind, I can withdraw at any time. 
 
Score 
Subtotal: _______________ 
 Total Understanding Score (22–0): _______________ 
Appreciation (Each item is rated 2–0) 
1. Object not personal benefit 
Interview Questions: Earlier, we discussed benefits and risks of participation in 
this study. Do you believe that you have been asked to be in this study primarily 
for your personal benefit? [If yes, then:] What makes you believe that this is the  
reason you were asked? 
 
 
 
 
 167 
Rating 
2: Subject acknowledges that he or she is being recruited for a valid reason 
unrelated to potential benefit from being in the study (e.g., because he or she has 
had a stroke and has a caregiver who is willing to participate). 
1: Subject acknowledges being recruited for reasons both related to and unrelated 
to potential personal benefit. Or, subject maintains being recruited for a reason 
related to only to potential personal benefit, but has a plausible explanation for 
why this is the case. 
0: Subject maintains he or she is being recruited for a reason related only to 
potential personal benefit, but does not have a plausible explanation for why this 
is the case. Or, subject offers response that is unrelated to the question or 
unintelligible. 
 
Score: _______________ 
 
2. Withdrawal possible 
 
Interview Questions: What do you believe would happen if you decided not to 
be in this study? 
Expected Answer: If I do not participate in this study, my medical care will still 
be provided. 
 
Rating 
2: Subject acknowledges that failure to participate or later withdrawal will not 
adversely affect him or her (in particular, in the context of a treatment setting, that 
subject can continue to receive ordinary care, assuming that this in the case). 
1: Subjects is uncertain whether failure to participate or later withdraw will 
adversely affect him or her. Or, subject believes failure to participate or later 
withdrawal will adversely affect him or her and has a plausible explanation for 
why this is the case. 
0: Subject believes failure to participate or later withdrawal will adversely affect 
him or her and dose not have a plausible explanation for why this is the case. Or, 
subject offers response that is unrelated to the question or unintelligible. 
 
Score: _______________ 
 Total Appreciation Score (4–0): _______________ 
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Reasoning (Each item is rated 2–0) 
1. Consequential reasoning 
Interview Question: Do you think that you are more likely to want to participate 
in the study or not participate in the study? 
Expected Answer: Yes or No. 
 
Rating 
2: Subject states a choice. 
1: Subject states more than one choice, seems ambivalent. 
0: Subject does not state a choice. 
 
Score: _______________ 
 
2. Comparative reasoning 
Interview Question: Tell me what it is that makes that your [option named by 
patient] better than [option not chosen by patient]? 
 
Rating 
2: Subject offers at least one statement in the form of a comparison at least two 
options, with the comparison including a statement of at least one specific 
difference. For example: “I’d prefer not to take part in the study, because I am not 
comfortable someone who is not involved in my care to see my medical record.” 
1: Subject makes comparison statement, but does not include a statement of a 
specific consequence. For example, “It will be better if I stay out of the study”. 
0: Subject makes no comparative statements. 
 
Score: _______________ 
 
3. Generating consequences 
Description and Interview Questions: “If you agree to participate in this 
research project, a member of the research team will review your hospital record. 
You will not be asked to do anything.” What are some ways that participating in 
the study could affect your everyday activities? 
Expected Answer: My participation will not affect my everyday activities. 
 
Rating 
2: Subject recalls the content of the item and offers a fairly clear version of it. 
1: Subject shows some recollection of the item content, but describes it in a way 
that renders understanding uncertain, even after the interviewer has made efforts 
to obtain clarification from the subject. 
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0: Subject (a) does not recall the content of the item; or (b) describes it in a way 
that is clearly inaccurate, or (c) describe it in a way that seriously distorts its 
meaning, even after the interviewer has made efforts to obtain clarification from 
the subjects; or offers a response that is unrelated to the question or unintelligible. 
 
Score: _______________ 
 
      4. Logical consistency of choice 
 
There are no specific questions. The interviewer will determine whether 
participant’s statements have been consistently logical, thus, signifying ability to 
provide informed consent. 
 
Rating 
2: Subject’s final choice (in Expressing a Choice) follows logically from the 
subject’s own reasoning, as explained by the subject in response to the three 
previous subparts. 
1: It is not clear whether the choice follows logically from the subject’s own 
reasoning. 
0: Subject’s choice clearly does not follow logically form subject’s own reasoning. 
 
Score: _______________ 
 Total Reasoning Score (8–0): _______________ 
Expressing a Choice (Rate 2–0) 
Description and Interview Questions: “As you know, you have been invited to 
participate in a research project to describe caregiver experience in response a 
loved one’s health event, that is, a stroke.” Do you think you are more likely to 
want to participate or not to want to participate? 
Expected Answer: Yes, I would like to participate in the study. Or, no, I would 
not like to participate in this study. 
 
Rating 
2: Subject states a choice. 
1: Subject states more than one choice, seems ambivalent. 
0: Subject does not state a choice. 
 
Score: _______________ 
 Total Expressing a Choice Score (2–0): _______________ 
 
Total Scores (0–36): _______________ (Cut off score: 13) 
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APPENDIX P. UNIVERSITY OF PENNSYLVANIA INFORMED CONSENT 
FORM (CAREGIVERS) 
 
 
Title of the Research Study: The effect of early uncertainty on caregiver stress and 
psychological outcomes: The case of stroke survivor caregivers 
Protocol Number: 813927 
Principal Investigator: Lois K. Evans, PhD, RN, FAAN, 
van Ameringen Professor in Nursing Excellence, University of Pennsylvania School of 
Nursing, 418 Curie Boulevard, Room 419, Philadelphia, PA, 19104-4217, Telephone: 
215-898-2140. Email: evans@nursing.upenn.edu 
Co-investigator: Eeeseung Byun, MSN, RN, ACNP-BC, Doctoral Student, University of 
Pennsylvania School of Nursing, 418 Curie Boulevard, Room 310H, Philadelphia, PA, 
19104-4217, Telephone: 215-746-4454. Email: eeeseung@nursing.upenn.edu 
Emergency Contact: (name, address, phone and email) Eeeseung Byun, MSN, RN, 
ACNP-BC, Telephone: 215-746-4454. Email: eeeseung@nursing.upenn.edu 
 
 
You are being asked to take part in a research study. This is not a form of treatment or 
therapy. It is not supposed to detect a disease or find something wrong. Your 
participation is voluntary which means you can choose whether or not to participate. If 
you decide to participate or not to participate, there will be no loss of benefits to which 
you are otherwise entitled. Before you make a decision, you will need to know the 
purpose of the study, the possible risks and benefits of being in the study and what you 
will have to do if you decide to participate. As the researcher, I will talk with you about 
the study and give you this consent form to read. You do not have to make a decision 
now; you can take the consent form home and share it with your family, friends, or 
family doctor and family. 
 
If you do not understand what you are reading, do not sign it. Please ask me, the 
researcher, to explain anything you do not understand, including any language contained 
in this form. If you decide to participate, you will be asked to sign this form and a copy 
will be given to you. Keep this form; in it you will find contact information and answers 
to questions about the study. You may ask to have this form read to you. 
 
 
What is the purpose of the study? 
 
The purpose of the study is to learn more about the feelings and experiences of caregivers 
of older adults with stroke in the first 6 weeks of caregiving. The study is a doctoral 
dissertation in the School of Nursing, University of Pennsylvania. 
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Why was I asked to participate in the study? 
 
You are being asked to join this study because you (a) are a family member or friend of 
an older adult (age 65 or older) who was diagnosed with new or recurrent stroke within 
the past 2 weeks, (b) expect to be the primary caregiver for this older adult with stroke, 
(c) can communicate in English, (d) are able to demonstrate capacity for informed 
consent and (e) are age 21or older. 
 
How long will I be in the study? How many other people will be in the study? 
 
If you decide to participate in the study, you will be involved for about four weeks. You 
will be interviewed in-person two times: within two weeks after the older person’s stroke 
while they are still in the hospital and again four weeks later. This will take about 40–50 
minutes for the first interview and 30–40 minutes for the second interview. 
 
On a day following each interview, you will be also asked to collect your saliva (spit) 
using a sponge that you will place in your mouth for one minute twice in the same day. 
Collecting and labeling each saliva (spit) sample will take up to 5 minutes. 
 
With the permission from your older adult with stroke, we will also review their hospital 
medical record to get information about his/her health, the type of stroke he/she has had 
and the severity of his/her stroke. 
 
You will be one of 230 participants (115 caregivers and 115 stroke survivors) in the study. 
The entire study is expected to be completed within one year. 
 
Where will the study take place? 
 
Depending on your preference, you will be interviewed for the first time at hospital, your 
home, or another convenient location. For the second interview [four weeks later] you 
can be interviewed at home or another convenient location. 
 
You will collect your own saliva (spit) sample at home. 
 
What will I be asked to do? 
 
You will be asked to respond to questions asked by the researcher who will read the 
questions aloud and record your answers. You will be given a written copy of the 
questions to view at the same time. This will take about 40–50 minutes for the first 
interview and 30–40 minutes for the second interview. The interview questions include 
information about you (for example, your age, gender, education, caregiving experience); 
questions about your feelings of uncertainty, stress, depression and caregiving burden, as 
well as your quality of life, health, ways of coping, and social support. You will be also 
asked about your older adults’ functional status and characteristics (for example, age, 
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gender, education). If any of the information is missing, you will be re-contacted by 
investigator over the phone in an attempt to complete the information. 
 
You will be also asked to collect your saliva (spit) to assess your biologic stress level 
(salivary cortisol) using a sponge that you will place in your mouth for one minute twice 
in the same day: 1) within 2 weeks after stroke and 2) 4 weeks after the first interview. 
Collecting each saliva sample will take up to 5 minutes. You will place the samples in a 
plastic bag and keep them in your freezer overnight. The researcher will pick up the 
saliva samples or you will place the bag in a pre-paid FedEx clinical envelope and mail it 
to the researcher. 
 
What are the risks? 
 
No major risks are expected from this study. You, however, may become tired while 
answering the interview questions or you may feel upset discussing your experience in 
taking care of your older adult family member/friend with a stroke. If you become tired, 
you may stop and complete the interview later. If you experience uncomfortable feelings 
and upset during the interview, you may take a break in the interview. The investigator is 
prepared to be sensitive and respectful if you decide not to participate or not to answer 
some of the questions. You may withdraw from the study at any time. You will not be 
asked to answer any questions that you do not wish to answer. To protect your privacy, a 
quiet place will be provided for an interview that is held in the hospital or another 
healthcare facility, with permission of the facility. 
 
If you feel severely distressed during the hospital-based interview at the hospital, the 
investigator will contact a hospital-based psychiatric counseling service for your 
assistance. If you should develop this response during the interview at your home or other 
location, the investigator will help you contact emergency psychiatric services for your 
assistance. 
 
All information including completed interview tools and coded computerized information 
will be cared for in a manner to protect your privacy and confidentiality. An 
identification code number will be assigned to you, and will be used to identify all the 
information you provide so that your name will not be placed at risk for identification. To 
ensure confidentiality, all research information will be kept in a locked filing cabinet in a 
secure area at the University of Pennsylvania School of Nursing and only the researchers 
will be allowed to see your personal data. In addition, all information in computerized 
files will be stored using a special protection tool specifically for research studies. No 
individual identifying information will be made public in any presentations or 
publications of the results of this study. 
 
How will I benefit from the study? 
 
There is no benefit to you. Your participation could help us understand the caregiving 
experience for older family members or friends with stroke, however, which can benefit 
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you indirectly. This study will guide future research and promote improved clinical 
practice and education for caregivers of stroke survivors. You may feel satisfaction from 
having had the opportunity to participate in the study and contribute to increased 
knowledge in science. 
 
What other choices do I have? 
 
Your alternative to being in the study is to not be in the study. 
 
What happens if I do not choose to join the research study? 
 
You may choose to join the study or you may choose not to join the study. Your 
participation is voluntary. 
 
If you choose not to join the research study, you will lose no benefits or advantages that 
are now coming to you, or would come to you in the future. Neither will this decision 
affect the care for your older family member or friend with stroke. His or her health care 
providers will not be upset with your decision either way. 
 
When is the study over? Can I leave the study before it ends? 
 
The study is expected to end after all participants have completed all interviews and 
provided saliva samples. Your role in the study is complete after your second interview 
and return of the second set of saliva samples. The overall study may be stopped without 
your consent for the following reasons: 
 
o The investigators, the sponsor or the Office of Regulatory Affairs at the 
University of Pennsylvania can stop the study anytime 
 
You have the right to drop out of the study at any time during your participation. There is 
no loss of benefits to which you are otherwise entitled if you decide to do so. Withdrawal 
will not interfere with your future care. 
 
If you no longer wish to be in the research study, please contact Eeeseung Byun at 215-
746-4454 and talk with her directly or leave a message regarding your wish to voluntarily 
withdraw from the study. 
 
How will confidentiality be maintained and my privacy be protected? 
 
The researcher will make every effort to keep all the information you share during the 
study strictly confidential, as required by law. The Institutional Review Board (IRB) at 
the University of Pennsylvania is responsible for protecting the rights and welfare of 
research volunteers like you. The IRB has access to study information. Any forms you 
sign where you can be identified by name will be kept in a locked drawer in a safe area at 
the University of Pennsylvania School of Nursing. These forms will be kept confidential.  
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All these forms will be destroyed when the study is over. 
 
Will I have to pay for anything? 
 
There are no costs associated with participating in the study. 
 
Will I be paid for being in this study? 
 
You will receive a $10 gift card upon completion of the quantitative interview and 
collection of saliva samples for each of two times: 1) within 2 weeks after stroke and 2) 4 
weeks after the first interview (a total maximum value of $20). 
 
Who can I call with questions, complaints or if I’m concerned about my rights as a 
research subject? 
 
If you have questions, concerns or complaints regarding your participation in this 
research study or if you have any questions about your rights as a research subject, you 
should speak with the Principal Investigator listed on page one of this form. If a she or 
the researcher cannot be reached or you want to talk to someone other than those working 
on the study, you may contact the Office of Regulatory Affairs with any question, 
concerns or complaints at the University of Pennsylvania by calling (215) 898-2614. 
 
When you sign this form, you are agreeing to take part in this research study. This means 
that you have read the consent form, your questions have been answered, and you have 
decided to volunteer. Your signature also means that you are permitting the University of 
Pennsylvania to use your personal health information collected about you for research 
purposes within our institution. You are also allowing the University of Pennsylvania to 
disclose that personal health information to outside organizations or people involved with 
the operations of this study. If you have any questions or there is something you do not 
understand, please ask. You will receive a copy of this consent form. 
 
________________________________________ __________________ 
Signature of Participant Date 
 
________________________________________ __________________ 
Print Name of Participant Date 
 
________________________________________ __________________ 
Signature of Investigator  Date 
 
________________________________________ __________________ 
Print Name of Investigator Date 
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APPENDIX Q. UNIVERSITY OF PENNSYLVANIA INFORMED CONSENT 
AND HIPAA AUTHORIZATION FORM (STROKE SURVIVORS) 
 
 
Title of the Research Study: The effect of early uncertainty on caregiver stress and 
psychological outcomes: The case of stroke survivor caregivers 
Protocol Number: 813927 
Principal Investigator: Lois K. Evans, PhD, RN, FAAN, 
van Ameringen Professor in Nursing Excellence, University of Pennsylvania School of 
Nursing, 418 Curie Boulevard, Room 419, Philadelphia PA 19104-4217, Telephone: 215-
898-2140. Email: evans@nursing.upenn.edu 
Co-investigator: Eeeseung Byun, MSN, RN, ACNP-BC, Doctoral Student, University of 
Pennsylvania School of Nursing, 418 Curie Boulevard, Room 310H, Philadelphia, PA, 
19104-4217, Telephone: 215-746-4454. Email: eeeseung@nursing.upenn.edu 
Emergency Contact: Eeeseung Byun, MSN, RN, ACNP-BC, Telephone: 215-746-4454. 
Email: eeeseung@nursing.upenn.edu 
 
 
You are being asked help with a research study by allowing us to see your hospital 
medical record information. This is not a form of treatment or therapy. It is not supposed 
to detect a disease or find something wrong. Your agreement is voluntary which means 
you can choose whether or not to allow us to see your hospital medical record. If you 
decide not to allow us to see your hospital medical record, there will be no loss of 
benefits to which you are otherwise entitled. Before you make a decision you will need to 
know the purpose of the research study, the possible risks and benefits of sharing your 
hospital medical record information and what you will have to do if you agree. The 
researcher is going to talk with you about the study and give you this consent form to 
read. You do not have to make a decision now; you can keep the consent form 
and discuss it with your family, friends and health care providers. 
 
If you do not understand what you are reading, do not sign it. Please ask the researcher to 
explain anything you do not understand, including any language contained in this form. If 
you decide allow us to use your hospital medical record information, you will be asked to 
sign this form and a copy will be given to you. Keep this form; in it you will find contact 
information and answers to questions about the study. You may ask to have this form 
read to you. 
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What is the purpose of the study? 
 
The purpose of the study is to learn more about the experience of caregivers of older 
adults with stroke in the first 6 weeks of caregiving. This is a doctoral dissertation study 
being conducted at the School of Nursing, University of Pennsylvania. 
 
Why was I asked to participate in the study? 
 
You are being asked to allow us to see your hospital medical record because (a) your 
family or friend caregiver is participating in the study, (b) you have been diagnosed with 
new or recurrent stroke, (c) you are within the first 2 weeks after having had the stroke, 
(d) you are age 65 or older, and (e) you can communicate in English. 
 
How long will I be in the study? How many other people will be in the study? 
 
The entire study is expected to be completed within one year. Your agreement to allow us 
to review your hospital medical record will be a one time to get information about your 
health, the type of stroke you have had and the severity of your stroke. 
 
You will be one of 230 participants (115 caregivers and 115 stroke survivors) in the study. 
 
Where will the study take place? 
 
If you agree, the researcher will review your hospital medical record at the hospital. 
 
What will I be asked to do? 
 
You will not be asked to do anything. The researcher will review your hospital medical 
record to get selected information about your health, type of stroke and severity of stroke. 
 
What are the risks? 
 
No major risks are anticipated from this study. 
 
The form onto which the information from your hospital medical record is written and the 
computerized file will be handled and processed in a way to protect your privacy and 
confidentiality. An identification code number will be assigned to your caregiver who is 
participating in the study, and will be used to identify all the information including the 
information from your hospital medical record. No personal names will be attached in 
order to prevent your identification. To ensure confidentiality, all research information 
will be kept in a locked filing cabinet in a secure area at University of Pennsylvania 
School of Nursing and only the investigator will be allowed to access the information. In 
addition, all computerized information will be stored using a special secure tool for 
research studies. No individual identifying information will be shared in scientific 
presentations or published papers in which study results are presented. 
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How will I benefit from the study? 
 
There is no benefit to you. Your agreement to allow us see your hospital medical record 
could help us understand the caregiving experience for older adults with stroke, however, 
which can benefit you indirectly. This study will guide future research and promote 
improved clinical practice and education for caregivers of stroke survivors. You may feel 
satisfaction from having had the opportunity to participate in the study and contribute to 
increased knowledge in science. 
 
What other choices do I have? 
 
Your alternative to agreeing to allow the researcher to review your hospital medical 
record is to not agree. 
 
What happens if I do not choose to join the research study? 
 
You may choose to allow the researcher to review your hospital medical record or you 
may choose not to. Your participation is voluntary. 
 
If you choose not to allow the researcher to review your hospital medical record, you will 
lose no benefits or advantages that are now coming to you, or would come to you in the 
future, nor will it affect the care you receive at the hospital. Your health care providers 
will not be upset with your decision. 
 
When is the study over? Can I leave the study before it ends? 
 
Your hospital medical record will be reviewed only once while you are still in the 
hospital to get information about your health, the type of stroke you have had and the 
severity of your stroke. No further information regarding your medical condition will be 
collected. The entire study with 230 participants (115 caregivers and 115 stroke 
survivors) is expected to end after all the information from caregivers and the stroke 
survivors for whom they care has been collected. The study may be stopped at any time 
without consent of the caregiver participants by the researchers, the sponsor or the Office 
of Regulatory Affairs at the University of Pennsylvania. 
 
You have the right to ask that your hospital medical record information be removed from 
the research study at any time during your caregiver participation. There is no loss of 
benefits to which you are otherwise entitled if you decide to do so. Withdrawal will not 
interfere with your future care. 
 
If you no longer wish your hospital medical record information to be included in the 
study, please contact Eeeseung Byun at 215-746-4454 and talk with her directly or leave 
a message regarding your wish. 
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How will confidentiality be maintained and my privacy be protected? 
 
The research team will make every effort to keep all the information we review from 
your hospital medical record for this study strictly confidential, as required by law. The 
Institutional Review Board (IRB) at the University of Pennsylvania is responsible for 
protecting the rights and welfare of research volunteers like you. The IRB has access to 
study information. Any forms you sign where you can be identified by name will be kept 
in a locked drawer in secure area at the University of Pennsylvania School of Nursing. 
These forms will be kept confidential. All of these forms will be destroyed when the 
study is over. 
 
Will I have to pay for anything? 
 
There are no costs associated with allowing the researcher to review your hospital 
medical record. 
 
Will I be paid for being in this study? 
 
Your caregiver who is participating in the study will receive a gift card for each of the 
two times s/he is interviewed. 
 
Who can see or use my information? How will my personal information be 
protected? 
 
A federal regulation known as the Privacy Rule gives you certain rights concerning the 
privacy of your health information. The Privacy Rule was issued under a law called the 
Health Insurance Portability and Accountability Act of 1996 (HIPAA). Researchers 
covered by this regulation are required to get your permission to use and share with 
others any health information that could identify you. If you sign this informed consent 
form, you are giving permission for the use and disclosure of your health information for 
purposes of this research study. You do not have to give this permission. We will do our 
best to make sure that the personal information from your hospital medical record will be 
kept private. However, we cannot guarantee total privacy. Your personal information 
may be given out if required by law. If information from this study is published or 
presented at scientific meetings, your name and other personal information will not be 
used. 
 
What information about me may be collected, used or shared with others? 
 
The study team will record the information regarding your health, type and severity of 
stroke on study forms. Your name will not appear on the study forms. Instead, subject 
identification number assigned to your caregiver will be written on your forms. 
Representatives from the groups identified below may need to look at your hospital 
medical records to make sure that the information on the study forms is correct or that the 
study was conducted properly. Reviews like that will take place at the study center or  
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where the hospital medical records are stored and can take place after the study is over. 
 
Why is my information being used? 
 
Your information will be used to: 
 do the research 
 oversee the research 
 to see if the research was done right. 
 
Who may use and share information about me? 
 
The following individuals may use or share your information for this research study: 
 The principal investigator (researcher) for the study and her faculty mentor 
 Other authorized personnel at University of Pennsylvania 
 
Who, outside of the School of Medicine, might receive my information? 
 
Your personal health information may be shared with the following people or groups: 
 University of Pennsylvania School of Nursing 
 The institutional review board (ethics committee) that approved this study and 
any other committees responsible for overseeing the research 
 Government health agencies in the US or other countries. 
 
Representatives from these groups may receive information from your caregiver’s study 
forms or may review your medical records (as described above) or both. Once your 
personal health information is disclosed to others outside the School of Medicine, it may 
no longer be covered by federal privacy protection regulations. The Principal Investigator 
or study staff will inform you if there are any additions to the list above during your 
active participation in the trial. Any additions will be subject to University of 
Pennsylvania procedures developed to protect your privacy. 
 
How long may the School of Medicine use or disclose my personal health 
information? 
 
Your authorization for use of your personal health information for this specific study 
does not expire. Your personal health information may be held in a research database. 
However, the School of Medicine may not re-use or re-disclose information collected in 
this study for a purpose other than this study unless: 
 You have given written authorization 
 The University of Pennsylvania’s Institutional Review Board grants 
permission 
 As permitted by law 
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Can I change my mind about giving permission for use of my information? 
 
Yes. You may withdraw or take away your permission to disclose and use your health 
information. You do this by contacting Eeeseung Byun at 215-746-4454 and talking with 
her directly or leaving a message regarding your wish to voluntarily withdraw from the 
study. If you withdraw your permission, your information will not be used. 
 
What if I decide not to give permission to use and give out my health information? 
 
You will be given a copy of this Research Subject HIPAA Authorization describing your 
confidentiality and privacy rights for this study. By signing this document you are 
permitting the School of Nursing to use and disclose personal health information 
collected about you for research purposes as described above. 
 
How will confidentiality be maintained and my privacy be protected? 
 
The researcher will make every effort to keep all the information you give us during the 
study strictly confidential, as required by law. The Institutional Review Board (IRB) at 
the University of Pennsylvania is responsible for protecting the rights and welfare of 
research volunteers. Your personal information may be shared with others if required by 
law. The IRB has access to study information. 
 
Since this is a study about your caregiver, we will assign an identification number to your 
caregiver when consents are obtained. All related data we collect about you from your 
hospital medical record will carry that code rather than your name, social security number 
or hospital record number. The researcher who collects the information will have access 
to private information about you as an individual. All information will be stored in a 
locked office in a locked cabinet. Any forms you sign where you can be identified by 
name will be kept in a locked drawer in a locked office. These forms will be kept 
confidential. All the documents will be destroyed when the study is over. 
 
Who can I call with questions, complaints or if I’m concerned about my rights as a 
research subject? 
 
If you have questions, concerns or complaints regarding sharing your personal 
information as part of this research study or if you have any questions about your rights 
in sharing such information, you should speak with the Principal Investigator listed on the 
first page of this form. If she or the researcher cannot be reached or you want to talk to 
someone other than those working on the study, you may contact the Office of 
Regulatory Affairs with any question, concerns or complaints at the University of 
Pennsylvania by calling (215) 898-2614. 
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When you sign this form, you are agreeing to allow us to see your hospital medical 
record. This means that you have read the consent form, your questions have been 
answered, and you have decided to volunteer. Your signature also means that you are 
permitting the University of Pennsylvania to use your personal health information 
collected about you for research purposes within our institution. You are also allowing 
the University of Pennsylvania to disclose that personal health information to outside 
organizations or people involved with the operations of this study. If you have any 
questions or there is something you do not understand, please ask. You will receive a 
copy of this consent form. 
 
________________________________________ __________________ 
Signature of Participant Date 
 
________________________________________ __________________ 
Print Name of Participant Date 
 
________________________________________ __________________ 
Signature of Surrogate  Date 
If surrogate signs this form 
 
________________________________________ __________________ 
Print Name of Surrogate Date 
If surrogate signs this form 
 
________________________________________ __________________ 
Signature of Investigator  Date 
 
________________________________________ __________________ 
Print Name of Investigator Date 
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APPENDIX R. PATIENT AGREEMENT FORM 
AGREEMENT TO PARTICIPATE IN RESEARCH 
 [Experience of caregivers for older adults with stroke] 
My name is Eeeseung Byun. I am a graduate student at the School of Nursing, University 
of Pennsylvania. I am studying the experience of caregivers for older adults with stroke. 
 
I am talking with you today because I am trying to learn more about the experience of 
caregivers for older adults with stroke in the first 6 weeks of caregiving, and your 
family/friend caregiver has agreed to be a join in this study. 
 
If you agree, I will see your hospital medical record to get information about your health, 
the type of stroke you have had, and severity of the stroke. You will not need to do 
anything. 
 
No major risks are expected from your allowing me to look at your hospital medical 
record as part of this study. 
 
The form onto which the information from your hospital medical record will be written 
and the computerized research file will be handled and kept safely in a way to protect 
your privacy. 
 
There is no benefit to you. Having being able to use your health information could help 
us understand the caregiving experience for older adults with stroke, however, which can 
benefit you indirectly. 
 
Please talk this over with your family, friend or health care providers before you decide 
whether or not to agree. We will also ask your family or friend to give their permission to 
allow us to look at your hospital medical record. But even if your family or friend says 
“yes,” you can still decide not to allow it. 
 
If you don’t want your medical record information to be used in this study, you do not 
have to agree. Remember, sharing this information is up to you and no one will be mad if 
you don’t want to participate or even if you change your mind later and want to stop. 
 
You can ask any questions that you have about this study. If you have a question later 
that you didn’t think of now, you can call me (215-746-4454) or ask me the next time you 
see me. 
 
Signing your name below means that you agree to for your hospital medical record 
information to be used in this study. You and your family or friend caregiver will be 
given a copy of this form after you sign it. 
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________________________________________ __________________ 
Signature of Participant Date 
 
________________________________________ __________________ 
Print Name of Participant Date 
 
________________________________________ __________________ 
Signature of Investigator  Date 
 
________________________________________ __________________ 
Print Name of Investigator Date 
 
 
 
Contact Information: Eeeseung Byun, MSN, RN, ACNP-BC, Doctoral Student, 
University of Pennsylvania School of Nursing, 418 Curie Boulevard, Room 310H, 
Philadelphia, PA, 19104-4217, Telephone: 215-746-4454. Email: 
eeeseung@nursing.upenn.edu 
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APPENDIX S. THOMAS JEFFERSON UNIVERSITY INFORMED CONSENT 
DOCUMENT FOR HUMAN-SUBJECTS RESEARCH (CAREGIVERS) 
 
Department:  Nursing         
 
Principal Investigator: Meg Bourbonniere, PhD, RN                                                  
Telephone: 215-503-6122                                                                                        
 
Co-Investigator(s): Lois Evans, PhD, RN, FAAN                                                     
Telephone: 215-898-2140                                                                                                
Co-Investigator(s):  Eeeseung Byun, PhD(c), MSN, RN, ACNP-BC                                 
Telephone: 215-746-4454                                                                                                  
   
Nursing Study Title: The effect of early uncertainty on caregiver stress and 
psychological outcomes: The case of stroke survivor caregivers     
 
Lay Study Title: Experience of Caregivers for Older Adults with Stroke   
 
 
What Is Informed Consent? 
 
You are being asked to take part in a nursing research study. As required by federal 
regulations, this research study has been reviewed and approved by an Institutional 
Review Board (IRB), a University committee that reviews, approves and monitors 
research involving humans. Before you can make a knowledgeable decision about 
whether to participate, you should understand the possible risks and benefits related to 
this study. This process of learning and thinking about a study before you make a 
decision is known as informed consent and includes: 
 
 Receiving detailed information about this research study; 
 Being asked to read, sign and date this consent form, once you understand the 
study and have decided to participate. If you don’t understand something 
about the study or if you have questions, you should ask for an explanation 
before signing this form; 
 Being given a copy of the signed and dated consent form to keep for your own 
records. 
 
What is the purpose of this study? 
 
The purpose of the study is to learn more about the feelings and experiences of caregivers 
of older adults with stroke in the first 6 weeks of caregiving. The study is a doctoral 
dissertation in the School of Nursing, University of Pennsylvania. 
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Why was I asked to participate in the study? 
 
You are being asked to join this study because you (a) are a family member or friend of 
an older adult (age 65 or older) who was diagnosed with new or another stroke within the 
past 2 weeks, (b) expect to be the primary caregiver for this older adult with stroke, 
(c) can communicate in English, (d) are able to demonstrate an understanding of the 
informed consent and (e) are age 21or older. 
 
How many individuals will participate in the study and how long will the study last? 
 
230 participants (115 caregivers and 115 stroke survivors) from the Thomas Jefferson 
University Hospitals and University of Pennsylvania Health System will participate in the 
study. We hope to enroll at least 130 participants (65 caregivers and 65 stroke survivors) 
at Jefferson. Your involvement in the study will last about 6 weeks. The entire study will 
take about 12 months to complete. 
 
What will I have to do during the study? 
 
You will be asked to respond to questions asked by the researcher who will read the 
questions aloud and record your answers. You will be given a written copy of the 
questions to view at the same time. This will take about 40–50 minutes for the first 
interview and 30–40 minutes for the second interview. The interview questions include 
information about you (for example, your age, sex, education, caregiving experience); 
questions about your feelings of uncertainty, stress, depression and caregiving burden, as 
well as your quality of life, health, ways of coping, and social support. You will be also 
asked about your older adults’ functional status and characteristics (for example, age, sex, 
education). If any of the information is missing, you will be re-contacted by the 
investigator over the phone in an attempt to complete the information. 
 
You will also be asked to collect your saliva (spit) to assess your biologic stress by 
measuring a substance in saliva (salivary cortisol) using a sponge that you will place in 
your mouth for one minute twice in the same day: 1) within 2 weeks after stroke and 2) 4 
weeks after the first interview. Collecting each saliva sample will take up to 5 minutes. 
You will place the samples in a plastic bag and keep them in your freezer overnight. The 
researcher will pick up the saliva samples or you will place the bag in a pre-paid FedEx 
clinical envelope and mail it to the researcher. 
 
What are the risks or discomforts involved? 
 
No major risks are expected from this study. You may become tired while answering the 
interview questions or you may feel upset discussing your experience in taking care of 
your older adult family member/friend with a stroke. If you become tired, you may stop 
and complete the interview later. If you experience uncomfortable feelings and upset 
during the interview, you may take a break in the interview. The investigator is prepared 
to be sensitive and respectful if you decide not to participate or not to answer some of the 
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questions. You may withdraw from the study at any time. You will not be asked to 
answer any questions that you do not wish to answer. To protect your privacy, a quiet 
place will be provided for an interview that is held in the hospital or another healthcare 
facility, with permission of the facility. 
 
If you feel severely distressed during the interview at the hospital, and if you agree, the 
investigator will contact a hospital-based psychiatric counseling service for your 
assistance. If you should develop this response during the interview at your home or other 
location, the investigator will help you contact emergency psychiatric services for your 
assistance. 
 
Are there alternatives to being in the study? 
 
Your alternative to being in the study is to not be in the study. 
 
How will privacy and confidentiality (identity) be protected? 
 
All information including completed interview results and coded computerized 
information will be cared for in a manner to protect your privacy and confidentiality. An 
identification code number will be assigned to you, and will be used to identify all the 
information you provide so that your name will not be placed at risk for identification. To 
ensure confidentiality, all research information will be kept in a locked filing cabinet in a 
secure area at the University of Pennsylvania School of Nursing and only the researchers 
will be allowed to see your personal data. In addition, all information in computerized 
files will be stored using a special protection program specifically for research studies. 
No individual identifying information will be made public in any presentations or 
publications of the results of this study. 
 
The researcher will make every effort to keep all the information you share during the 
study strictly confidential, as required by law. The Institutional Review Board (IRB) is 
responsible for protecting the rights and welfare of research volunteers like you. The IRB 
has access to study information. Any forms you sign where you can be identified by 
name will be kept separate from your questionnaires in a locked drawer in a safe area at 
the University of Pennsylvania School of Nursing. These forms will be kept confidential. 
All these forms will be destroyed when the study is over. 
 
The information from this study may be published in scientific journals or presented at 
scientific meetings but you will not be personally identified in these publications and 
presentations. 
 
Will I benefit from being in this study? 
 
There is no benefit to you. Your participation could help us understand the caregiving 
experience for older family members or friends with stroke, however, which can benefit 
you indirectly. We hope this study will guide future research and promote improved  
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clinical practice and education for caregivers of stroke survivors. You may feel  
satisfaction from having had the opportunity to participate in the study and contribute to  
increased knowledge in science. 
 
Will I be paid for being in this study? 
 
You will receive a $10 gift card upon completion of the quantitative interview and 
collection of saliva samples for each of two times: 1) within 2 weeks after stroke and 2) 4 
weeks after the first interview (a total maximum value of $20). 
 
Will I be told about any new findings? 
 
You will not receive the study results or other data about the study. However, this study 
will guide future research and promote improved clinical practice and education for 
caregivers of stroke survivors. 
 
Are there costs related to being in this study? 
 
There are no costs associated with participating in the study. 
 
Can I be removed from the study or quit the study? 
 
Your decision to participate in this research study is entirely voluntary. You have been 
told what being in this study will involve, including the possible risks and benefits. 
 
Your participation in this research project may be terminated by the researcher for any 
reason. 
 
You may refuse to participate in this investigation or withdraw consent and quit this 
study without penalty and without affecting the care for your older family member or 
friend with stroke at the Thomas Jefferson University. His or her health care providers 
will not be upset with your decision either way. If you no longer wish to be in the 
research study, please contact Eeeseung Byun at 215-746-4454 (or Dr. Meg 
Bourbonniere at 215-503-6122) and talk with her directly or leave a message regarding 
your wish to voluntarily withdraw from the study. 
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CONTACT INFORMATION 
 
Telephone number for questions 
about your rights as a research 
participant 
The Jefferson Institutional 
Review Board 
215-503-8966 
For questions, concerns or 
complaints about the research, or 
if you suspect a research-related 
injury 
The Principal Investigator, 
Dr. Meg Bourbonniere 
Co-investigators, 
Dr. Lois Evans 
Eeeseung Byun 
 
215-503-6122 
 
215-898-2140 
215-746-4454 
If you have difficulty contacting 
the study staff 
Call the Jefferson Office of 
Human Research 
215-503-0203 
 
If you want more information about the Jefferson Institutional Review Board or 
Jefferson’s Human Research Protection Program, please visit our website at 
http://www.jefferson.edu/human_research/irb/index.cfm. 
 
Non-Waiver of Legal Rights Statement 
 
By your agreement to participate in this study, and by signing this consent form, 
you are not waiving any of your legal rights. 
 
In order to be in this research study, you must sign this consent form. 
 
You affirm that you have read this consent form. You have been told that you will 
receive a copy. 
Signatures: 
 
________________________________________ __________________ 
Your Name (Please print or type) Date 
 
________________________________________ __________________ 
Your Signature  Date 
 
________________________________________ __________________ 
Name of Person Conducting Consent Interview Date 
 
________________________________________ __________________ 
Signature of Person Conducting Consent Interview Date 
 
______________________________________ __________________ 
Signature of Principal Investigator or Co-Investigator Date 
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APPENDIX T. THOMAS JEFFERSON UNIVERSITY INFORMED CONSENT 
DOCUMENT FOR HUMAN-SUBJECTS RESEARCH (STROKE SURVIVORS) 
 
Department:  Nursing         
 
Principal Investigator: Meg Bourbonniere, PhD, RN                                                  
Telephone: 215-503-6122                                                                                        
 
Co-Investigator(s): Lois Evans, PhD, RN, FAAN                                                     
Telephone: 215-898-2140                                                                                                
Co-Investigator(s):  Eeeseung Byun, PhD(c), MSN, RN, ACNP-BC                                 
Telephone: 215-746-4454                                                                                                  
   
Nursing Study Title: The effect of early uncertainty on caregiver stress and 
psychological outcomes: The case of stroke survivor caregivers     
 
Lay Study Title: Experience of Caregivers for Older Adults with Stroke   
 
 
What Is Informed Consent? 
 
You are being asked to take part in a nursing research study. As required by federal 
regulations, this research study has been reviewed and approved by an Institutional 
Review Board (IRB), a University committee that reviews, approves and monitors 
research involving humans. Before you can make a knowledgeable decision about 
whether to participate, you should understand the possible risks and benefits related to 
this study. This process of learning and thinking about a study before you make a 
decision is known as informed consent and includes: 
 
 Receiving detailed information about this research study; 
 Being asked to read, sign and date this consent form, once you understand the 
study and have decided to participate. If you don’t understand something 
about the study or if you have questions, you should ask for an explanation 
before signing this form; 
 Being given a copy of the signed and dated consent form to keep for your own 
records. 
 
What is the purpose of this study? 
 
The purpose of the study is to learn more about the feelings and experiences of caregivers 
of older adults with stroke in the first 6 weeks of caregiving. The study is a doctoral 
dissertation in the School of Nursing, University of Pennsylvania. 
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Why was I asked to participate in the study? 
 
You are being asked to allow us to see your hospital medical record because (a) your 
family or friend caregiver is participating in the study, (b) you have been diagnosed with 
new or another stroke, (c) you are within the first 2 weeks after having had the stroke, (d) 
you are age 65 or older, and (e) you can communicate in English. 
 
How many individuals will participate in the study and how long will the study last? 
 
230 participants (115 caregivers and 115 stroke survivors) from the Thomas Jefferson 
University Hospitals and University of Pennsylvania Health System will participate in the 
study. We hope to enroll at least 130 participants (65 caregivers and 65 stroke survivors) 
at Jefferson. Your involvement in the study will last about 6 weeks. The entire study will 
take about 12 months to complete. 
 
What will I have to do during the study? 
 
You will not be asked to do anything. The researcher will review your hospital medical 
record to get selected information about your health, type of stroke and severity of stroke. 
 
What are the risks or discomforts involved? 
 
No major risks are anticipated from this study. 
 
Are there alternatives to being in the study? 
 
Your alternative to agreeing to allow the researcher to review your hospital medical 
record is to not agree. 
 
How will privacy and confidentiality (identity) be protected? 
 
The form onto which the information from your hospital medical record is written and the 
computerized file will be handled and processed in a way to protect your privacy and 
confidentiality. An identification code number will be assigned to your caregiver who is 
participating in the study, and will be used to identify all the information including the 
information from your hospital medical record. No personal names will be attached in 
order to prevent your identification. To ensure confidentiality, all research information 
will be kept in a locked filing cabinet in a secure area at University of Pennsylvania 
School of Nursing and only the investigator will be allowed to access the information. In 
addition, all computerized information will be stored using a special secure program for 
research studies. No individual identifying information will be shared in scientific 
presentations or published papers in which study results are presented. 
 
Federal regulations require that certain information about individuals be kept confidential. 
This information is called “protected health information” (PHI). PHI includes 
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information that identifies you personally such as name, address and social security 
number, or any medical or mental health record, or test result, that may have this sort of 
information on it. The laws state that you may see and review your TJU or Thomas 
Jefferson University Hospital medical records at any time. 
If you sign this informed consent form, you are giving permission for the use and 
disclosure of your PHI for purposes of this research study. You do not have to give this 
permission. The following individuals or entities may have access to your PHI and by 
law must protect it. These include investigators listed on this consent form and other 
personnel of Thomas Jefferson University and Thomas Jefferson University Hospitals, 
Inc. involved in this specific study, the University’s Division of Human Subjects 
Protection and the Institutional Review Board (IRB). It may also be provided to other 
people or groups as follows: 
 
 Authorized personnel at University of Pennsylvania. 
 
Your PHI may also be shared with the following entities that, while not obligated by law 
to protect PHI, will protect it to the best of their ability: 
 
 University of Pennsylvania School of Nursing 
 University of Pennsylvania Institutional review board (ethics committee) that 
approved this study and any other committees responsible for overseeing the 
research 
 Government health agencies in the US or other countries 
 Any person or agency required by law. 
 
The following information will be provided to the study sponsor and other entities noted 
above: 
 
Your health, the type of stroke you have had and the severity of your stroke. 
The information from this study may be published in scientific journals or presented at 
scientific meetings but you will not be personally identified in these publications and 
presentations. 
 
You may withdraw or take away your permission to disclose and use your PHI. You do 
this by contacting Eeeseung Byun at 215-746-4454 (or Dr. Meg Bourbonniere at 215-
503-6122) and talking with her directly or leaving a message regarding your wish to 
voluntarily withdraw from the study. If you withdraw your permission, your information 
will not be used. 
 
Will I benefit from being in this study? 
 
There is no benefit to you. Your agreement to allow us see your hospital medical record 
could help us understand the caregiving experience for older adults with stroke, however, 
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which can benefit you indirectly. We hope this study will guide future research and 
promote improved clinical practice and education for caregivers of stroke survivors. You 
may feel satisfaction from having had the opportunity to participate in the study and 
contribute to increased knowledge in science. 
 
Will I be paid for being in this study? 
 
Your caregiver who is participating in the study will receive a gift card for each of the 
two times s/he is interviewed. 
 
Will I be told about any new findings? 
 
You will not receive the study results or other data about the study. However, this study 
will guide future research and promote improved clinical practice and education for 
caregivers of stroke survivors. 
 
Are there costs related to being in this study? 
 
There are no costs associated with participating in the study. 
 
Can I be removed from the study or quit the study? 
 
You may choose to allow the researcher to review your hospital medical record or you 
may choose not to. Your participation is voluntary. 
 
If you choose not to allow the researcher to review your hospital medical record, you will 
lose no benefits or advantages that are now coming to you, or would come to you in the 
future, nor will it affect the care you receive at the hospital. Your health care providers 
will not be upset with your decision. 
 
You may withdraw or take away your permission to disclose and use your hospital record 
by contacting Eeeseung Byun at 215-746-4454 (or Dr. Meg Bourbonniere at 215-503-
6122) and talking with her directly or leaving a message regarding your wish to 
voluntarily withdraw from the study. 
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CONTACT INFORMATION 
 
Telephone number for questions 
about your rights as a research 
participant 
The Jefferson Institutional 
Review Board 
215-503-8966 
For questions, concerns or 
complaints about the research, or 
if you suspect a research-related 
injury 
The Principal Investigator, 
Dr. Meg Bourbonniere 
Co-investigators, 
Dr. Lois Evans 
Eeeseung Byun 
 
215-503-6122 
 
215-898-2140 
215-746-4454 
If you have difficulty contacting 
the study staff 
Call the Jefferson Office of 
Human Research 
215-503-0203 
 
If you want more information about the Jefferson Institutional Review Board or 
Jefferson’s Human Research Protection Program, please visit our website at 
http://www.jefferson.edu/human_research/irb/index.cfm. 
 
Non-Waiver of Legal Rights Statement 
 
By your agreement to participate in this study, and by signing this consent form, 
you are not waiving any of your legal rights. 
 
In order to be in this research study, you must sign this consent form. 
 
You affirm that you have read this consent form. You have been told that you will 
receive a copy. 
Signatures: 
 
________________________________________ __________________ 
Your Name (Please print or type) Date 
 
________________________________________ __________________ 
Your Signature  Date 
 
________________________________________ __________________ 
Name of Person Conducting Consent Interview Date 
 
________________________________________ __________________ 
Signature of Person Conducting Consent Interview Date 
 
________________________________________ __________________ 
Signature of Principal Investigator or Co-Investigator Date 
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APPENDIX U. THOMAS JEFFERSON UNIVERSITY SURROGATE CONSENT 
FOR A RESEARCH PROTOCOL 
Department:  Nursing         
 
Principal Investigator: Meg Bourbonniere, PhD, RN                                                  
Telephone: 215-503-6122                                                                                        
 
Co-Investigator(s): Lois Evans, PhD, RN, FAAN                                                     
Telephone: 215-898-2140                                                                                                
Co-Investigator(s):  Eeeseung Byun, PhD(c), MSN, RN, ACNP-BC                                 
Telephone: 215-746-4454                                                                                                  
   
Nursing Study Title: The effect of early uncertainty on caregiver stress and 
psychological outcomes: The case of stroke survivor caregivers     
 
Lay Study Title: Experience of Caregivers for Older Adults with Stroke   
 
Name of Subject: ____________________________________________________________________________ 
 
COMPLETE SECTIONS “A,” “B” AND “C” BELOW. 
 
A. REASON FOR SURROGATE CONSENT: 
 
______ The subject is unable to give informed consent. 
 
 Reason for Subject’s Inability To Give Informed Consent:1 
_______________________________________________________________
_______________________________________________________________ 
 
B. SURROGATE INFORMATION: 
 
______ COURT ORDER AUTHORIZING GUARDIAN CONSENT 
 
Date of Order: ___________  Name of Guardian: _______________________________ 
 
______ POWER OF ATTORNEY  Name: ___________________________________ 
 
 
                                                 
1 Examples of evidence to consider include indications in the medical record concerning whether the subject was 
oriented times three, whether the subject was alert and communicating with others, whether the subject was able to 
write messages on paper, and whether the subject was able to adequately respond to questioning regarding his or her 
participation in the research.  Other considerations include the subject’s baseline cognitive status and the administration 
of medications that might impair mental capacity. 
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______ SPOUSE   Name: _______________________________________________ 
 
______ PARENT   Name: _______________________________________________ 
 
______ ADULT CHILD   Name: _________________________________________ 
 
______ ADULT BROTHER/SISTER Name: ______________________________ 
 
______ OTHER ADULT RELATIVE Name:______________________________                 
                                                                        Relationship:_________________________ 
 
C. PATIENT’S ASSENT TO PARTICIPATE: 
 
______ The subject’s assent to inclusion in the study was sought and obtained. 
 
______ The subject’s assent to inclusion in the study was sought and denied. 
 
______ The subject’s assent was not sought. 
 
 Reason for Subject’s Inability to 
Assent:_________________________________________________________ 
_______________________________________________________________
_______________________________________________________________ 
 
 
Signatures: 
 
————————————————(Date) 
Surrogate’s Signature 
 
 
————————————————(Date) 
Name of Person Conducting Consent Interview 
 
 
————————————————(Date) 
Signature of Person Conducting Consent Interview 
 
 
————————————————(Date) 
Signature of Principal Investigator or 
Co-Investigator 
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APPENDIX V. RECRUITMENT SCRIPT 
Hello, my name is ____, and I am a nurse here at the University of Pennsylvania. I am 
also a PhD student in the School of Nursing (I am Research Assistant in the School of 
Nursing). I am working with Dr. XX and the nurses here on the unit, and we are worried 
about the amount of stress that families have/experience when their loved one has had a 
stroke. So our project is to learn more about family caregiver stress. 
Could I talk with you for a few minutes now about the project? [If this is not a good time 
for you, would you mind my coming back later? etc….]. 
The study is about feelings and experiences when taking care of, or helping care for, an 
older family member in the first few weeks after stroke, when they first begin to provide 
care for their loved ones. 
I am going to give you a general picture of the study. There are several survey questions 
that I will ask you or read to you. Answering the questions will take a maximum of 40–50 
minutes. Questions are related to how members of the family feel and what they 
experience from their caregiving. 
The next day after the interview, we will ask you collect your saliva on a cotton sponge 
that we will provide and collect from you. The saliva will be used to measure the stress 
level of family caregivers. Then, one month later, we will meet with you for the second 
interview and again ask you to collect your saliva. 
Let me explain how to collect your salvia. You will collect saliva after waking up and 
then around 9 pm before you go to bed. Basically, each time you will put a cotton sponge 
under your tongue for a minute, take it out and place it in the tube we will give you, and 
then keep it in a plastic bag in your freezer overnight. The research team will pick up the 
two tubes or arrange a time and place to pick them up from you. We provide a $10 gift 
certificate for the first interview and saliva collection and another $10 one month later for 
the second interview and saliva collection. 
Would you like to participate in this study? 
{If the person indicates that they do not wish to collect saliva}: If you are not 
comfortable collecting your saliva, we can do only the survey questions. Would you be 
able to do only the survey questions? {If the person indicates they are too busy to meet us 
for the second interview}: If you are too busy to meet for the second interview, we can 
give you a copy of the survey questions to take home and then we can do the second 
interview over the phone while you are reading the questions and answering them at the 
same time. 
 197 
APPENDIX W. PHONE SCRIPT TEMPLATE 
Hello, my name is ____, and I am a nurse at the University of Pennsylvania. I am also a 
research assistant in the School of Nursing. I am working with Dr. Meg Bourbonniere 
and the nurses here on the unit at the Thomas Jefferson University Hospital, and we are 
interested in studying the amount of stress that families have/experience when their loved 
one has had a stroke. So our project is to learn more about family caregiver stress. 
 
Is this good time to talk with you? If you do not have time now, can I call you back later? 
 
The study is about feelings and experiences when taking care of, or helping care for, an 
older family member in the first few weeks after stroke, when they first begin to provide 
care for their loved ones. 
 
I am going to give you a general picture of the study. There are several survey questions 
that I will ask you or read to you. Answering the questions will take up to 40–50 minutes. 
Questions are related to how members of the family feel and what they experience from 
their caregiving. 
 
The next day after the interview, we will ask you collect your saliva on a cotton sponge 
that we will provide and collect from you. The saliva will be used to measure chemicals 
that indicate your stress level as a family caregiver. Then, one month later, we will meet 
with you for the second interview and again ask you to collect your saliva for a repeat of 
the test. 
 
Let me explain how to collect your salvia. You will collect saliva after waking up and 
then around 9 pm before you go to bed. Basically, each time you will put a cotton sponge 
under your tongue for a minute, take it out and place it in the tube we will give you, and 
then keep it in a plastic bag in your freezer overnight. The research team will arrange a 
time and place to pick up the saliva samples from you or you will place the bag in a pre-
paid FedEx clinical envelope and mail it to the researcher. 
 
We provide a $10 gift certificate for the first interview and saliva collection and another 
$10 one month later for the second interview and saliva collection. 
 
Your participation in this study is entirely voluntary, and you can refuse to participate or 
stop your participation at any time without penalty or loss of benefits to which you are 
otherwise entitled, and without affecting your loved one or their care at Jefferson. 
 
Would you like to participate in this study? 
 
{If the person indicates that they do not wish to collect saliva}: If you are not 
comfortable collecting your saliva, we can do only the survey questions. Would you be 
able to do only the survey questions? {If the person indicates they are too busy to meet us 
for the second interview}: If you are too busy to meet for the second interview, we can 
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give you a copy of the survey questions to take home and then we can do the second 
interview over the phone while you are reading the questions and answering them at the 
same time. 
 
(If no) Thank you for your time. I won’t call you again. 
(If yes) When would be good time for you to meet? 
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APPENDIX X. FLYER 
 
                                                         
               Care to change the world.
TM 
School of Nursing 
Claire M. Fagin Hall 
418 Curie Boulevard 
Philadelphia, PA  19104 - 4217 
       Research Study Seeks Family Caregivers 
for Older Adults with Stroke 
You May be Eligible if You: 
1. Are a family member or friend of an older adult (age 65 
or older) who had a stroke or brain hemorrhage within 
the past 2 weeks.   
2. Expect to be the primary caregiver for the older adult 
with a stroke or brain hemorrhage.  
3. Can communicate in English. 
4. Are age 21 or over. 
 
Qualified Participants will:  
1. Take part in two interviews about caregiving and collect 
samples of saliva.   
Participants will be compensated with gift cards worth up to 
$20 for their time and effort.                                                                                 
For more information about this study call 215-746-4454.  
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